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ABSTRACT 
Chemokines are chemoattractant cytokines which act on specific receptors and 
play an important role in tumour biology. The aim of this project was to determine 
whether the chemokine receptors XCRI, CXCRI and CXCR2 and their respective 
ligands lymphotactin, IL-8 (CXCRI&2) and GRO-a regulate the behaviour of 
normal and malignant oral epithelial cells. 
XCR1, CXCR1 and CXCR2 mRNA and surface protein expression was detected 
in normal and oral cancer cell lines. Lymphotactin, IL-8 and GRO-a facilitated 
intracellular activation of ERKU2 signaling pathway and stimulated migration, 
invasion and proliferation of all cells. These effects were mediated through XCR1 
for lymphotactin, CXCR1 and CXCR2 for IL-8 and CXCR2 for GRO-a. The 
cancer cells showed a greater response than normal cells and a direct relationship 
between receptor expression and migration, invasion and proliferation was 
observed. 
XCRI but not lymphotactin was expressed by epithelial cells in normal oral 
mucosa in vivo and both were expressed and up-regulated in inflammation and 
cancer. Constitutive expression of both XCRI and lymphotactin was found in 
regional lymph nodes and on metastatic tumours. 
Lymphotactin mRNA and constitutive intracellular protein was detected in 
normal and cancerous oral cells. Exposure of normal cells to lymphotactin 
resulted in increased adhesion to fibronectin but not collagen and stimulated 
MMP-2 and -9 release whereas exposure of cancer cells resulted in increased 
adhesion to both collagen and fibronectin and stimulated MMP-2,9 and MMP-7 
release. 
These findings show for the first time that XCRI and its ligand lymphotactin are 
expressed by epithelial cells in a range of oral conditions and strongly suggest that 
they play an important role in regulating the behaviour of normal and malignant 
epithelial cells. Similarly CXCR1 and CXCR2 are up-regulated on malignant oral 
cells in vitro and may be important in the biology of oral cancer. 
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Chapter I- Introduction and Literature Review 
1.1 INTRODUCTION 
Oral cancer is a significant cause of morbidity and mortality and has a worldwide 
distribution. The term 'oral' includes the lips and all other intra-oral sites 
corresponding to the ICD-10 codes (International classification of disease-version 10) 
COO-C14 (W. H. O., 1996). It is the sixth most common mortality-related cancer in the 
world and accounts for approximately 4% of all cancers and 2% of all cancer deaths 
world-wide (Kademani 2007; Parkin, Pisani, and Ferlay 1993; Parkin, Pisani, and 
Ferlay 1999). 
Since majority of oral cancers are squamous cell carcinomas (OSCC), they will be 
referred to as `oral cancer' in this thesis. Oral cancer constitutes about 2% of all 
malignant tumours in UK and USA but its incidence is variable and in India and Sri 
Lanka it rises to 40%. Approximately 30,000 new cases are registered during one 
calendar year in USA and 4,400 in UK (Cancer Research UK, 2001) (Conway et al., 
2006; Davies and Welch 2006; Johnson and Warnakulasuriya 1991; Johnson and 
Wamakulasuriya 1993; Parkin, Pisani, and Ferlay 1999). 
The aetiology of oral cancer is not entirely clear with a multitude of factors being held 
responsible, including smoking (Llewellyn et al., 2004; Llewellyn, Johnson, and 
Warnakulasuriya 2001; Warnakulasuriya, Sutherland, and Scully 2005), alcohol 
(Altieri et al., 2004; Llewellyn et al., 2004), viruses (Cox, Scully, and Maitland 1991; 
Scully, Prime, and Maitland 1985), malnutrition, betel (pan) chewing (Jacob et al., 
2004; Warnakulasuriya, Sutherland, and Scully 2005) and genetic factors (Mackenzie 
et al., 2000; Scully and Bedi 2000). 
Despite the increased knowledge of mechanisms involved in the development and 
behaviour of oral carcinoma, understanding of the underlying cellular processes is 
incomplete. The most frequent sites affected include the lower lip, tongue, floor of the 
mouth and lingual aspect of the alveolar margin. These areas constitute only about 
20% of the oral cavity but more than 70% of oral cancers are concentrated there. 
Metastasis of oral cancer is primarily to the regional lymph nodes through lymphatics. 
As most of the cancers arise in the lower part of the mouth, the sub-mandibular and 
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jugulo-digastric nodes are most commonly involved. Oral cancers spread 
preferentially down the jugular lymphatic chain and usually do not involve the supra- 
clavicular lymph nodes until a late stage. 
The precise mechanism utilized by oral cancer cells to metastasize to the submental, 
submandibular, and deep cervical lymph nodes is not known. Recent reports suggest 
that chemokines and chemokine receptors may facilitate cancer cell migration, 
proliferation and invasion. This may contribute to their ability to escape surveillance 
and may partially explain preferential patterns of metastasis to sites such as lymph 
nodes, skin and lung. 
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1.2 LITERATURE REVIEW 
1.2.1 CHEMOKINES 
Chemokines are small (8-14 kDa), structurally related molecules that regulate 
trafficking and localization of different types of leukocytes through interaction with 
specific G-protein-coupled receptors. They are structurally and functionally related to 
growth factors (Baggiolini, Dewald, and Moser 1997). Many novel chemokines and 
chemokine receptors have been identified during the last few years as a result of 
large-scale sequencing projects bringing the number up to 46 chemokine ligands and 
19 functionally signaling chemokine receptors (Zlotnik, Yoshie, and Nomiyama 
2006). 
When initially identified, these proteins were characterized by their ability to induce 
chemotaxis of leukocytes. However, it is now appreciated they have a critical role that 
extends beyond the regulation of lymphocyte development and migration. Expression 
of chemokines and their receptors has been reported in a wide range of cells 
(haematopoietic as well as non-haematopoietic) and tissues where they participate in 
many physiological and pathological processes. 
1.2.1.1 Classification 
Chemokines have been subdivided into four families on the basis of the relative 
position of their conserved two N-terminal cysteine residues (Baggiolini, Dewald, and 
Moser 1997). These include CXC (a), CC (ß), C (y), and CXXXC or CX3C (8) (Table 
1.1). In the a family, one amino acid separates the first two cysteine residues 
(cysteine-X amino acid-cysteine, or CXC). In the ß family the first two cysteine 
residues are adjacent to each other (cysteine-cysteine, or CC). Two chemokines that 
do not fit into this classification are 'lymphotactin' and fractalkine'. Lymphotactin 
contains only two cysteines (XCL1) (Keiner et al., 1994; Kennedy et al., 1995) 
whereas fractalkine has the first two cysteine residues separated by three amino acids 
(CX3CL 1) (Bazan et al., 1997). 
The genes encoding for a- chemokines cluster on chromosome 4 and are further 
subdivided into two groups. Those that contain the sequence `glutamic acid-leucine- 
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arginine' (ELR) near the N-terminal (preceding the CXC sequence) are chemotactic 
for neutrophils in addition to being potent angiogenic factors e. g. Interleukin-8 (IL-8). 
Those not containing the ELR sequence act on lymphocytes and are angiostatic e. g. 
Interferon Inducible Protein-10 (IP-10) and Monokine induced by Interferon-y (MIG) 
attract activated T lymphocytes and stromal cell-derived factor-1 (SDF-1) acts on 
resting lymphocytes (Luster 1998; Keane et al., 1998). 
The genes encoding for ß-chemokines cluster on chromosome 14 and in general, do 
not act on neutrophils but attract monocytes, eosinophils, basophils and lymphocytes 
(Luster 1998). They can be subdivided into two families; the monocyte- 
chemoattractant-protein-eotaxin family containing the five monocyte chemoattractant 
proteins and eotaxin, and all other ß-chemokines (Luster and Rothenberg 1997). 
Important members include `monocyte chemoattractant protein-1' (MCP-1), 
`macrophage inflammatory protein-la' (MIP-la), `regulated upon activation normal 
T-cell expressed and secreted' (RANTES) and eotaxin. 
Lymphotactin (LptnIXCL1) and XCL2 are the only members of the -y-(C) chemokine 
family. Lymphotactin was considered out of the ordinary upon discovery as it 
possessed a number of conserved amino acid residues present in the CXC and CC 
chemokines, including two cysteines corresponding to cysteines 2 and 4, but was 
missing cysteines 1 and 3 (Keiner et al., 1994; Kennedy et a!., 1995) (Table 1.1). 
Systematic Name Synonym Receptor(s) 
CXC Chemokines 
CXCLI Groa CXCR2 
CXCL2 Groß CXCR2 
CXCL3 Groy CXCR2 
CXCL4 PF4 CXCR3B 
CXCLS ENA-78 CXCR2 
CXCL6 GCP-2 CXCRI, CXCR2 
CXCL7 NAP-2 Unknown 
CXCLS IL-8 CXCRI, CXCR2 
CXCL9 MIG CXCR3, CXCR3B 
CXCL10 IP-10 CXCR3, CXCR3B 
CXCLII 1-TAC CXCR3, CXCR3B 
CXCLI2 SDF-1a/ß CXCR4 
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Systematic Name Synonym Receptor(s) 
CXC Chemokines 
(continued) 
CXCL13 BLC, BCA-i CXCR5 
CXCL14 BRAK, Bolekine Unknown 
CXCL16 CXCR6 
CXCLi7 DMC Unknown 
CC Chemokfnes 
CCLI 1-309 CCR8 
CCL2 MCP-1 CCR2 
CCL3 MIP-1a, LD78a CCRI, CCR5 
CCL3L1 LD-78p CCRi, CCR5 
CCL3L3 LD-78p CCRI, CCR5 
CCL4 MIP-iß CCR5 
CCL4L1 AT744.2 CCR5 
CCL4L2 CCR5 
CCL5 RANTES CCRI, CCR3, CCR5 
CCL7 MCP-3 CCRI, CCR2, CCR3 
CCL8 MCP-2 CCR1, CCR2, CCR3, CCR5 
CCLÜ Eotaxin CCR3 
CCL13 MCP-4 CCR1, CCR2, CCR3 
CCL14 HCC-1 CCRI 
CCLI5 HCC-2 CCRI, CCR3 
CCL16 HCC-4 LEC CCRI, CCR2, CCR5, 
CCL17 TARC CCR4 
CCLI8 PARC Unknown 
CCL19 MIP-30, ELC CCR7 
CCL20 MIP-3a, LARC CCR6 
CCL21 SLC CCR7 
CCL22 MDC CCR4 
CCL23 MPIF-I CCRI 
CCL24 Eotaxin 2 CCR3 
CCL25 TECK CCR9 
CCL26 Eotaxin 3 CCR3 
CCL27 CTACK, ILC CCR10 
CCL28 MEC CCRIO, CCR3 
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Systematic Name Synonym Receptor(s) 
Other Chemokines 
XCLI Lymphotactin, SCM-1a XCRi 
XCL2 SCM-10 XCRi 
CX3CL1 Fractalkine CX3CRI 
Table 1.1. Human chemokines and their receptors. 
1.2.2 CHEMOKINE RECEPTORS 
Chemokines induce cell migration and activation by binding to specific G-protein- 
coupled (seven transmembrane) cell-surface receptors on target cells (Figure 1.1). 
Migration of cells takes place down a chemokine gradient and involves changes in 
chemokine concentrations which are detected by the receptors. As a result, directional 
cell movement takes place through re-arrangements of cell cytoskeleton as well as 
interactions with the extra-cellular matrix (Sanchez-Madrid and del Pozo 1999). 
Extracellular 
Cell Membrane 
Intracellular 
NH2 
Figure I. I. Typical structure of a chemokine receptor. 
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The CXC chemokine receptors selectively bind CXC chemokines and include 
chemokine receptors CXCR1-7. The CC receptor family (CCR) currently consists of 
ten receptors, CCR1-10. Receptors for fractalkine (CX3CR1) and lymphotactin 
(XCRI) have also been identified recently. Chemokines also interact with two types 
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of non-signaling molecules. The first one is known as the 'Duffy antigen receptor for 
chemokines' (DARC) and has been known since 1950s as the determinant of Duffy 
blood groups. It is expressed on erythrocytes and endothelial cells and has been 
demonstrated to bind promiscuously to both CXC and CC chemokines (Neote et al., 
1993). The second type is a group of `Heparan sulfate proteoglycans'. Chemokines 
are basic proteins and bind avidly to negatively charged heparan and heparan sulfate. 
Together they serve to establish a local concentration gradient (Luster 1998). 
1.2.2.1 Signaling 
Chemokine receptor binding initiates a cascade of intracellular events that culminate 
in the expression of biological effects. Chemokine receptors are functionally linked to 
phospholipases through G-proteins (Bokoch 1995). Ligation of the receptor by its 
high affinity ligand induces a conformational change leading to the dissociation of the 
receptor associated G proteins into a and fry subunits. The `Bordtella Pertussis' toxin 
causes inhibition of a number of these signaling events, indicating the relationship 
between the chemokine receptors and the G proteins of the G, class. The G-protein 
subunits can then activate various effector enzymes, including phospholipases, which 
lead to inositol phosphate production, increase in intracellular Ca+2 and activation of 
protein kinases. GTP binding proteins of the Ras and Rho families are also activated 
by such signaling. This signal transduction cascade not only leads to the activation of 
chemotaxis by modulating actin-dependent cellular processes and up-regulating 
adhesion proteins, but also of a wide range of intracellular functions. 
1.2.2.2 Expression 
Chemokine receptors are expressed on different types of leukocytes. Some receptors 
are restricted to certain cells (e. g. CXCR1 and CXCR2 are usually restricted to 
neutrophils), whereas others are more widely expressed (e. g. CCR2 is expressed on 
monocytes, T cells, natural killer cells, dendritic cells and basophils). Chemokine 
receptors are constitutively expressed on some cells, whereas they are inducible on 
others. CCR1 and CCR2 are constitutively expressed on monocytes but are expressed 
on lymphocytes only after stimulation by interleukin-2 (Loetscher et al., 1996). Some 
of the constitutive chemokine receptors can be down-regulated e. g. CCR2 is down- 
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regulated by lipopolysaccharide, making the cells unresponsive to MCP-1 (Monocyte 
chemoattractant protein, which activates only this receptor), but it remains responsive 
to MIP-la (Macrophage inflammatory protein 1-a which also activates CCR1 and 
CCRS) (Sica et al., 1997). 
1.2.3 Functions of Chemokines 
Along with the accelerated rate of discovery of chemokines has come the realization 
that these molecules not only control haematopoietic cell migration, but are also 
involved in a number of other physiological and pathological processes (Table 1.2). 
Chemokine Lymphocyte effects 
C chemokines 
  Lymphotactin Specifically chemotactic for T and B lymphocytes 
C-C chemokines 
  RANTES Activation of T lymphocytes, activation of NK cells; 
chemotaxis of T lymphocytes and NK cells 
  MIP-la Chemotaxis of naive T cells, B cells and NK cells; 
Inhibition of T-cell proliferation and IL-2 production; 
activation of NK cells 
  MIP-1p Chemotaxis of naive T cells, B cells and NK cells; 
activation of NK cells 
  MCP-1 Chemotaxis of NK cells; activation of NK cells 
" MCP-2 Chemotaxis of NK cells; activation of NK cells 
  MCP-3 Chemotaxis of NK cells; activation of NK cells 
C-X-C chemokines 
  IP-10 Chemotaxis of T cells and NK cells 
  IP-9 B-cell growth and regulation; chemotaxis of T cells 
and NK cells 
  Mig Specifically chemotactic for activated T cells 
" SDF-1ß B-cell growth factor 
Table 1.2. Actions of chemokines on haematopoietic cells. 
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Chemokines and their receptors have a wide scope of functions extending from 
development of lymphocytes, maturation of dendritic cells, development of Thl/Th2 
responses, lymphoid trafficking, cell recruitment, inflammation, organogenesis and 
angiogenesis to tumour growth and metastases. Chemokines can facilitate as well as 
inhibit tumour growth and angiogenesis e. g. PF-4/CXCL-4 and IP-10 inhibit neo- 
vascularization. tumour growth and metastases (Yamaguchi el al., 2005; Sato et al., 
2007), whereas IL-8 promotes angiogenesis and metastases (Yuan ei al., 2005; 
Varney. Johansson, and Singh 2006) (Figure 1.2). 
Lymphoid 
Trafficking 
Lymphoid 
Organ 
Developmen 
Wound 
Angiogenesis 
Healing 
Chemokines 
Inflammation 
Metastasis 
)OF 
Figure 1.2. Major biological functions of chemokines. Chemokines play an important role in a 
range of physiological process including lymphoid trafficking and lymphoid organ 
development, inflammation and wound healing. They have also been shown to facilitate 
epithelial tumour growth, angiogenesis and metastasis. 
During inflammation, there is a significant increase in the selective recruitment of 
leukocytes because of increased secretion of chemokines at the site of injury. 
Chemokines have been associated with inflammation in a number of organs such as 
skin (Fierro et al., 2006; Tanaka et a!., 2006; Homey et al., 2006). Joints (Blaschke et 
al., 2003. Dai et al., 2007; Aggarwal, Agarwal, and Misra 2007), lungs (Garingo et 
al., 2007: Meyts et al., 2006), kidneys (Krensky and Ahn 2007; Durkan et al., 2007), 
gastrointestinal tract (Schmitz et a!., 2007; Yoshino et al., 2005; Bodger et al., 2001) 
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and periodontium (Silva et al., 2005). It is known now that most cells can secrete 
chemokines when provided the apt stimulus. Pro-inflammatory cytokines (IL-1, TNF, 
bacterial products) act as main stimuli for chemokine release. 
1.2.4 CHEMOKINES/CHEMOKINE RECEPTORS IN TUMOUR BIOLOGY 
Chemokines are a central part of the host defence system and facilitate directional 
movement of leukocytes in addition to performing a wide range of other physiological 
functions. It is perhaps not surprising that chemokine receptors have been exploited 
by pathogens and tumours in assisting cell entry/transmission and metastasis. 
According to some recent reports chemokines and their receptors facilitate site- 
specific metastasis. However, chemokines appear to function more than as attractants 
and the interactions between chemokines and their receptors are vital in every step of 
tumour development, including tumour growth, progression and metastasis. 
i) Tumour transformation, survival and growth 
Chemokine production by tumours may directly contribute to transformation of 
tumour cells by acting as growth and survival factors. Melanoma cells constitutively 
express the CXCR2 receptor and produce CXCLI (GRO-a) and CXCL8 (IL-8). An 
autocrine growth signal is transmitted via CXCR2 in several tumour cell types 
facilitating survival, angio-proliferation and migration of tumour cells (Tanaka et al., 
2005). Blocking either the ligands or the receptor, results in diminished tumour 
growth due to decreased autocrine stimulation by these chemokines (Dhawan and 
Richmond 2002; Luan et al., 1997). 
Chemokines can also trigger cell growth (Figure 1.9). Exposure to GRO-a and IL-8 
facilitates growth of pancreatic cell lines (Takamori et al., 2000). These cells also 
proliferate in response to the chemokine CCL20 (MIP-3a) since they express the 
CCR6 receptor (Kleeff et a!., 1999). Interactions between CXCL12 (SDF-1) and its 
receptor CXCR4 also stimulate proliferation of prostate cancer cells (Sun et al., 2003; 
Taichman et al., 2002), glioblastoma cells (Zhou et al., 2002) and malignant plasma 
cells of multiple myeloma (Alsayed et al., 2007). 
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In addition, chemokines provide survival signals to tumour cells in some instances. 
For example, SDF-la can enhance the survival of CXCR4 expressing glioma cells by 
preventing apoptosis in sub-optimal conditions, such as low serum concentration 
(Zhou et al., 2002). 
ii) Angiogenesis/Angiostasis 
Chemokines can indirectly affect tumour growth by promoting or inhibiting 
angiogenesis. CXC chemokines bearing an ELR (Glu-Leu-Arg) motif at their NH2 
terminus are angiogenic, whereas those lacking the ELR motif are angiostatic. 
Significant levels of IL-8 are observed in prostate cancer cells, but not in normal or 
benign hyperplastic cells (Ferrer et al., 1998). Anti-IL-8 antibody effectively inhibits 
the tumour-related angiogenesis of an IL-8-producing prostate cancer cell line, PC-3, 
in severe combined immunodeficiency (SCID) mice (Moore et al., 1999). 
CXCL10 (IP-10) is an angiostatic chemokine produced at high levels by human non- 
small cell lung cancer cells. In SCID mice, IP-10 production is inversely related to the 
tumour progression, and an intratumoral injection of IP-10 results in retardation of 
growth and neo-vascularization of the tumour (Arenberg et al., 1996b). 
iii) Local invasion 
The ability of tumour cells to secrete metalloproteinases (MMPs) and other protease 
enzymes aids invasiveness through the extracellular matrix (ECM) (Vihinen, la-aho, 
and Kahari 2005). IL-8 expression by human melanoma cells induces transcriptional 
activation of the gene encoding MMP-2, leading to increased invasiveness through the 
ECM (Bar-Eli 1999; Luca et al., 1997). IL-8 over-expression in prostate cancer also 
induces increased MMP-9 expression, which facilitates increased local tumour 
invasion in a mouse model (Inoue et al., 2000). 
Tumour invasion and metastasis are very important aspects of tumour biology. 
Chemokines may be important in both and this is discussed in greater detail below. 
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1.2.5 METASTASIS 
1.2.5.1 Mechanism of metastasis 
Metastasis is a complex process and involves a multitude of sequential steps. The 
clonal expansion, growth and angiogenesis of the tumour cells facilitate their adhesion 
to, and invasion of the basement membrane. After breaching the basement membrane, 
these metastatic cells traverse the extracellular matrix (ECM) by breaking it down, 
finally gaining access to the lymphatics or circulation. The same cycle is repeated 
when these tumour cells extravasate at distant sites. This enables the cancer cells to 
migrate to distant sites in the body resulting in metastasis. 
i. Invasion 
The first step in the metastatic cascade is the loosening of intercellular junctions in the 
tumour cells. There is an associated change in the pattern of expression of cell 
adhesion molecules (Bissell and Radisky 2001). 
The second step involves attachment of tumour cells to ECM proteins such as 
fibronectin and laminin and is mandatory for invasion and metastasis. Tumour cells 
have a more widespread receptor expression for these constituents compared to 
normal epithelial cells. An altered pattern of integrin expression also facilitates 
invasion. 
The third step involves degradation of the basement membrane and interstitial 
connective tissue. Tumour cells may secrete proteolytic enzymes on their own or 
induce the host cells to perform the same function (Bissell and Radisky 2001; Lynch 
and Matrisian 2002). The ECM can be degraded by proteinases which are classified 
into four separate groups, serine-, aspartate-, cysteine- and metalloproteinases. The 
serine and metalloproteinases play a predominant role in ECM turnover. The matrix 
metalloproteinases (MMPs) are a family of Zn2+ and Ca2+ dependent proteinases, 
which can catabolise most of the macromolecular components of the ECM. 
Expression of MMPs and the tissue inhibitors of metalloproteinases (TIMPs) is 
regulated by many cytokines/growth factors, mechanical properties of the ECM/actin 
cytoskeleton and cell/matrix interactions. They have also been documented to possess 
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a vital role in tumour invasion and metastasis by facilitating ECM degradation 
(Kalluri 2003; Lynch and Matrisian 2002). 
The final phase of invasion involves movement of the tumour cells through the 
degraded ECM. This migration may be facilitated by chemokines in addition to some 
of the cleavage products of matrix components (e. g. collagen, laminin) and growth 
factors. 
ii. Metastasis 
Tumour cells finally enter the circulation via extravasation through the vascular 
endothelium or through lymphatics. The site of extravasation and the resulting 
metastasis are generally related to the primary tumour location and its vascular or 
lymphatic drainage. However, this is not always the case and the location/drainage of 
the primary site may not readily explain metastasis. 
1.2.6 THEORIES OF METASTASIS 
Metastasis is not a random process and different cancers have different, yet specific 
metastatic sites. In 1889, the concept of 'seed' (tumour cell) and 'soil' (specific organ) 
was first described to explain the non-random metastasis of breast cancer to specific 
organs (Paget 1989). This theory suggests that different organs provide growth 
conditions optimised for specific cancers. A second concept is that endothelial cells in 
the vascular beds of certain organs express adhesion molecules that specifically trap 
circulating tumour cells (Nicolson 1993a). A `chemo-attraction' or 'homing' theory 
suggests that organ-specific attractant molecules enter the circulation, stimulating the 
migrating tumour cells to adhere to and invade through the walls of vessels and thus 
enter the organs (Nicolson 1993a; Nicolson 1993b). However, the molecules involved 
in the metastasis of tumour cells to specific sites must have some special properties. 
First, the chemoattractant should be constitutively expressed at the site of metastasis. 
Second, the tumour cells should express receptors for the chemoattractant. Third, 
adhesion molecules should be present on tumour cells allowing them to bind to the 
endothelium and last, the chemoattractant should aid the invasion of cells into tissues 
and facilitate their survival at the site of penetration. 
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Chemokines and their receptors as well as adhesion molecules play a vital role in 
leukocyte trafficking and homeostasis, and fulfil many of these criteria important in 
the chemoattractant theory of tumour metastasis. 
1.2.7 EXPERIMENTS OF MÜLLER et aL, 2001 
Muller et al. fashioned a series of experiments to study whether 
chemokinetchemokine receptor interactions are important in the metastasis of breast 
cancer. They found that amongst 17 different chemokine receptor genes, CXCR4 and 
CCR7 were significantly up-regulated in human breast cancer cell lines, malignant 
breast tumours and metastases compared with normal breast epithelial cells. They 
screened a range of normal human organs for the ligands of these receptors (CXCL12 
and CXCL21) and found peak levels of ligand expression in organs preferred for 
breast cancer metastasis (i. e. lymph nodes, lungs and bone marrow) (Figure 1.13). In 
vitro, these ligands stimulated pseudopodia formation and directional migration in 
cells and this chemotactic activity could be neutralized by an anti-CXCR4 antibody. 
The same group also found that melanoma cell lines express the receptors CCR7 and 
CCR10 and that skin and lymph nodes, the two major sites of metastatic melanoma, 
selectively expressed ligands for both these receptors (Muller et al., 2001). 
CXCR4 has now been implicated in a wide range of cancers including acute myeloid 
and lymphoblastic leukemia, chronic lymphocytic leukemia, non-Hodgkin B-cell 
lymphoma, and pancreatic cancer (Muller et al., 2001), melanoma (Kim et al., 2006); 
(Mori et al., 2005; Scala et al., 2006), non-small cell lung cancer (Phillips et al., 
2003), ovarian cancer (Jiang et al., 2006; Scotton et al., 2001), prostate cancer (Arya 
et al., 2004; rash-Yahana et al., 2004; Taichman et al., 2002), kidney cancer 
(Schrader et al., 2002) and oral cancer (Muller et al., 2006). Up-regulation of CXCR4 
compared to their normal counterparts has been shown in these neoplastic conditions 
and this up-regulation is associated with tumour progression and metastasis. 
Other chemokine receptors have also been implicated in chemokine-dependent 
tumour cell attraction to certain tissues. CXCR3 promotes colon cancer metastasis to 
lymph nodes (Kawada et al. 2004; Kawada et al. 2007). Functional expression of the 
CCR7 receptor, which is a receptor for two major chemokines, CCL19 (ELC) and 
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CCL21 (SLC), enhances the metastasis of B16 murine melanoma cells. This 
metastasis is blocked by neutralizing anti-CCL21 antibodies (Wiley et al., 2001) 
CCR10 is expressed in melanoma cells, and its ligand, CCL27 (CTACK), is produced 
constitutively by keratinocytes in the skin, to which melanomas often metastasize 
(Mori et al., 2005). CCR4 is often expressed in T-cell leukemias that preferentially 
invade the skin, where one of the CCR4 ligands CCL17 (TARC) is expressed by 
endothelial cells (Ishida et al., 2003). CCR3 is expressed in cutaneous lymphomas 
and its ligand CCLI1 (Eotaxin) is often expressed in tumour cells and tumour 
associated skin lesions (Kleinhans et al., 2003; Kouno et al., 2004). 
Chemotaxis has been suggested as a possible mechanism for this organ-specific 
metastasis. However, it is questionable that tumour metastasis over a long distance, is 
governed by the concentration gradient of a single chemokine, since it is a highly 
complex phenomenon. The magnitude of the importance of this chemokine-receptor 
interaction, therefore, stands unknown. 
1.2.8 CHEMOKINES/CHEMOKINE RECEPTORS IN ORAL CANCER 
A number of groups have tried to emulate the work of Muller (Muller et al., 2001) by 
studying the role of chemokines and chemokine receptors in oral cancer. The clinico- 
pathological significance of expression of the CXCR4 receptor has been investigated 
in detail. 
i) CXCR4 in OSCC 
A significant correlation between CXCR4 expression and regional lymph-node 
metastasis has been reported (Almofti et al., 2004; Ishikawa et al., 2006). Primary 
tumour cells in OSCC have stronger CXCR4 expression compared to normal 
epithelium whereas expression intensity is even stronger in metastatic tumour cells in 
regional lymph nodes (Delilbasi et al., 2004; Ishikawa et al., 2006; Uchida et al., 
2003). Expression of its ligand SDF-la. is occasionally detected on metatastatic 
tumour cells but not on normal or primary tumour cells. CXCR4 expression has also 
been shown on oral cancer cells in vitro and exposure of these cells to SDF-la 
facilitates an up-regulation in intracellular calcium mobilization, chemotaxis, ERK1/2 
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phosphorylation, adhesion to extracellular matrix components and MMP-9 secretion 
(Samara et al. 2004; Uchida et al., 2003). All of these effects can be blocked by an 
antibody against CXCR4 or an inhibitor of SDF-la suggesting that the response is 
specific. Expression of CXCR4 is also up-regulated on lymph node metastatic cells 
(HNt and B88) compared with normal or primary oral cancer cells. Exposure of oral 
cancer cells B88 and HNt to SDF-la results in downregulation of epithelial markers 
E-cadherin and ß-catenin, and up-regulation of mesenchymal markers vimentin and 
snail (Onoue et al., 2006). This suggests an important role for CXCR4 and SDF-la in 
epithelial-mesenchymal transition which is observed during tumour progression and 
facilitates invasion and metastasis. 
Uchida et al., observed a significant increase in metastases to cervical lymph nodes 
after inoculation of CXCR4-transfected cells in nude mice compared with 
untransfected cells. However, no metastases were observed in lungs even after 90 
days which indicates a preferential metastasis of oral cancer cells to cervical lymph 
nodes (Uchida et al., 2004). However, transfection of SDF-la into B88 cells 
(expressing functional CXCR4) yielded very interesting results. Expression of 
CXCR4 and SDF-la by the same cells provides an autocrine mechanism of activation 
whereas B88 cells expressing only CXCR4 can only be activated in a paracrine 
manner. Inoculation of CXCR4/SDF- Ia co-expressing cells into nude mice results in 
increased frequency and more aggressive metastatic foci in the regional lymph nodes 
compared with cells expressing only CXCR4. In addition, the CXCR4/SDF-la 
coexpressing cells show a significant increase in distant metastases to the lung 
whereas no such effect is observed with cells expressing CXCR4 on its own (Uchida 
et al., 2007). Administration of a CXCR4 antagonist significantly decreases distant 
lung metastases and improves the survival rate of the mice. This suggests that 
autocrine CXCR4/SDF-la signaling plays a more important role in distant OSCC 
mestastases than paracrine signaling (Uchida et a!., 2007). 
The ligand for CXCR4 is SDF-la and is expressed in abundance in lymphoid tissues, 
lung, liver and bone. However, its expression has not been studied as extensively as 
CXCR4. Uchida et al., reported that expression of SDF-la in metastatic tumours in 
regional lymph nodes is significantly higher than the primary tumour and is correlated 
with a poor prognosis (Uchida et al., 2007). Almofti et al., could not find a significant 
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correlation between SDF-1 expression and clinico-pathological factors of OSCC 
including age, sex, lymph node metastasis, invasion, recurrence and prognosis 
(Almofti et al., 2004). 
All these findings suggest an important role for CXCR4/ SDF-la interaction in the 
biology of oral cancer and in local and distant metastasis. However, metastasis is a 
highly complex phenomenon and the concentration gradient of a single chemokine 
over a longer distance may not be enough on its own and may require influence of 
other factors. 
ii) Other chemokine receptors and chemokines in OSCC 
a) CCR7 
Expression of CCR7 has also been associated with tumour progression and poor 
prognosis in OSCC. CCR7 binds to two chemokines, CCL19/ELC/MIP-3ß and 
CCL21/SLC/6Ckine. CCR7 expression is observed in primary tumours as well as 
metastatic deposits in regional lymph nodes and a significant correlation exists 
between CCR7 expression and prognostic factors such as metastasis to cervical lymph 
nodes, tumour size, clinical stage, local recurrence and mortality (Tsuzuki et al., 
2006). In addition, a correlation between tumour cell proliferation (PCNA expression) 
and CCR7 expression also exists (Xu et al., 2007). Since the two ligands for CCR7 
are abundantly expressed in lymph nodes, it is possible that this interaction may 
facilitate tumour cell proliferation, migration, invasion and metastasis to cervical 
lymph nodes. However, the extent of the involvement of CCR7 and its ligands in the 
pathogenesis of OSCC needs to be studied further. 
b) CCL20 
Expression of CCL20 (MIP-3a) mRNA has also been detected in OSCC in vitro and 
in vivo and this expression is up-regulated by infection with Actinobacillus 
actinomycetemcomitans and by stimulation with lipopolysaccharide (LPS) and tumour 
necrosis factor-a (TNF-a). Increase in MIP-3a is also correlated with the number of 
Langerhans cells suggesting a regulatory role on the growth of cells in OSCC (Abiko 
et al., 2003). However, conflicting results were reported by Wang et al. who showed 
down-regulation of CCR6 (the only known receptor for MIP-3a) in metastatic OSCC 
cells and tissues compared with normal mucosa (Wang et al., 2005). Further work 
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needs to be done to establish the precise role of CCL20 and CCR6 in the pathogenesis 
of OSCC. 
c) IL-8 and IL-6 
IL-8 and IL-6 have been studied in patients with OSCC as potential biomarkers. IL-8 
concentration in saliva and IL-6 concentration in serum are significantly increased at 
both RNA and protein levels in OSCC patients compared with negative controls 
(disease free patients). However, no association is observed with sex, age, alcohol or 
tobacco use (St John et al., 2004). Expression and role of the IL-8 receptors CXCRI 
and CXCR2 has also been reported in OSCC and will be discussed later on in section 
1.2.13.5. 
d) Eotaxin 
The chemokine eotaxin exerts its effects through the CCR3 receptor. Expression of 
eotaxin has been reported in normal as well as neoplastic oral mucosa with and 
without an intense eosinophilic inflammatory infiltrate. Staining is observed on 
kearatinocytes, neutrophils, fibroblasts and plasma cells but is much stronger on 
eosinophils associated with OSCC (Lorena et al., 2003). This suggests a potential 
mechanism for eosinophil recruitment which may influence adhesion and 
angiogenesis of tumour cells. 
e) CXCL14 
CXCL14 (BRAK) is constitutively expressed in certain normal tissues and is absent 
from many cancers. Abundant BRAK expression is observed in normal tongue 
mucosa whereas consistent absence is seen in tongue SCC at both mRNA and protein 
levels. It also acts as a potent inhibitor of angiogenesis and chemotaxis, suggesting 
that loss or down-regulation of BRAK may lead to tumour neo-vascularization and 
metastasis (Shellenberger et al., 2004). 
1) CXCL10 
CXCL10 (IP-10) is a chemoattractant for activated T-cells expressing the CXCR3 
receptor. Consistent expression of IP-10 is observed in nasopharyngeal carcinoma 
(NPC)-derived cell lines as well as tissue biopsies of OSCC of tongue (Teichmann et 
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al., 2005). These results are unusual since IP-10 has been shown to be angiostatic in 
vitro (and is regarded as an anti-neoplastic chemokine). This endogenous expression 
of IP-10 by tumours suggests that it might not exert an anti-neoplastic effect in vivo 
and needs to be studied further. 
All these findings indicate that chemokines and their receptors may have a potential 
role in the pathogenesis of oral cancer. 
1.2.9 PRELIMINARY STUDIES 
As part of a previous study on the role of chemokine receptors in oral cancer, a 
microarray analysis of normal oral epithelial cells and several oral cancer cell lines 
was carried out in our research group (J. Collier- personal communication). Two 
findings were of interest. First, mRNA for XCR1 was observed in both normal and 
cancerous oral epithelial cells. This was surprising as XCR1 expression appears to be 
almost exclusively restricted to the immune system and expression by epithelial cells 
has not been shown to date. Second, CXCR1 mRNA appeared to be significantly 
increased in oral cancer compared with normal epithelial cells. This preliminary data 
suggests XCR1 and CXCR1 may have some role in the biology of oral cancer and 
these receptors and their ligands (lymphotactin and IL-8) will be discussed in greater 
detail. 
1.2.10 XCRI/GPR5 
1.2.10.1 Discovery 
XCRI is the sole C family chemokine receptor and is specific for the chemokines. 
lymphotactin (XCLI/SCM-1a) and XCL2/SCM-lp. XCR1 was first cloned and 
mapped by Heiber et al. in 1995. They isolated a novel human gene encoding an 
orphan G protein-coupled receptor and named it GPR5. The entire coding region for 
this gene was contained on a single exon and was localized to chromosome 3 (p21.3- 
p21.1) (Heiber et al., 1995). 
GPRS was identified as XCR1 by Yoshida et al. in 1998. By stably expressing eight 
known chemokine receptors and three orphan receptors in murine L1.2 cells and 
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testing their responsiveness, they found that the orphan receptor GPR5 functioned as a 
high affinity receptor for SCM-1/lymphotactin (Yoshida et al., 1998). SCM-la and 
SCM-1ß mediated efficient chemotactic responses and calcium mobilization and this 
response was completely suppressed by pre-treatment with pertussis toxin, indicating 
coupling of XCR1 with a Gai class of G-proteins in murine L1.2 cells. Lymphotactin 
bound specifically to GPR5-expressing L1.2 cells and northern blot analysis showed 
GPRS mRNA in placenta, spleen and thymus. Later on, Yoshida et al. isolated and 
cloned the murine homologue of XCR1 (Yoshida et al., 1999b) by screening a mouse 
liver genomic library using XCRI cDNA as a probe. It was named mXCRI. 
1.2.10.2 Structure 
Like other chemokine receptors, XCR1 also belongs to the seven transmembrane 
domain G-protein-coupled receptor superfamily. Phylogenic depiction of the 
evolutional relation of the various chemokine receptors shows XCR1 to be on a 
branch containing human CC chemokine receptors (Yoshida et al., 1998). Its gene is 
mapped to chromosome 3p21.3-p21.1 close to other CC chemokine receptor genes 
clustered at 3p21 (Heiber et al., 1995). This is consistent with the close phylogenic 
relationship of lymphotactin to CC chemokines (Yoshida et al., 1995). 
1.2.10.3 Expression 
XCRI expression in mouse tissues has been detected in spleen and lung. However it 
is not known precisely which cells express XCR1 in these tissues (Yoshida et al., 
1999b). XCRI mRNA is expressed by CD8+ T cells and natural killer (NK) cells 
which is striking because these cells are also the main producers of lymphotactin 
when stimulated (Yoshida et al., 1999a). XCR1 expression has also been detected in 
tissue macrophages in a murine model of listeriosis (Donner et al., 2002). 
Among human tissues, XCR1 expression is not as widespread as some of its 
chemokine receptor counterparts. Its mRNA is expressed in selected tissues including 
placenta, spleen, and thymus (Yoshida et a!., 1998; Yoshida et al., 1999b) but it is not 
known precisely which cells in these tissues express XCR1. T and B lymphocytes and 
neutrophils express XCR1 and respond to lymphotactin by chemotaxis (Huang et al., 
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2001b). Recently, XCR1 expression has been demonstrated in fibroblast-like 
synoviocytes in rheumatoid synovium (Blaschke et al., 2003) and melanocytic lesions 
(Seidl et al., 2007). Strong XCR1 staining is observed on mclanocytes and nevus cells 
in deeper parts of the dermis whereas staining is weaker in nests adjacent to the 
epidermis. However, no correlation between XCR1 expression and disease 
progression is observed in melanocytic lesions and Seidl et al. did not compare 
expression to normal tissue. Therefore, the significance of this expression is not 
known. 
Expression of XCR1 by epithelial cells has not been shown to date. 
XCRI Expression in Mouse XCRI Expression in Human 
Cells/Tissues Cells/Tissues 
T lymphocytes T lymphocytes 
NK cells B Lymphocyte 
Spleen Neutrophils 
Lung Placenta 
Macrophages Spleen 
(after IFN-y exposure) 
Thymus 
Fibroblast-like Synoviocytes 
Melanocytic lesions 
Table 1.3. Summary of cells/tissues expressing XCR1. 
1.2.11 LIGAND FOR XCR1: LYMPHOTACTIN (SCM-la/ATAC/Lptn/XCL1) 
1.2.11.1 Discovery 
In 1994, Keiner et al., tried to establish the cytokine-producing profile of murine 
progenitor T cells (Keiner et al., 1994). During screening of a mouse pro-T cell cDNA 
library, they came across a clone, the protein translation of which consistently 
matched a short COOH-terminal segment of CC chemokine protein chains in `Basic 
local alignment search tool' (BLAST) searches of protein and nucleic acid databases. 
A weaker similarity in this region was also noted with CXC chemokine sequences. On 
the basis of its specific chemotactic activity for lymphocytes (considered a unique 
trait at that time), this molecule was designated lymphotactin (Ltn). 
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The human analogue of lymphotactin was discovered simultaneously and isolated by 
three independent groups i. e. Kennedy et al. (Kennedy et al., 1995), Yoshida et al., 
(who called it Single C Motif-1/SCM-1) (Yoshida et al., 1995) and Muller et al., 
named it Activation-induced, T cell-derived, and Chemokine-related molecule 
(ATAC) (Muller et al., 1995). It was later realized that the three groups had actually 
identified the same chemokine and the name lymphotactin was designated. 
Lymphotactin was deemed interesting as it possessed a number of the conserved 
amino acid residues present in CXC and CC chemokines, including two cysteines 
corresponding to cysteine 2 and 4, but was missing cysteines 1 and 3. Data from 
chromosomal mapping provided further evidence for identification of a new class of 
chemokine. All the previously described CC chemokines map to human chromosome 
17 and mouse chromosome 11. The CXC chemokines map to human chromosome 4 
and to mouse chromosome 5. Lymphotactin is unique as it maps to the distal region of 
chromosome I in both human and mouse (Keiner et al., 1995). 
Taken together, the structure, biologic activity and chromosomal location of 
lymphotactin merited it to be classified as a distinct class of the chemokine 
superfamily. 
1.2.11.2 Structure 
Human lymphotactin encodes a 114 amino acid residue precursor protein with a 21 
amino acid residue predicted signal peptide (Kennedy et al., 1995). It maintains the 
secondary and tertiary architecture of classical chemokines in spite of missing two 
cysteines. Lymphotactin consists of an amino-terminal domain attached to the rest of 
the molecule by one disulfide bond (Hedrick and Zlotnik 1998). 
Studies on lymphotactin structure by molecular dynamics have proved that the lack of 
one disulfide bond and the extension of the C-terminus in human lymphotactin are 
complementary to each other. The role of the extended C-terminus is most likely to 
stabilize the molecule enabling it to function with a single disulfide bond however, it 
may also be responsible for other functions (Buyong et a!., 2000). 
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1.2.11.3 Expression 
i) Expression in lymphoid cells 
Expression of lymphotactin in both mouse and humans is observed in activated CD8+ 
T cells and activated NK cells (Dorner et al., 1997; Hedrick et al., 1997; Keiner et al., 
1995; Muller et al., 1995). Lymphotactin expression has been shown in activated pro- 
T cells (Keiner et al., 1994; Keiner and Zlotnik 1995). Low levels of mRNA 
expression have also been observed in mouse spleen and thymus tissue (Keiner et al., 
1994). However, the exact cells expressing lymphotactin in spleen and thymus have 
not been documented so far although it is likely that they are lymphocytes. Activated 
murine epidermal dendritic T cells and intraepithelial yS T cells have also been shown 
to express lymphotactin (Boismenu et al., 1996). 
Lymphotactin expression in human tissues is more widespread than in the mouse but 
is still predominant in lymphoid tissues including thymus, spleen, and peripheral 
blood lymphocytes. However, the expression of lymphotactin by lymphocytes is 
dependent upon activation (activated CD8+ T cells express more lymphotactin than 
activated CD4+ T cells) (Hedrick and Zlotnik 1997; Hedrick and Zlotnik 1998; 
Kennedy et al., 1995; Muller et al., 1995). Recently, CD8+ aß+ T cells that lack 
surface CD5 antigen expression have been described as a major cellular source of 
lymphotactin in peripheral blood (Stievano et al., 2003). Expression has also been 
shown in activated NK cells (Giancarlo et al., 1996; Hedrick et al., 1997; Hedrick and 
Zlotnik 1997; Maghazachi 1999), mature dendritic cells (Middel et al., 2001), mast 
cells (Rumsaeng et al., 1997) and a/ß thymocytes (Keiner et al., 1994). A significant 
increase in lymphotactin expression has been reported in intraepithelial lymphocytes 
(IEL) in patients suffering from Crohn's disease compared with those having a non- 
inflammatory gut disorder (Middel et al., 2001). This suggests a role for lymphotactin 
in inflammatory conditions. 
ii) Expression in non-lymphoid cells 
Low levels of lymphotactin mRNA are present in small intestine, colon, lung, ovary, 
and testes tissue (Keiner et al., 1994; Kennedy et al., 1995; Muller et al., 1995; 
Yoshida et al., 1995). The cells expressing lymphotactin in these tissues have not 
been reported precisely but are most likely to be lymphocytes and NK cells. It is also 
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possible that the epithelial cells in these tissues may also contain mRNA for 
lymphotactin. Glomerular mesangial and vascular endothelial cells express 
lymphotactin mRNA after stimulation with IL-Iß in an experimental murine model of 
glomerulonephritis (Natori et al., 1998), but the significance this expression is 
unclear. 
Lymphotactin Expression Lymphotactin Expression (Human) 
(Mouse) (only after activation) (only after activation) 
T cells T cells 
NK cells NK cells 
Spleen Spleen 
Thymus Thymus 
Dendritic cells Dendritic cells 
Thymocytes Colon 
Epidermal Intraepithelial T cells Small Intestine 
Glomerular mesanglal and 
vascular endothelial cells (after Lung 
IL-iß exposure) in 
glomerulonephritis 
Ovary 
Testes 
Mast cells 
Synovial fluid In Rheumatoid Arthritis 
Table 1.4. Summary of cellsltissues expressing lymphotactin. 
Recently, lymphotactin expression has been demonstrated in the synovium of 
Rheumatoid Arthritis (RA) patients (Blaschke et al., 2003). Expression of 
lymphotactin by epithelial cells has not been shown so far. 
1.2.11.4 Functions of lymphotactin 
As expression of lymphotactin and its receptor XCR1 has been predominantly 
observed in the lymphoid system, the scope of its known functions is largely in the 
same vicinity. 
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i) Chemotaxis of lymphoid cells 
Lymphotactin was originally reported to be specifically chemotactic for CD4+ and 
CD8+ T lymphocytes in both mouse and human (Keiner et al., 1994; Kennedy et al., 
1995) and this finding was corroborated by other groups (Dourer et al., 1997). Later 
on, it was discovered that mouse and human NK cells also respond to lymphotactin 
(Giancarlo et al., 1996; Hedrick et al., 1997; Maghazachi et al., 1997). 
ii) Role in Immunity 
Lymphotactin enhances antigen-specific immune responses suggesting an important 
role in mucosal immunity. Even low doses of lymphotactin up-regulate antibody 
levels against a specific antigen as well as supplementing the systemic antibody 
responses (Lillard, Jr. et al., 1999). Therefore, lymphotactin appears to act as an 
innate mucosal adjuvant for induction of adaptive immunity. 
There is also some evidence lymphotactin may augment antigen specific immune 
responses. Antigen-specific T cell activation is characterized by an alteration in 
expression of several cell surface molecules including a decrease in CD62L (L- 
Selectin). CD62L is utilized by naive T cells to enter high endothelial venules in 
lymph nodes. Down-regulation of CD62L following T cell activation is therefore 
associated with an increased ability to arrive at tertiary inflammatory sites. 
Lymphotactin facilitates the preferential recruitment of CD62LI° (with low L-Selectin 
expression) over CD62Lhi (with high L-Selectin expression) cells in vitro, making it 
the first chemokine to preferentially recruit recently activated antigen-specific T cells 
towards the site of inflammation (Kurt et al., 2001). 
iii) Role in disease 
There is evidence that lymphotactin plays a role in Th-1 mediated diseases. 
Lymphotactin has been reported to be induced by T-cell receptor stimulation in ThI 
but not in 712 cells and it has also been found to be co-secreted with IFN-y at a higher 
level by activated Thl cells (Dormer et al., 2002; Zhang et al., 2000). Lymphotactin is 
produced by islet-specific Thl cells in autoimmune diabetes, and is detected in 
peripheral blood mononuclear cells (PBMCs) from patients with multiple sclerosis 
(Bradley et al., 1999; Jalonen et al., 2002). However the precise role of lymphotactin 
in the biology of these diseases remains unknown. 
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The in vitro functional properties of lymphotactin suggest an important role in the 
recruitment of T cells in the pathogenesis of chronic inflammatory disorders. A 
significant increase in lymphotactin expression compared to normal has been 
observed in Crohn's disease. The cells which express lymphotactin have been 
identified as T cells, mast cells and dendritic cells and are present throughout the 
inflamed bowel wall (Middel et al., 2001). Lymphotactin mRNA expression along 
with MCP-1 and RANTES, is up-regulated in sarcoidosis and is associated with 
disease progression (Petrek et al., 2002). This suggests that lymphotactin may be 
involved in lymphocyte migration to the lung in vivo. However, the significance of 
this role needs to be studied in detail. 
Lymphotactin also plays an important role in Rheumatoid Arthritis (RA). 
Lymphotactin mRNA and protein is expressed by CD4+ CD28- T cells in the 
peripheral blood as well as in CD4+ and CD8+ T cells in the synovial infiltrate from 
RA patients. Strong lymphotactin expression is observed in lymphocytic infiltrate and 
a noticeable relationship exists between the expression of lymphotactin and the 
density of the mononuclear cell infiltrate (Blaschke et al., 2003). As a result, levels of 
lymphotactin are significantly higher in the synovial fluid of patients suffering from 
RA compared with disease free patients (Wang et al., 2004). Exposure of fibroblast- 
like synoviocytes (expressing XCRI) to lymphotactin causes down-regulation of 
MMP-2 secretion suggesting an important role for lymphotactin/XCR1 interaction in 
the pathogenesis of RA. All these findings indicate that lymphotactin may act as an 
immunomodulatory influence in chronic inflammatory disorders. 
iv) Role as an anti-tumour agent 
Lymphotactin is potentially an attractive anti-tumour agent because of its ability to 
attract the effector cells (CD8+ T cells and NK cells) which eliminate tumours. This 
potential has been studied and lymphotactin has been shown to be effective in tumour 
vaccines in a number of experimental tumour models. 
Subcutaneous injections of a vaccine containing lymphotactin in conjunction with 
interleukin-2 (IL-2) in neuroblastoma patients results in tumour infiltration by CD4+ 
and CD8+ T cells, NK cells, eosinophils and langerhans cells. This is associated with 
an increase in circulating IgG antibodies and most tumours are either partially or 
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completely destroyed (Rousseau et al., 2003). However, this study contained only 21 
patients and variable responses were seen in some. Transfection of lymphotactin into 
a mouse myeloma model does not inhibit tumour development but tumour growth is 
retarded compared with controls due to infiltration of CD4+ and CD8+ T cells and 
neutrophils (Cairns et al., 2001). 
A dendritoma of gene-modified dendritic cells (DCs) (containing lymphotactin) and 
mouse hepatocellular carcinoma cell line H-22 attracts T cells and NK cells in 
chemotactic assays and successfully enhances proliferative and cytotoxic activity 
(Zhang et a!., 2004). DCs containing just lymphotactin fail to elicit a similar response 
which suggests that lymphotactin requires some sort of carrier to exert its effects. 
However, this study focussed on in vitro studies only and different results might have 
been obtained in vivo. Pre-existing tumours and their metastases are significantly 
decreased when treated with lymphotactin gene-modified dendritic cells in tumour 
models of lung carcinoma and melanoma (Cao et a!., 1998; Zhang et a!., 1999). Co- 
transfection of lymphotactin and melanoma antigen gplOO in murine dendritic cells 
results in increased cytotoxicity of lymphocytes and NK cells and increased 
production of IL-2 and IFN-y, thus leading to an improved anti-tumour response (Xia 
et a!., 2002). 
All these findings suggest that lymphotactin has the ability to attract immune effector 
cells to tumour sites. It can also act in harmony and facilitate release of various 
cytokines and has natural adjuvant activities that result in augmented antitumor 
immune responses. 
v) Other biological functions 
Lymphotactin wields various biological functions in addition to its chemotaxis. 
a. Role as type 1 cytokine 
Lymphotactin along with MIP-la, MIP-lß and RANTES, has been shown to be co- 
secreted with IFN-y from NK cells and T cells. It acts as a type 1 cytokine by up- 
regulating CD40, IL-12 and TNF-a in macrophages in a murine model of listeriosis. 
This suggests that lymphotactin may play a key role in Thl mediated immunity 
(Donner et al., 2002). 
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b. Effects on T cell proliferation 
Lymphotactin has differential proliferative effects on CD4+ and CD8+ T cells. It 
inhibits CD4+ T-cell proliferation in vitro through a diminished production of Thl 
(IL-2, IFN-y) cytokines. In contrast, lymphotactin directly stimulates proliferation of 
CD8+ T-cells and IL-2 secretion (Cerdan, Serfling, and Olive 2000). 
c. Role in T cell regulation 
Lymphotactin acts as a direct inhibitor of CD4+ T cells and co-stimulates their 
apoptosis. Conversely, it increases CD8+ T cell activation and is the first chemokine 
known to exert a direct differential regulation on CD4+ and CD8+ T-cell activation 
(Cerdan et al., 2001). The extent of this role still needs to be elucidated. 
1.2.11.5 Mechanism of XCR1/lymphotactin signaling and function 
Coupling of lymphotactin and XCR1 mobilizes intracellular calcium permitting the 
chemokine to exert its functions. Pertussis toxin (PT) was used to determine the 
coupling of lymphotactin to G-proteins in natural killer cells. It was found that 
lymphotactin induces the chemotaxis and mobilization of intracellular calcium 
through pertussis toxin sensitive and -insensitive heterotrimeric G-proteins (Gai, Gao 
and Gaq) (Maghazachi et al., 1997; Maghazachi 1999). The role of phosphoinositide- 
3y kinases (PI-3K) was also studied which revealed that lymphotactin signaling 
within NK cells is mediated by a ternary complex of proteins, including G-protein, 
pleckstrin and PI-3y kinase (al-Aoukaty, Roistad, and Maghazachi 1999). 
To summarize, XCRI and its ligand lymphotactin are expressed predominantly within 
the lymphoid system. Lymphocytes and neutrophils express high levels of XCRI and 
the principal function of lymphotactin appears to be chemoattraction of these cells. 
Recent reports have shown expression of XCR1 in melanocytes of melanocytic 
lesions and in rheumatoid synovium, but the importance of this expression is 
unknown. XCRI expression on epithelial cells has not been shown to date. 
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1.2.12 CXCR1 and CXCR2 
(IL-8RA/IL-8R1 and IL-8RB/IL-8R2) 
In addition to XCR1, preliminary microarray results showed significant difference in 
CXCRI mRNA expression between normal and malignant oral epithelial cells. The 
principle ligand for CXCRI is IL-8 and the interactions of IL-8 with its receptors 
CXCRI and CXCR2 appear to play an important role in the biology of cancer. An 
outline of their roles is discussed below. 
1.2.12.1 Discovery 
CXCRI was first described by several groups as a high affinity receptor for IL-8 on 
neutrophils (Besemer, Hujber, and Kuhn 1989; Grob et al., 1990; Moser et al., 1991; 
Samanta, Oppenheim, and Matsushima 1990; Thomas, Taylor, and Navarro 1991). 
However cross-linking experiments revealed that two proteins of 44 kDa (p44) and 70 
kDa (p70) became specifically labelled with radio-iodinated IL-8, GRO-a and NAP-2 
(Moser et al., 1991; Schumacher et al., 1992). IL-8 bound to both proteins with high 
affinity, whereas GRO-a and NAP-2 had much higher affinity for p70 (Kd 30 nM) 
compared to p44 (Kd 0.3-0.7 nM) (Lee et al., 1992; Schnitzel et al., 1991; 
Schumacher et al., 1992). These results suggested that all three cytokines (IL-8, GRO- 
a and NAP-2) acted on neutrophils through common receptors. 
The two interleukin-8 receptors were initially called IL-8 RA (IL-8 RI) and IL-8 RB 
(IL-8 R2) but were renamed CXCRI and CXCR2 based on a new classification 
(Zlotnik and Yoshie 2000). The cDNA of CXCRI was first cloned by Murphy and 
Tiffany in 1991 using L-60 neutrophils (Murphy and Tiffany 1991). Holmes and 
colleagues cloned the cDNA of CXCR2 in 1991 (Holmes et al., 1991). 
1.2.12.2 Structure and expression 
Both CXCRI and CXCR2 are transmembrane G-protein-associated receptors and 
belong to the CXC family and map to chromosome 2. Both receptors bind to IL-8 
with high affinity. CXCRI is specific for IL-8 and Granulocyte chemotactic protein-2 
(GCP-2), whereas CXCR2 can interact with a range of other CXC chemokines 
possessing the N-terminal ELR motif with similar affinity (CXCLI-CXCL7). 
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Patterns of expression of CXCR1 and CXCR2 appear to differ between different 
leukocytes. In 1993 Moser et al. studied the expression of both IL-8 receptors in 
myeloid, lymphoid and other tissue cells using northern-blot analysis and reverse 
transcription polymerase chain reaction (RT-PCR). They found that CXCRI mRNA 
is expressed at much higher levels in neutrophils compared to blood monocytes and 
myeloid cell lines and no CXCRI mRNA is present in lymphocytes and lymphoid cell 
lines. CXCR2 mRNA is expressed in neutrophils, monocytes but in contrast to 
CXCRI also in lymphocytes (Moser et al., 1993). This suggests different roles for the 
two receptors. 
Expression of both CXCRI and 2 has since been reported in several other cell types 
including epidermal keratinocytes (Michel et al., 1992), mast cells (Lippert et al., 
1998), endothelial cells (Li et al., 2003), bronchial epithelial cells (Farkas et al., 2005) 
and oesophageal mucosa (Isomoto et al., 2005). Human gastric epithelial cells express 
CXCRI and CXCR2 after exposure to Helicobacter pylori infection (Backhed et al., 
2003). Expression on gingival keratinocytes has also been reported in vitro and in vivo 
(Sfakianakis, Barr, and Kreutzer 2002). Sfakianakis et al. also reported an up- 
regulation of CXCR1 and CXCR2 in periodontitis compared to normal gingival 
epithelium and suggested that this upregulation facilitates IL-8 mediated migration 
and proliferation of gingival keratinocytes. However, their conclusions seem 
speculative as they only showed cell surface expression of CXCRI and CXCR2. 
None of their results show a significant difference in expression of CXCR1 and 
CXCR2 expression between normal and inflamed tissue and they did not study the 
role of these receptors in cell migration and proliferation. 
1.2.13 INTERLEUKIN-8 
(I L-8/CXCL-8/NAFAIDNCF/NAP-1/MONAP) 
1.2.13.1 Discovery 
The principle ligand for CXCRI, interleukin-8, was one of the first chemokines to be 
discovered and was reported in 1987-88 by a number of groups simultaneously. 
Yoshimura, Matsushima and colleagues (1987) identified it from LPS-stimulated 
human monocyte culture supernatants (Matsushima et al., 1988; Yoshimura et al., 
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1987a; Yoshimura et al., 1987b). It was named `monocyte-derived neutrophil 
chemotactic factor' (MDNCF) and was chemoattractant for neutrophils but not for 
monocytes/macrophages. Walz et al. reported that human blood monocytes stimulated 
with E. coli LPS, phytohaemagglutinin or concanavalin A produced a novel 
`neutrophil-activating factor' (or NAF) (Walz et al., 1987). Stimulation of human 
peripheral blood monocytes with LPS and phorbol myristate acetate (PMA) lead to 
production of a chemoattractant which facilitated neutrophil chemotaxis. It was 
named `monocyte-derived neutrophil-activating peptide' (MONAP) (Schroder et 
al., 1987). 
Later on, the name Interleukin-8 (IL-8) was assigned and it was discovered that IL-8 
exerts a range of actions including induction of lysosomal enzyme release from 
neutrophils (Walz et al., 1987), expression of adhesion molecules on neutrophils 
(Detmers et a!., 1990), stimulation of histamine release from basophils (White et al., 
1989) and chemoattraction of T lymphocytes (Larsen et al., 1989). 
1.2.13.2 Structure 
IL-8 is an 8kD protein generated as a 99-amino acid precursor with a characteristic 
leader sequence of 22 amino acids (Matsushima et al., 1988). Several mature forms 
have been recognized (Gregory et al., 1988; Lindley et al., 1988; Yoshimura et al., 
1989) and the major form consists of 72 amino acids (Lindley et al., 1988). 
IL-8 has considerable sequence homology with platelet derived peptides such as 
platelet basic protein (PBP), connective tissue activating peptide III and platelet factor 
4. It also possesses both structural and biological similarities with macrophage 
inflammatory protein-2 (MIP-2) (Matsushima et al., 1988). 
1.2.13.3 Expression 
IL-8 was originally described as a product of mononuclear phagocytes (Peveri et al., 
1988; Schroder, Mrowietz, and Christophers 1988; Van et al., 1988; Walz et al., 
1987; Yoshimura et al., 1987a; Yoshimura et al., 1987b) but was later found to be 
expressed by a variety of cells. The stimulus for expression appears to vary between 
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cell types. IL-8 expression is induced in fibroblasts (Strieter et al., 1989b), epithelial 
cells and hepatocytes (Thornton et al., 1990) in response to IL-1 a, IL-1ß and TNF-a, 
while monocytes (Peveri et al., 1988; Yoshimura et al., 1987b) and endothelial cells 
(Schroder and Christophers 1989; Strieter et al., 1989a) express it after stimulation 
with IL-6, IL-2, LPS and type I or II interferons (IFNs) (Walz et al., 1987). 
IL-8 expression has also been shown in oral keratinocytes (Bickel et al., 1996; 
Zehnder et al., 1999). Constitutive expression of IL-8 mRNA is seen in primary oral 
keratinocytes and keratinocyte cell lines and stimulation with IL-lß increases this 
expression (Bickel et al., 1996). However this group did not study IL-8 secretion by 
oral keratinocytes in culture or in vivo. IL-8 is expressed in vivo in gingival 
keratinocytes, microvascular endothelial cells (MVEC) and leukocytes within the 
gingival epithelium (Sfakianakis, Barr, and Kreutzer 2002). Fibroblasts from 
nasopharyngeal mucosa constitutively express IL-8 in vitro and in vivo (Knerer et al., 
1999). Nasal epithelial cells also express IL-8 after stimulation with TNF-a in culture 
(Rudack et al., 2003). 
1.2.13.4 Functions of IL-8 
i) Actions on neutrophils 
The biological profile of newly discovered IL-8 was thought to be restricted to 
neutrophil chemotaxis. However, subsequent studies have demonstrated a multitude 
of in vitro effects on neutrophils including shape change, production of superoxide 
and hydrogen peroxide (Thelen et al., 1988), release of lysosomal enzymes (Peveri et 
al., 1988), induction of respiratory burst (Schroder et al., 1987), generation of 
bioactive lipids (Schroder 1989) and increased expression of adhesion molecules on 
neutrophils (Detmers et al., 1990; Paccaud, Schifferli, and Baggiolini 1990). 
IL"8 is not species specific, and its effects in vivo have been studied with various 
laboratory animals. Injection of IL-8 into the skin of rabbits results in plasma 
exudation and a long lasting massive neutrophil infiltration (Colditz et al., 1989). 
Intradermal injection of human IL-8 causes a transient and dose-dependent neutrophil 
infiltration in various animal species including rats, mice, guinea pigs, dogs and 
humans (Colditz et al., 1989; Larsen et al., 1989; Leonard et al., 1991). 
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ii) Signaling 
IL-8 exerts its functions by eliciting a transient and rapid intracellular increase in 
cytosolic calcium (Peveri et al., 1988; Thelen et al., 1988). All IL-8 mediated 
responses, including the calcium changes, are abrogated by pre-treatment of cells with 
pertussis toxin, indicating that IL-8 signaling is dependent on a GTP-binding protein. 
1L-8 mediated respiratory burst is also inhibited by Genistein (a protein tyrosine 
kinase inhibitor), indicating a role for protein kinase C (Thelen et al., 1988). Like a 
number of other chemokines, IL-8 has also been shown to signal transduce through 
the ERKI/2 signaling cascade (Shyamala and Khoja 1998). 
iii) Chemotaxis of other haematopoietic cells 
The chemotactic effects of IL-8 are not restricted to neutrophils and other 
granulocytes and monocytes also respond to it. IL-8 facilitates in vitro and in vivo 
chemotaxis of CD4+ and CD8+ human peripheral T lymphocytes (Larsen et al., 
1989). It is also chemotactic for basophils (White et al., 1989) and IL-3 or GMCSF- 
primed eosinophils (Warringa et al., 1991). However, the pathophysiological 
relevance of the effects of IL-8 on basophils and eosinophils is not completely 
understood. 
iv) Actions on non-haematopoietic cells 
In addition to its effects on leucocytes, IL-8 also acts on non-haematopoietic cells 
such as epithelial cells, fibroblasts, melanoma cells and endothelial cells which 
express the receptors for IL-8. It has a variety of effects and these are discussed 
below. 
a) Neovascularization and angiogenesis 
IL-8 possesses an ELR motif before the first cysteine residues like other CXC 
chemokines which appears to confer angiogenic activity. IL-8 has been shown to 
mediate angiogenesis of endothelial cells (Koch et al., 1992; Li et al., 2003; Li et al., 
2005). Addition of human recombinant IL-8 results in a significant increase in 
angiogenesis of human umbilical vein endothelial cells (HUVECs). In addition, 
administration of a blocking antibody against IL-8 significantly inhibits the 
angiogenic activity present in the conditioned media of inflamed human rheumatoid 
synovial tissue macrophages or LPS-stimulated blood monocytes (Koch et al., 1992). 
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IL-8 also facilitates angiogenesis in a range of neoplastic conditions such as prostate 
cancer (Araki et al., 2007; Inoue et al., 2000; Kim et al., 2001), melanoma (Bar-Eli 
1999) and pancreatic cancer (Wente et al., 2006). Administration of anti-IL-8 
antibody decreases tumourigenicity and neovascularization of bronchogenic cancer 
cell lines in SCID mice (Arenberg et al., 1996a). 
All these findings suggest that IL-8 production by tumours may regulate 
neovascularization and in due course tumour growth and metastasis. Additionally, 
tissue injury mediated local IL-8 production may facilitate wound healing through 
angiogenesis. 
b) Role as an autocrine growth factor 
Endothelial cells are a major source of IL-8 and this expression is regulated by 
inflammation, infection, stress and interaction with tumours (Liang et al., 2002; 
Ramjeesingh, Leung, and Siu 2003; Sica et al., 1990; Vadeboncoeur et al., 2003). 
Several reports have demonstrated that IL-8 directly modulates endothelial cell 
proliferation and migration and regulates angiogenesis in vitro and in vivo in a 
paracrine manner (Koch et al., 1992; Masood et al., 2001). Neutralizing antibody to 
IL-8 results in inhibition of endothelial cell proliferation and MMP-2 production 
compared to controls (Li et al., 2005). In addition, IL-8 can also act as a growth factor 
for tumour cells in pancreatic and lung cancer (Kamohara et al., 2007; Zhu et al., 
2004; Zhu and Woll 2005). 
Melanoma cells produce IL-8 in vitro (Schadendorf et al., 1993) and possess specific 
receptors for IL-8 (Varney et al., 2003). It also enhances proliferation of some 
melanoma and lung cancer cell lines (Norgauer, Metzner, & Schraufstatter 1996; 
Schadendorf et al., 1993; Zhu et al., 2004) suggesting that it can act as an autocrine 
growth factor in tumour progression. 
c) Role in health and disease 
IL-8 appears to play a role in a variety of diseases that are characterised by neutrophil 
accumulation. IL-8 has been demonstrated in a number of inflammatory conditions 
such as psoriasis, scleroderma and Crohn's disease (Gijsbers et al., 2004; Kreuter et 
al., 2006; Ozawa, Terui, and Tagami 2005). Stimulation of synoviocytes in 
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rheumatoid arthritis leads to up-regulation of IL-8 release (Cho et al., 2007; Hwang et 
al., 2004; Nanki et al., 2001). This local IL-8 production facilitates neutrophil 
accumulation which is a major source of cartilage-degrading enzymes. 
A role for IL-8 has been reported in adult respiratory distress syndrome (ARDS). An 
increase in the bronchoalveolar fluid level of IL-8 has been shown in ARDS patients 
(Miller et al., 1992). This level correlates with the incidence of ARDS development in 
patient groups at risk (Donnelly et al., 1993). IL-8 also plays an important role in the 
pathogenesis of glomerulonephritis. Urine IL-8 levels are elevated and 
immunoreactive IL-8 protein is detected in infiltrating mononuclear cells in glomeruli. 
Anti-1L8 antibody reduces neutrophil infiltration into glomeruli and abrogates the 
impairment of renal function (Wada et al., 1994a; Wada et al., 1994b). 
An up-regulation of IL-8 serum level is seen in recurrent aphthous ulcers of the oral 
cavity and in lichen planus suggesting its use as a marker for these diseases (Sun et 
al., 2004; Sun et al., 2005). However, no IL-8 protein expression on oral mucosal 
keratinocytes in oral lichen planus (OLP) or oral lichenoid reactions (OLR) is seen in 
vivo (Little et al., 2003). On the contrary, suprabasal epidermal keratinocytes express 
IL-8 in active regions of psoriatic plaques. A possible explanation for this may be the 
difference in inflammatory reaction between these lesions. In psoriasis, the 
inflammatory infiltrate predominantly consists of neutrophils whereas that is not the 
case in OLP or OLR. Since IL-8 is a potent neutrophil chemoattractant, this would 
explain IL-8 expression in psoriasis and not in OLP. 
IL-8 also appears to play an important role in wound healing. IL-8 expression is 
induced in the superficial wound bed within 24 hours and is associated with 
neutrophil infiltration. A strong correlation exists between IL-8 expression, 
angiogenesis and keratinocyte migration. This IL-8 expression starts decreasing with 
wound re-epithelialization and becomes undetectable after wound closure at four 
days. However, neutrophils consistently express IL-8 throughout the process 
(Engelhardt el at., 1998). 
Sfakianakis et al. compared expression of normal gingival epithelium with inflamed 
tissue and suggested that IL-8 expression by gingival keratinocytes is up-regulated by 
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microbial pathogens and influences polymorphonuclear cell chemotaxis, angiogenesis 
and epithelial proliferation via specific receptors in periodontitis (Sfakianakis, Barr, 
and Kreutzer 2002). However, their study was a small one in which they only showed 
expression of IL-8 in both normal and inflamed oral tissue. No significant difference 
in IL-8 expression between normal and inflamed tissue is noticeable from their results 
and no experiments were conducted to study the role of IL-8 in chemotaxis, 
angiogenesis or epithelial proliferation. Huang et al. also studied the role of IL-8 in 
periodontitis and showed an up-regulation of IL-8 and ICAM-1 expression after 
stimulation with A. actinomycetemcomitans or F. nucleatum but not with P. gingivalis 
which down-regulated IL-8 secretion from oral epithelial cells. However, this 
decrease in IL-8 production was only seen with adherent strains of P. gingivalis 381 
and 33277. Poorly invasive and non-adherent P. gingivalis strains W50 and W83 did 
not have a similar effect suggesting that attachment and invasion of P. gingivalis are 
mandatory for IL-8 down-regulation (Huang et al., 1998; Huang et al., 2001a; Huang, 
Haake, and Park 1998). 
1.2.13.5 Expression of CXCR1, CXCR2 and IL-8 in tumours 
Expression of both CXCR1 and CXCR2 has been observed in a wide variety of 
tumours including gastric carcinoma (Eck et al., 2003a), nasopharyngeal carcinoma 
(Horikawa et al., 2005) lung cancer (Zhu et al., 2004), colon carcinoma cell lines 
Caco-2, KM12C and KM12L4 (Li, Varney, and Singh 2001), malignant melanoma 
(Varney, Johansson, and Singh 2006) and melanoma-derived cell lines A375P, 
A375SM and SBC-2 (Varney et al., 2003). In addition, CXCR2 is expressed 
consistently in acute lymphomblastic leukaemias of B-lineage (Corcione et al., 2006). 
IL-8 is also produced by a variety of tumours. Tumours such as human transitional 
cell carcinoma and renal cell carcinoma express IL-8 both constitutively and in 
response to cytokines (Abruzzo et al., 1992). IL-8 is expressed in vivo in primary 
gastric carcinoma (Eck et al., 2003b) as well as in colon carcinoma cell lines Caco2, 
KM12C and KM12L4 (Li, Varney, and Singh 2001). Expression in non-small lung 
cancer (Wang et al. 1996), breast cancer (Miller et al., 1998) pancreatic (Kamohara et 
al., 2007) and prostate cancer cells (Inoue et al., 2000) has also been reported. 
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1.2.13.6 Role of CXCRI, CXCR2 and IL-8 in tumour biology 
As mentioned earlier, IL-8 can act as an angiogenic agent in tumours. In addition, the 
interaction of IL-8 with CXCRI and CXCR2 on cancer cells can yield a number of 
other responses. 
i) Proliferation 
IL-8 mediates in vitro proliferation of epithelial cells in a number of tumours 
including prostate (Araki et al., 2007), melanoma (Varney et al., 2003), non small cell 
lung carcinoma (Luppi et al., 2006), colon (Li, Varney, and Singh 2001), breast (Yao 
et al., 2007), hepatocellular (Akiba et al., 2001) and epidermoid cancer cells (Metzner 
et al., 1999). Individual roles for CXCR1 and CXCR2 in IL-8 mediated proliferation 
have also been studied. IL-8 increases proliferation in melanoma and prostate cancer 
through both CXCR1 and CXCR2 as addition of antibodies to either receptor 
significantly decreases proliferation (Murphy et al., 2005; Varney et al., 2003). 
However, another study showed that CXCR1 plays a more important role in IL-8 
mediated proliferation in prostate cancer than CXCR2 (Araki et al., 2007). The 
findings of Metzner et al., indicate that CXCR2 is the predominant receptor in IL-8 
mediated proliferation in epidermoid carcinoma compared with CXCR1 (Metzner et 
a!., 1999). This suggests that different cells may respond in a different manner to IL-8 
and that signaling through CXCR1 or CXCR2 may vary depending upon the cell type 
or the response. 
ii) Migration and invasion 
Exposure to IL-8 causes migration and invasion of a variety of cancer cells in vitro 
including ovarian (So et al., 2004), breast (Kim et al., 2005; Yao et al., 2007) colon 
(Li, Varney, and Singh 2001), gastric (Kitadai et al., 2000) pancreatic (Kuwada et al., 
2003) and hepatocellular cancer (Kubo et al., 2005). Some data exists regarding the 
individual roles of CXCR1 and CXCR2 in IL-8 induced cell migration. Migration of 
colon carcinoma cells is mediated through CXCRI and not CXCR2 (Bates, DeLeo, 
III, and Mercurio 2004). In contrast, CXCR2 and not CXCR1 appears to mediate 
migration of HUVECs and human dermal microvascular endothelial cells (HMECs) 
towards IL-8 (Li et al., 2005). However the individual roles of CXCRI and CXCR2 
in cancer cell migration and invasion need to be characterized further. 
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1.2.13.7 Expression and role of CXCRI, CXCR2 and IL-8 in oral cancer 
Expression of both IL-8 receptors CXCR1 and CXCR2 has been reported in OSCC in 
vitro and in vivo. Head and neck squamous cell carcinoma (HNSCC) cells and 
associated microvascular endothelial cells (MVEC) express both receptors and IL-8 in 
vivo and staining intensity is much higher in well-differentiated cells within the 
tumour compared to basal layer and normal oral epithelium (Richards et al., 1997). 
However this group did not perform any in vitro studies and did not provide any 
comparison of staining intensity or pattern between normal and cancerous oral 
epithelial cells even though controls were included in the study. 
IL-8 expression has been reported in fresh tumour homogenates as well as primary 
cultures of HNSCC and continuous HNSCC cell lines. Stimulation of both primary 
culture and cell lines with IL-1 and TNF significantly up-regulates IL-8 expression 
while no such effect is observed with other cytokines (Cohen et al., 1995). This 
suggests that IL-8 expression in HNSCC may be regulated by cytokines such as IL-1 
and TNF. 
IL-8 is detected in the supernatants of I-INSCC cultures derived from cell lines as well 
as primary tumours. Serum concentration of IL-8 is significantly higher in OSCC 
patients compared with healthy controls and a correlation exists between IL-8 serum 
concentration and primary tumour volume (Chen et al., 1999). An association 
between IL-8 gene polymorphism and OSCC risk has also been shown. 
Polymorphism of IL-8 (-251 A/T) which influences IL-8 gene expression, is directly 
proportional to increased OSCC risk (Vairaktaris et al., 2007). This suggests a role for 
IL-8 in the biology of OSCC and it may hold potential as a biomarker 
IL-8 expression is induced in oral and pharyngeal tumour cells in vitro after 
stimulation with fibrin while fibrinogen, thrombin and collagen are unable to do so 
(Lalla et al., 2001). IL-8 expression is also observed in the cytoplasm of OSCC tissue 
sections adjacent to fibrin deposition in vivo again suggesting a possible association 
between fibrin and IL-8 in OSCC (Lalla et al., 2003). It appears that fibrin can 
stimulate production of tumourigenic agents such as IL-8 from the tumour cells. Since 
IL-8 is a potent angiogenic factor, another possibility is that new blood vessel 
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formation facilitates increased fibrinogen outflow into the tumour microenvironment. 
This fibrinogen (after conversion into fibrin) can cause a further increase in IL-8 
production. However, this interaction needs to be studied in much more detail to 
establish the precise relationship between fibrin and IL-8 in OSCC. 
In SCID mice, secretion of IL-8 by endothelial cells in OSCC overexpressing BCI-2 is 
up-regulated and directly induces angiogenesis and proliferation. Addition of an anti- 
IL-8 antibody significantly reduces both (Nor et al., 2001). In addition, systemic 
treatment of these SCID mice with anti-IL-8 antibody significantly reduces tumour 
weight and volume whereas no such effect is observed in the control group. 
Administration of an anti-IL-8 antibody also facilitates a significant decrease in 
tumour neovascularization compared with controls. However, this group did not study 
the expression or role of CXCR1 and CXCR2 in their experimental model and 
therefore it is not known which receptor is more important in mediating these effects. 
Constitutive in vitro expression of CXCRI, CXCR2 and IL-8 is observed in the HSC- 
4 and NA oral cancer cell lines (Watanabe et al., 2002). CXCRI expression is higher 
in these cells lines compared with CXCR2 and this expression is not affected by 
addition of TNF-a and IL-1p. However, IL-8 expression is significantly up-regulated 
after stimulation with TNF-a and IL-Iß suggesting that cytokines in the tumour 
microenvironment may regulate IL-8 release by OSCC cells. Exposure to IL-8 causes 
migration and invasion of NA and HSC-4 cells in vitro in a dose dependent manner. 
Administration of both CXCRI and CXCR2 blocking antibodies partially inhibits IL- 
8 mediated migration but does not reduce it to control levels. The 
migrational/invasive capacity of oral cancer cells appears proportional to the 
expression levels of IL-8 receptors as HSC-4 cells expressing higher levels of CXCRI 
and CXCR2 migrate and invade more than the NA cells (Watanabe et al., 2002). 
However this study has a number of shortcomings. All of their experiments were 
performed in vitro and no in vivo studies were carried out to corroborate the in vitro 
findings. Expression of CXCRI and CXCR2 was not studied at mRNA level. Also, 
they did not compare expression of CXCRI and CXCR2 on oral cancer cells to that 
on normal oral keratinocytes which may have provided some valuable insight into the 
difference in expression and behaviour between normal and cancerous oral epithelial 
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cells. Furthermore, they did not use blocking antibodies against CXCRI and CXCR2 
to study their individual roles in IL-8 mediated cell invasion. 
To summarize, IL-8 and its receptors CXCRI and CXCR2 are expressed in malignant 
oral epithelial cells. IL-8 appears to mediate angiogenesis, proliferation, migration and 
invasion in OSCC but whether this is mediated by CXCRI or CXCR2 is not well 
characterized. Migration appears to be mediated through both CXCRI and CXCR2 
whereas the roles of the receptors in angiogenesis, proliferation or invasion are not 
known. Overall, these findings suggest an important role for IL-8 in the biology of 
OSCC. 
1.2.14 AIMS AND OBJECTIVES 
As mentioned previously in Section 1.2.8, the preliminary microarray results 
suggested that mRNA for XCRI is present in both normal oral epithelial cells as well 
as oral cancer cell lines. However it is not known whether XCR1 is expressed on the 
surface of these cells and if so whether the oral cells respond to its ligand 
lymphotactin. 
The micro-array data also suggested that CXCRI mRNA appears to be up-regulated 
in oral cancer cell lines compared with normal oral epithelial cells. However it is not 
known whether normal and malignant oral epithelial cells differ in their response to 
IL-8, the ligand for CXCRI, or if its effects are mediated through CXCR2, the 
alternate IL-8 receptor. 
1.2.14.1 Aim 
The overall aim of this study is to investigate the roles of XCRI and its ligand 
lymphotactin and CXCRI and CXCR2, receptors for IL-8 in the regulation of both 
normal and malignant oral epithelial cell behaviour. 
1.2.14.2 General Objectives 
1. To confirm the preliminary data and determine whether XCRI, CXCRI and 
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CXCR2 are expressed by normal and malignant oral epithelial cells. 
2. To determine whether these receptors are functional on the surface of normal 
and cancer cells and respond to their respective ligands. 
1.2.14.3 Specific Objectives 
1. To determine whether mRNA for XCR1, CXCRI and CXCR2 is present in 
normal oral keratinocytes (NOK) and oral cancer cell lines (OCCL). 
2. To determine whether XCRI, CXCR1 and CXCR2 are expressed on the 
surface of NOK and OCCL. 
3. To determine whether XCR1, CXCR1 and CXCR2 are functional on the 
surface of these cells and can respond via signal transduction, migration, 
invasion and proliferation. 
4. If these receptors are functional, to find out whether there is any difference in 
response of normal and malignant oral epithelial cells. 
1.2.15 EXPERIMENTAL DESIGN 
The following techniques will be used to determine whether NOK express XCRI, 
CXCRI and CXCR2 receptors in vitro. 
1. RT-PCR will be employed to study receptor expression at mRNA level. 
2. Immunocytochemistry and flow cytometry will be used to study receptor 
expression at the protein level. 
3. A cell-based ELISA will be performed to study signal transduction in oral 
epithelial cells in response to the ligands for the receptors. 
4. Migration/chemotaxis and invasion assays will be performed to study effect on 
cell migration and invasion. 
5. Proliferation assays will be performed to study the role of these receptors and their 
ligands in cell proliferation. 
For this purpose, primary oral keratinocytes and gingival fibroblasts will be grown 
along with a range of oral cancer cell lines (derived from oral squamous cell 
carcinoma) for comparison. The melanoma cell line A375P and isolated neutrophils 
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will be used as positive controls for CXCR1 and CXCR2 as they have been shown to 
express CXCRI and CXCR2 previously (Moser et al., 1993; Varney et al., Singh 
2003). The T-cell leukaemia cell line Jurkat and isolated neutrophils will be used as a 
positive controls for XCRI (Blaschke et al., 2003; Huang et al., 2001b). 
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2.1 INTRODUCTION 
A number of factors have to be taken into consideration while studying the 
physiological or pathological significance of a cell surface receptor. First, it is 
essential to show that the mRNA for the receptor is present. Second, the receptor 
should be expressed on the cell surface, and third, stimulation of the receptor should 
result in a functional response. 
Therefore, first of all mRNA expression of XCRI, CXCRI and CXCR2 was studied 
to confirm expression in normal and cancerous oral epithelial cells. 
2.2 AIM 
The aim of this chapter was to establish whether the mRNA for XCR1, CXCR1 and 
CXCR2 is present in normal and malignant oral cells. 
2.3 EXPERIMENTAL PROTOCOL 
RT-PCR was used for subjective analysis of mRNA expression. The following 
methods were used in conjunction: 
  Normal oral keratinocytes (NOK), normal skin keratinocytes (NSK) and oral 
cancer cell lines (OCCL) (H357, TR146, SCC4, SCC25, CAL27, FADU) were 
cultured along with human gingival fibroblasts (HGF). 
  A375P cell line was used as a positive control for CXCRI and CXCR2 as it has 
been previously shown to express these two receptors (Varney et al., 2003). 
  Commercially available neutrophil RNA (Ambion) was used as positive control 
for XCR1 as well as CXCR1 and CXCR2. 
  RNA was isolated from the cultured cells to be used for RT-PCR. Isolated RNA 
was quantified and its quality checked using gel electrophoresis and 
spectrophotometry. 
  Primers were designed for all receptors (sense and anti-sense). 
  DNase-treatment of all RNA samples was carried out to eliminate the risk of false 
positive results due to genomic DNA contamination. 
  RT-PCR was carried out at least three times for XCRI, CXCR1 and CXCR2. 
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2.4 MATERIALS AND METHODS 
2.4.1 CELL CULTURE 
2.4.1.1 Cell types 
The following cells were used in this study. 
1. Primary cells (Non-cancerous) 
i. Primary human gingival fibroblasts (HGF) 
Primary human gingival fibroblasts (HGF) were obtained from the department 
archive of frozen cells (Department of Oral Pathology, University of Sheffield). 
These cells were originally obtained from clinically healthy gingival tissue removed 
during third molar extraction and originally frozen in 1999. 
ii. Primary Normal oral keratinocytes (NOK) 
Normal oral keratinocytes (NOK) were a gift from Jonathan Collier (Barts and The 
London). These cells were obtained from clinically healthy tissue removed during 
third molar extraction and frozen down after second passage. 
iii. Primary normal skin keratinocytes (NSK) 
Normal skin keratinocytes (NSK) were a gift from Jonathan Collier (Barts and The 
London). They were established from normal skin removed at the time of breast 
reduction surgery and frozen at the time of first passage in 2002. 
2. Established cancer cell lines 
1. H357 
The cell line H357 was a gift from Prof. Steve Prime (Bristol) and is derived from a 
well differentiated oral squamous cell carcinoma from the tongue of a 74 year old 
male (Prime et al., 1990). The original tumour was less than 4cm in diameter with 
regional lymph node involvement but no distant metastases. 
ii. TR146 
The continuous cell line TR146 is derived from a human neck metastasis originating 
from a buccal carcinoma (Rupniak et at., 1985). 
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iii. SCC4 
The SCC4 cell line (ATCC, CRL-1624) is derived from a squamous cell carcinoma of 
the tongue of a 55 year old male (Rheinwald and Beckett 1981). 
iv. SCC25 
The SCC25 cell line (ATCC, CRL-1628) is derived from a squamous cell carcinoma 
of the tongue of a 70 year old male (Rheinwald and Beckett 1981). 
v. CAL27 
The CAL27 cell line (ATCC, CRL-2095) was established in 1982 from tissue taken 
prior to treatment from a 56 year old caucasian male with OSCC of the middle of the 
tongue (Gioanni et al., 1988). CAL27 cells are epithelial, polygonal with a highly 
granular cytoplasm. 
A. FaDu 
The FADU cell line (ATCC, HTB-43) was established in 1968 from a hypo- 
pharyngeal tumour removed from a 56 year old patient (Rangan 1972). The 
established line contains bundles of tono-filaments in the cell cytoplasm and 
desmosomal regions are prominent at cell boundaries. 
vii. A375P 
The A375P cell line, a variant of A375 cell line (ATCC, CRL-1619) is derived from 
malignant melanoma of a 53 year old female (Giard et al., 1973). 
viii. JURKAT 
The Jurkat cell line (ATCC, TIB-152) was established from the peripheral blood of a 
14 year old boy and expressed characteristics of leukaemic T cells in addition to 
complement receptors (Schneider, Schwenk, and Bomkamm 1977). 
2.4.1.2 Media for Cells 
NOK and H357 cell line were cultured in keratinocyte growth medium (KGM) 
(Formanek et al., 1996) independent of fibroblast feeder cells (Appendix 10.1.1). 
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CAL27, FADU and Jurkat cells were cultured in RPMI-1640 with 25mM Hepes and 
L-Glutamine (Invitrogen, Carlsbad, CA, USA) (Appendix 10.1.4). 
HGF, TR146 and A375P cells were grown in Dulbecco's Modified Eagle Medium 
(Invitrogen) (Appendix 10.1.2). Medium for SCC4 and SCC25 cells was prepared 
using DMEM: F12 (1: 1 Mix) with 15mM Hepes and L-Glutamine (Invitrogen) 
(Appendix 10.1.3). All media contained 10% foetal bovine serum (Invitrogen), 
penicillin/streptomycin (Invitrogen) and fungizone/Amphotericin B (Invitrogen) 
unless otherwise specified. 
2.4.13 Culture of cells 
Cells were cultured in 12m1 of their respective media in T75 cm2 flasks (Nunc 
GmbH, Wiesbaden, Germany) at 37°C in 5% CO2 and 99% humidity. They were fed 
every third day. 
2.4.1.4 Passaging of cells 
All cell lines were cultured in T75cm2 tissue culture flasks until confluent and 
passaged. Medium was removed from the flasks by aspiration and 5ml of sterile 
phosphate buffered saline (PBS) used to wash the cells. 3m1 trypsin/EDTA 
(Invitrogen) was introduced in the flask after PBS removal. The flask was incubated 
in a CO2 incubator until the cells could be dislodged by gentle agitation. 3ml of 
medium was added to neutralize the trypsin. This cell suspension was transferred to a 
15m1 conical centrifuge tube and centrifuged for 5min at 1000rpm. Medium was 
removed by aspiration taking special care to avoid removing the cell pellet at the base 
of the tube. Cells were re-suspended in 2m1 of their respective fresh medium and lml 
of this added to two new T75cm2 flasks containing I1 ml of fresh medium. The flasks 
were labelled and placed in a CO2 incubator at 37 °C in 99% humidity. 
The Jurkat cell line grows in suspension and does not require trypsin for removal from 
the tissue culture flask. Cell suspension was removed from the flask, added to a 
conical centrifuge tube and centrifuged as described previously. Medium was 
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aspirated and cells were re-suspended in fresh medium before being added to a new 
flask. 
2.4.2 RNA EXTRACTION AND ISOLATION 
2.4.2.1 RNA Extraction 
RNA extraction was carried out when the cells were 80-100% confluent. Trizol 
(Invitrogen) which is a reagent for total RNA isolation was used for this purpose. 
Medium was removed from the T75cm2 flasks and I ml of Trizol added to each flask. 
The entire growth surface of the flask was thoroughly wetted with Trizol and a cell 
scraper used to harvest the cells. This mixture of Trizol and cells (cell lysate) was 
transferred to a 2m1 micro-centrifuge tube. Samples were homogenized by vigorous 
pipetting, allowed to stand for 10min and archived at -80° C to be isolated later. 
2.4.2.2 RNA Isolation 
A range of materials were used for isolation and analysis of RNA (Appendix 10.2.1 
and 10.2.2). 
Cell lysates were allowed to warm to ambient temperature after retrieval from the - 
80°C archive and 200µ1 of chloroform (Sigma, Dorset, UK) was added to each 
sample. The sample was covered, shaken vigorously for 20sec and incubated at room 
temperature (RT) for 10min. The mixture was then centrifuged at > 10,000xg for 
15min at 4°C. This separated the mixture into three phases i. e. the colourless upper 
aqueous phase (containing the RNA), a semi-solid interphase (containing most of the 
DNA), and a lower organic phase. The upper aqueous phase was carefully transferred 
into a clean RNase-free tube without disrupting the interphase, followed by the 
addition of lml of isopropanol (Sigma), mixed well and incubated at RT for 10min. 
The samples were then centrifuged at > 10,000xg for 15min at 4°C to pellet the RNA. 
The supernatant was decanted and the pellet washed with lml of cold 75% ethanol 
(Sigma) by vortexing. Samples were centrifuged at > 7,500xg for 5min at 4°C. The 
supernatant was discarded and the pellet air dried for 10min. RNA was re-suspended 
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in 100µl of RNase-free water (Sigma). Brief vortexing was carried out to aid re- 
suspension. 
RNA was extracted from identically prepared samples from separate experiments. All 
dilutions and reagents were prepared in RNase-free water. 
2.4.2.3 DNase Treatment of RNA 
A final RNA concentration of 10µg was used in a 50µ1 solution. The following 
reagents were used: 
  RNase-free DNase 10 µl (1 pl per pg of RNA) 
(Promega, Madison, WI, USA) 
  Buffer 5 µl 
(Promega) 
  RNase-free Water variable 
Samples were mixed and incubated at 37°C for 30 min. 
2.4.2.4 RNA Re-isolation 
A 50/50 volume mixture of phenol and chloroform was prepared. 5011l of this solution 
was added to the DNase-treated samples and mixed by vortexing. Samples were then 
centrifuged at 10,000 rpm for 5min. The upper aqeous phase was removed and 
sodium acetate (0.1 vol. ) (Sigma) and ethanol (2.2 vol. ) (Sigma) added. Samples were 
placed in a freezer for one hour to facilitate RNA precipitation. Centrifugation at 4°C 
at 10,000 rpm was performed after removal from the freezer to pellet the RNA. The 
supernatant was discarded and the pellet washed with lml of cold 75% ethanol 
for 5min. The supernatant was decanted and the pellet air dried for 5-10 min. 
RNA was re-suspended in 50µl RNase-free water. Brief vortexing was carried out to 
aid re-suspension. 
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2.4.3 ANALYSIS OF ISOLATED RNA 
2.4.3.1 Spectrophotometry 
A 1: 100 dilution of all purified RNA samples was made (1µl sample + 99µl of RNase- 
free water). 100µl RNase-free water was used to blank the spectrophotometer. Water 
was discarded, the cuvette dried and the diluted sample read at 260nm (Al) and 
280nm (A2). Al, A2 readings and the Al : A2 ratios were recorded and amount of 
isolated RNA calculated. Spectrophotometric analysis was performed on all RNA 
samples (Appendix 10.2.3.1). 
2.4.3.2 RNA gel electrophoresis 
A 1% agarose gel was prepared by heating lg of RNase-free agarose (Sigma) in 72ml 
RNase-free water until dissolved, then cooled to 60°C. 10ml of MOPS running buffer 
(10x) (Eppendorf, Hamburg, Germany) and 18m1 of 37% formaldehyde (12.3 M) 
(Sigma) were added to this mixture. 
IOx MOPS running buffer contains: 
  0.4 M MOPS, pH 7.0 
  0.1 M sodium acetate 
  0.01 M EDTA 
The gel was poured after placing a teflon comb and enough lx MOPS running buffer 
added to cover the gel by a few millimetres. The comb was removed and RNA 
samples were prepared by adding 0.5 x sample loading buffer (Sigma) to 1-3µI of 
RNA. Samples were heat denatured at 65-70°C for 5min. The gel was loaded and run 
at 90mV for 2/3`d of the length of the gel. The 28S and 18S bands for RNA were 
visualized on a UV transilluminator and a visual record was made using GeneSnap 
software (Syngene, Cambridge, UK) (Appendix 10.2.3.2). 
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2.4.4 Reverse Transcriptase-Polymerase Chain Reaction 
(RT-PCR) 
2.4.4.1 Primer design 
Primers for XCRI, CXCR1 and CXCR2 were designed using Primer3 which is a 
web-based primer designing application (Rozen and Skaletsky). Specificity of the 
primers was tested using the Basic Local Search Alignment Tool (BLAST) (Altschul 
et al., 1997). 
Following sequences were used: 
i. XCRI 
F/Sense: AGCTGGGGTCCCTACAACTT 
R/Anti-sense: GACCCCCACGAAGACATAGA 
i. CXCR1 
F/Sense: AGCTTCTGTTCCGTGCTTGT 
R/Anti-sense: TGTGGACAAAGGGATCTTCC 
ii. CXCR2 
F/Sense: ACAGCTACTTGGGAGGCTGA 
R/Anti-sense: ATGGGTTCAAGTCCCTGCTT 
2.4.4.2 RT reaction 
The RT master mix per reaction was prepared as follows: 
  MgCI2 Buffer 4µ1 
(Promega) 
  dNTPs I VI 
  RNase inhibitor 0.5µl 
(Promega) 
  AmV RT buffer 0.5µ1 
(Promega) 
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  Oligo dT O. 5µ1 
(Promega) 
6.5µ1 of master mix was transferred to individual reaction tubes. 1 µg/ml of RNA for 
each sample was added and the total volume made up to 20µl using RNase-free water. 
All samples were placed in a DYAD PCR machine and the following program was 
used: 
  42 °C for one hour 
  95 °C for 5 min 
  4°C forever 
2.4.4.3 PCR 
The PCR master mix per reaction was prepared as follows: 
  MgC12 free buffer 2.5µl 
(Promega) 
  dNTPs 1µl 
  MgC12 2µI 
(Promega) 
  Taq polymerase 0.2µl 
(Promega) 
  H2O l7.3µ1 
  Sense/forward primer I µl 
  Antisense/reverse primer 1µl 
24µl of this mix was transferred to respective PCR tubes and 1µl of cDNA was added. 
Samples were placed in a DYAD PCR machine and the following program was used: 
  94 °C for 1 min (Denaturation) 
  60 °C for 2 min (Annealing) 
  72 °C for 3 min (Extention) 
After 35 cycles of the above mentioned program, the following steps were carried out: 
  72 °C for 7 min (Final extention step) 
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 4 °C forever (cooling cycle) 
2.4.4.4 Gel for PCR products 
A 1? o agarose gel was prepared by adding 1.5g agarose (Sigma) to I50rnl of IxTAE 
buffer (Tris base, acetic acid EDTA) (Invitrogen) and dissolved by heating in a 
microwave. After allowing the gel to cool, l pi of ethidiurn bromide (Sigma) was 
added and mixed. The gel was then poured into the gel-casting tray containing aI nun 
16-space teflon comb. A mixture of the PCR sample (12µI) and loading dye (2pl) 
(Sigma) was loaded in each well and separated by running in TAE buffer at 90V for 
40-60min along with 4µI DNA hyper ladder IV (Biolire, Taunton, MA, USA). The 
gel was viewed using a UV-transillunninator and a photographic record was made. 
2.5 RESULTS 
2.5.1 mRNA EXPRESSION OF XCR1 
All tested cells showed mRNA for XCRI. A band for XCRI mRNA was seen at 169 
base pairs (bp) in the positive control (neutrophil RNA). A similar band was observed 
in NOK, NSK and HGF. XCRI mRNA was also seen in all tested OCCL and 
surprisingly, A375P cells (positive control for CXCRI and CXCR2) (Figure 2.1). 
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H357 SCC4 SCC25 TR146 CAL27 FADU N A375P 
Figure 2.1. mRNA Expression of XCR1 (Where N denotes Neutrophil RNA) (Representative 
picture) Arrow indicates the PCR product of 169bp. Bands were strongest for neutrophils, 
CAL27, FaDu whereas NOK, HGF, TR146 and A375P showed weak bands 
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2.5.2 mRNA EXPRESSION OF CXCRI AND CXCR2 
A band for CXCRI mRNA was observed in the positive controls (neutrophil RNA 
and A375P) at 200bp. However, the band for A375P was very weak even though it 
has been shown to express CXCRI previously (Varney et ul., 2003). Expression was 
also observed in NOK and HGF (Figure 2.2). The band for NOK appeared stronger 
than HGF. CXCRI mRNA was also detected in OCCL however bands appeared 
much weaker for SCC25 and TRI46 cells compared with other cells. Multiple bands 
were observed for some cells. 
NOK HGF H357 SCC4 SCC25 TR146 CAL27 FADU A375P N 
200 BP 
Figure 2.2. mRNA Expression of CXCR1 (Where N denotes Neutrophil RNA) (Representative 
picture). Bands were strongest for neutrophils, SCC4 and FaDu whereas NOK and TR146 
showed weaker bands followed by HGF and SCC25. Surprisingly, the A375P cells which 
were used as positive control also showed very weak band density. 
CXCR2 mRNA was also observed in the neutrophils along with NOK and HGF. A 
very weak band was observed for HGF compared with NOK. H357, SCC4, CAL27 
and FaDu showed a strong hand for CXCR2. SCC25 and TR 146 cells showed a very 
weak band as did the A375P cells (used as positive control) even though strong 
CXCR2 mRNA has been reported before (Varney et ul., 2003) (Figure 2.3). 
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Figure 2.3. mRNA Expression of CXCR2 (Where N denotes Neutrophil RNA) (Representative 
picture). Bands were strongest for neutrophils, H357, SCC4, CAL27 and FaDu whereas NOK, 
HGF, SCC25 and TR146 showed weaker bands. The A375P cells which were used as 
positive control also showed very weak band density. 
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2.6 DISCUSSION 
Preliminary microarray results had shown expression of XCRI in NOK and OCCL 
and RT-PCR was used to corroborate these findings. A band for XCR1 was present at 
169bp in neutrophil RNA and this is agreement with existing literature as XCRI 
mRNA has previously been shown in neutrophils (Huang et al., 2001). A similar band 
was also observed in all tested cells including NOK, HGF and all OCCL (H357, 
TR146, SCC4, SCC25, CAL27 and FADU). Interestingly, a band was also observed 
in the melanoma cell line A375P. Variability in band density was seen between 
different cell types which could not be quantified as RT-PCR only provides a 
subjective assessment of mRNA expression. It is therefore not clear whether this 
variability represents differences in the levels of mRNA. 
A band for CXCR1 mRNA was detected in the positive controls (neutrophil RNA and 
the A375P cell line) at 200bp which is consistent with previous findings (Moser et al., 
1993; Varney et al., 2003). A 200bp band was also seen in both normal and cancerous 
oral cells. Similar results were obtained for CXCR2. A 202bp band for CXCR2 
mRNA was observed in OCCL as well as the positive controls (Neutrophils and 
A375P). Expression in NOK was also detected but HGF appeared negative for 
CXCR2. 
To our knowledge, XCR1 mRNA has predominantly been shown in lymphoid cells 
(Huang et al., 2001). Recent reports have shown XCR1 mRNA in fibroblast-like 
synoviocytes (Blaschke et al., 2003) and in melanoma cells lines (Seidl et al., 2007). 
However, the significance of this expression is not completely understood. Moreover, 
XCRI mRNA in epithelial cells has not been reported to date. Expression of CXCR1 
and CXCR2 on oral epithelial cells has only been shown at protein level (Sfakianakis, 
Barr, and Kreutzer 2002; Watanabe et al., 2002). CXCRI and CXCR2 mRNA was 
also seen in HGF which has not been reported before. 
The RT-PCR results confirmed that the message for XCRI, CXCRI and CXCR2 is 
present in both normal and cancerous oral epithelial cells at RNA level. Therefore, the 
next step was to study protein expression of the receptors. 
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2.7 INTRODUCTION 
The RT-PCR results in the previous section showed that mRNA for XCRI, CXCRI 
and CXCR2 is present in oral epithelial cells. Therefore, it was important to establish 
whether this mRNA is translated into protein and expressed on cell surface. 
2.8 AI51 
The aim of this chapter was to establish whether XCR1, CXCR1 and CXCR2 are 
expressed on the surface of normal and cancerous oral cells. 
2.9 EXPERIMENTAL PROTOCOL 
The following methods were used: 
1. Cell Culture 
  NOK, HGF and OCCL were cultured as previously described. 
" A375P cell line and isolated neutrophils were used as positive controls for 
CXCRI and CXCR2 (Varney et al., 2003; Moser et al., 1993). 
  The T-cell leukaemia cell line Jurkat and isolated neutrophils acted as positive 
controls for XCRI (Blaschke et al., 2003; Huang et al., 2001) 
2. Immunocytochemistry 
" Immunocytochemistry was performed on cultured monolayers of cells for 
subjective assessment of receptor expression at protein level. Staining was carried 
out at least three times for each cell type. 
3. Flow Cytometry 
" Flow cytometry was performed on cultured cells to quantify cell surface 
expression of XCRI, CXCR1 and CXCR2. Assay was performed three times for 
each cell type. 
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2.10 MATERIALS AND METHODS 
2.10.1 CELL CULTURE 
Cells were grown and maintained as previously described. 
2.10.2 IMMUNOCYTOCHEMISTRY 
2.10.2.1 Preparation of cultured cell monolayers 
Cells were detached from flasks using a non-enzymatic cell dissociation buffer 
(Sigma). Cells were seeded on BD-Falcon chamber slides (BD Biosciences, Franklin 
Lakes, NJ, USA) and grown for 48 hours before being washed and fixed with 2% 
paraformaldehyde for 10min at RT. Fixative was washed and slides were stored in 
PBS at 4°C to prevent drying. 
2.10.2.2 Immunocytochemistry protocol 
An indirect streptavidin-biotin immunoperoxidase technique was employed to detect 
expression in all the cell types. A Vectastain kit was used for this purpose (Vector 
Laboratories, Burlingame, CA, USA). A pilot study determined the optimum dilutions 
for the primary antibodies to be 20µg/ml. 
Slides recovered from storage were washed three times in PBS and endogenous 
peroxidase blocking achieved via 10min incubation with ChemMate peroxidase- 
blocking solution (Dako, Glostrup, Denmark) at RT. Cells were washed three times in 
PBS and serum block was applied for 30min at RT. 20µg/ml dilutions of primary 
antibodies were prepared using the blocking serum solution. The following primary 
antibodies were used: 
" Rabbit anti-human XCR1 antibody (Lifespan Biosciences, Seattle, WA, USA) 
" Mouse anti-human CXCRI antibody (R &D Systems, Minneapolis, MN, USA) 
" Mouse anti-human CXCR2 antibody (R &D Systems) 
Omission of the primary antibody and negative isotype antisera served & negative 
controls in the staining procedure. Cells were incubated with primary antibodies for 
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one hour and were washed in PBS three times. Secondary antibodies were prepared 
(provided with the Vectastain kit) and applied for 30min. ABC solution was prepared 
alongside secondary antibodies and allowed to stand for 30min before use (as 
recommended by the kit protocol). After removal of secondary antibodies, cells were 
washed three times in PBS and incubated with the ABC solution for 30min. After 
three more washes in PBS, the colouring solution (provided with the kit) was applied 
for 5min and slides washed with distilled water. Mayers haemotoxylin was used as a 
counterstain and slides were washed, dehydrated, cleared and mounted in DPX. 
Specimens were viewed and photographed using a digital camera. A red-brown 
staining reaction was considered a positive result when compared to negative controls. 
2.10.3 FLOW CYTOMETRY 
Single cell suspensions were prepared using a non-enzymatic solution (Sigma, Cat. 
No. Cat. No. C5914) and washed in staining buffer (PBS+2%FBS+1%BSA) by 
centrifugation (400xg, 5min, 4°C). The supernatants were discarded and cells re- 
suspended (lx106 cells/ml) in ice cold staining buffer. 2O0µl of cells were aliquoted 
into polypropylene tubes. The same antibodies as immunocytochemistry were used in 
this assay. Neutrophils were isolated from the blood of healthy volunteers and used as 
positive control XCR1, CXCR1 and CXCR2 (Appendix 10.3) 
Primary antibodies were added (20µg/m1), mixed by vortexing and incubated for 
30min at 4°C. Appropriate negative isotype antisera served as negative controls 
(Rabbit serum for XCR1, mouse immunoglobulin for CXCR1 and CXCR2) (Dako). 
Cells were washed three times in Iml staining buffer (400xg, 5min, 4°C), and re- 
suspended. The following FITC-conjugated secondary antibodies were added 
(10µd/million cells): 
" Swine anti-rabbit antibody (for XCR1), (Dako) 
" Goat anti-mouse antibody (for CXCRI and CXCR2), (Dako) 
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Cells were vortexed and incubated for 30min with secondary antibodies at 4°C in the 
dark. Cells were washed three times, re-suspended and kept on ice prior to analysis. 
Data was acquired on a FACSCalibur (BD Biosciences) and analyzed using F1owJo 
software (Tree Star, Ashland, OR, USA). Staining was considered positive when the 
percentage of positive cells for test antibodies was higher than the negative controls. 
2.11 RESULTS 
2.11.1 IMMUNOCYTOCHEMISTRY 
2.11.1.1 XCR1 
All tested cells stained consistently for XCRI. Staining was seen in NOK as well as 
HGF. Three distinct cell populations were observed in NOK i. e. a negative population 
and two positive ones, one with low staining intensity and a second with higher 
staining intensity. Staining in HGF however, was more uniform. Both NOK and HGF 
exhibited cell surface as well as cytoplasmic staining (Figure 2.4). 
OCCL (H357, TR146, SCC4) also stained for XCR1. In H357 cells (like NOK) three 
different populations were noticed as some cells showed stronger staining intensity 
than others and negative cells were also observed. This staining pattern was not 
observed in TR146 and SCC4 cells. Surprisingly, A375P cells (used as positive 
control for CXCRI and CXCR2) also consistently stained positive for XCR1. In all 
cancer cells, XCRI staining was seen on the cell surface as well as in the cytoplasm. 
No staining was observed in the negative controls (Figure 2.4). SCC4 and A375P 
cells appeared to have stronger staining intensity than other cell lines. 
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Figure 2.4. Representative pictures showing immunocytochemical XCR1 expression (Original 
magnification x 60, Antibody concentration 20pg/ml). No staining was observed in the 
negative controls (a, c, e, g, i, k). Staining was seen on the cell surface and in the cytoplasm 
and intensity appeared strongest in SCC4 cells (j) whereas it was similar in all the other cells. 
Negative cells were observed in NOK (b) and H357 cells (f). 
2.11.1.2 CXCRI 
NOK and HGF consistently stained positively for CXCRI. NOK showed a staining 
pattern similar to XCRI and in addition to some negative cells, a strongly-positive 
and a weakly-positive population was also seen. HGF showed a uniform staining 
intensity (Figure 2.5). 
H357. TR146. SCC4 cells also showed consistent CXCRI staining as did the A375P 
cell line (positive control). H357 cells exhibited negative, weak-positive and strong- 
positivc cells whereas staining was more uniform in TR146, SCC4 and A375P cells. 
CXCR1 expression was noticed on the cell surface as well as in the cytoplasm. No 
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staining was observed in the negative controls (Figure 2.5). 
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Figure 2.5. Representative pictures showing immunocytochemical CXCR1 expression 
(Original magnification x 60, Antibody concentration 20 pg/ml). No staining was observed in 
the negative controls (a, c, e, g, i, k). Staining was seen on the cell surface and in the 
cytoplasm and intensity appeared similar all cells. Negative cells were observed in NOK (b) 
and H357 cells (f). 
2.11.1.3 CXCR2 
CXCR2 staining was observed in all tested cells except HGF. NOK stained 
consistently for CXCR2 but the strongly-positive and weakly-positive cell 
populations were not as distinct as observed for XCRI and CXCRI (Figure 2.6). 
Staining was also observed on H357, TR146, SCC4 cells as well as the positive 
control A375P cells. H357 cells showed a different staining pattern for CXCR2 
compared with CXCR1 as they exhibited a more uniform staining pattern. SCC4 cells 
showed the strongest CXCR2 staining intensity while staining on TR146 and A375P 
cells was more granular and cytoplasmic compared to other cell types. None of the 
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negative controls showed any staining (Figure 2.6). 
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Figure 2.6. Representative pictures showing immunocytochemical CXCR2 expression 
(Original magnification x 60, Antibody concentration 20 pg/ml). No staining was observed in 
the negative controls (a, c, e, g, i, k). Staining was seen on the cell surface and in the 
cytoplasm and intensity and HGF did not show any staining (d). 
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2.11.2 FLOW CYTOMETRY 
2.11.2.1 XCRI 
Variable levels of cell surface expression of XCRI were observed with flow 
cytometry. XCRI expression was detected on NOK, HGF and all OCCL (Figure 2.7). 
Normal skin keratinocytes (NSK) and the melanoma cell line A375P (positive control 
for CXCRI and CXCR2) also exhibited cell surface expression of XCRI (Figure 2.7). 
All cell types showed a histogram shift towards the right indicating an increase in 
fluorescence intensity due to positive cells. However, three cell populations were 
observed in NOK i. e. a negative, a low expressing and a high expressing one as 
shown by the two peaks in the histogram (Figure 2.7). This correlates with the 
immunocytochemistry results and suggests that three different cell populations may 
be present within NOK. Two cell populations were also seen for H357 cells by flow 
cytometry. However, the two peaks were not as distinct as NOK. 
The histogram shift towards the right (increase in fluorescence intensity) was greatest 
for CAL27 and FaDu cells. However, the SCC4 cells showed the highest number of 
XCRI -positive cells (Figure 2.8). 
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Figure 2.7. Representative histograms showing fluorescence intensity for XCR1 (Red- 
Negative Control; Green-XCR1). Where 'Low Exp' is low level of expression and 'High Exp' is 
high level of expression. Neutrophils (a), Jurkat (b), H357 (d), SCC4 (h), CAL27 Q) and FaDu 
(k) cells showed more positivity for XCR1 than NOK (c) whereas HGF (e), TR146 (f) and 
SCC25 (i) were less positive. Fluorescence intensity was highest for CAL27 (j) and FaDu (k) 
cells. 
Approximately 40% of NOK and NSK were positive for XCRI whereas 60% of H357 
and more than 90% of SCC4 cells showed XCR1 positivity. HGF. SCC25 and TR146 
showed the lowest percentage of XCR1-positive cells whereas isolated neutrophils 
were 100% positive and also showed high fluorescence intensity for XCR1 (Figure 
2.7 and 2.8). 
The ('hemokine Receptors ACR1, C: kCRI and CX R2 Regulate Oral Epithelial Cell Behaviour 72 
Chapter 2- Expression o/. 1CR/, C CRI and C. VCR2 big Oral F_pilhelia/ ('ells 
0 
0 
0 
100 
80 
60 
40 
20 
0 
Neut Jurkat NOK NSK 
Figure 2.8. Number of XCR1-positive cells as determined by flow cytometry (mean % positive 
population ± SD) (n= average of 3 different experiments, Error bars= standard deviation). 
Neutrophils, Jurkat, H357, SCC4, CAL27, FaDu and A375P were more positive for XCR1 
than NOK whereas HGF, TR146 and A375P were less positive. NSK showed similar % XCR1 
positivity to NOK. 
2.11.2.2 CXCR1 
Both NOK and OCCL cells exhibited cell surface expression of CXCR I. Neutrophils 
and A375P cell line (positive controls) also showed CXCRI expression in addition to 
HGF and NSK (Figure 2.9). 
Histograms for all other cell types showed a shift towards the right and an increase in 
fluorescence intensity indicating positivity for CXCRI. Three distinct CXCRI 
populations (i. e. negative, low expression and high expression) were observed in 
NOK. TRI46, H357, SCC25 and FaDu cells indicated by an additional peak in the 
histogram (Figure 2.9). 
The percentage of CXCRI-positive cells was lowest for HGF, SCC25 and NOK and 
highest for SCC4. CAL27 and FaDu (Figure 2.10). 
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Figure 2.9. Representative histograms showing fluorescence intensity for CXCR1 (Red- 
Negative Control; Green-CXCR1). Where 'Low Exp' is low level of expression and 'High Exp' 
is high level of expression. Neutrophils (a), NSK (c), TR146 (e), H357 (f), SCC4 (g), CAL27 (i) 
and FaDu Q) cells showed more positivity for CXCR1 than NOK (b) whereas HGF (d) and 
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SCC25 (h) were less positive. Fluorescence intensity was highest for CAL27 (i) and FaDu 
cells Q). 
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Figure 2.10. Number of CXCR1-positive cells as determined by flow cytometry (mean % 
positive population + SD) (n= average of 3 different experiments. Error bars= standard 
deviation). Neutrophils, NSK, H357, SCC4, CAL27, FaDu and A375P were more positive for 
CXCR1 than NOK whereas HGF and A375P were less positive. 
Neutrophils exhibited highest positivity for CXCRI whereas between 80-100% of 
SCC4, CAL27 and FaDu were CXCRI-positive. More NSK were positive for 
CXCRI (42%) than NOK (20%). HGF, SCC25 and TR146 were the least positive 
(Figure 2.10). 
2.11.2.3 CXCR2 
Cell surface expression of CXCR2 was detected on all cells other than HGF. 
Percentage positive cell population for CXCR2 was highest in isolated neutrophils, 
SCC4 and FaDu compared with all other cells (Figure 2.11 ). 
Expression was variable between different cell types and some cancer cells such as 
SCC25. TR 146 and A375P were less positive than NOK. More NSK were positive for 
CXCR2 than NOK. The dual positive populations observed in NOK and H357 (for 
XCRI and CXCRI) were not seen with CXCR2 (which is in agreement with the 
immunocvtochemistry results) (Figure 2.11). 
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Figure 2.11. Representative histograms showing fluorescence intensity for CXCR2 (Red- 
Negative Control; Green-CXCR2). Neutrophils (a), SCC4 (g), CAL27 (i) and FaDu (j) cells 
showed more positivity for CXCR2 than NOK (b) whereas TR146 (e), SCC25 (h) and A375P 
(k) were less positive. Fluorescence intensity was highest for CAL27 (i) and FaDu (j) cells. 
HGF (d) did not show CXCR2 expression. 
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Figure 2.12. Number of CXCR2-positive cells as determined by flow cytometry (mean % 
positive population + SD) (n= average of 3 different experiments, Error bars= standard 
deviation). Neutrophils, NSK, SCC4, CAL27, FaDu and A375P were more positive for CXCR2 
than NOK whereas TR146, SCC25 and A375P were less positive. HGF did not express 
CXCR2. 
Like CXCRI, more NSK were positive for CXCR2 (45%) than NOK (25%). 
However, more CXCR2 positive cells were observed in NOK and NSK than CXCRI. 
No expression was detected on HGF and SCC25 cells were the least positive for 
CXCR2. A fewer number of H357, CAL27 and A375P cells were positive for 
CXCR2 than CXCR I (Figure 2.12). 
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2.12 DISCUSSION 
Two different methods were employed to study protein expression of XCR1, CXCR I 
and CXCR2. Immunocytochemistry was used for a subjective analysis of expression 
whereas flow cytometry was performed to quantify the cell surface expression. 
i. XCRI Protein Expression 
Immunocytochemistry showed XCRI staining in NOK and the intensity of this 
staining was variable as negative, weakly-positive and strongly-positive cells were 
observed within the NOK. Staining was seen on the cell surface as well as the 
cytoplasm. These results were confirmed by the flow cytometry data which showed 
that around 40% of NOK exhibited cell surface expression of XCRI. A similar pattern 
of staining to that of immunocytochemistry was noticed as the histograms consistently 
showed two distinct positive cell peaks suggesting that this finding is indeed real and 
there is a variable level of XCRI expression within the same NOK population (Figure 
2.7c). XCRI expression was also detected on NSK which had a similar number of 
XCR I -positive cells as NOK but had lower fluorescence intensity (Figure 2.7d). 
A more uniform pattern of expression was seen by immunocytochemistry and flow 
cytometry in HGF and XCRI staining was seen on the cell surface and in the 
cytoplasm. This finding is comparable to that of Blaschke et al., who showed XCRI 
expression in cultured fibroblast-like synoviocytes (FLS) (Blaschke et al., 2003). 
They utilised in situ hybridization to study XCRI expression in FLS which showed 
staining on the cell surface as well as in the cytoplasm. 
Staining for XCRI was also observed in cancerous oral and melanoma cells and this 
staining appeared stronger in some cancer cell lines. For example SCC4 cells showed 
stronger staining intensity for XCRI than other cells. Immunocytochemistry also 
suggested that three distinct cell populations may be present in H357 cells, a negative, 
a weakly positive and a strongly positive population whereas other tested cells (HGF, 
TR146, SCC4 and A375P) showed a uniform staining pattern. Cultured monolayers 
of cells were not permeabilised during the staining procedure. In spite of that, XCRI 
staining was seen on the cell surface and in the cytoplasm in all cells. The 
immunocytochemical results were confirmed by flow cytometry for XCR I which also 
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showed cell surface expression on the positive controls and all cancer cell lines. A 
higher number of SCC4, CAL27 and FaDu cells were positive for XCRI whereas 
TR146 and SCC25 were less positive. The CAL27 and FaDu cells also showed the 
highest fluorescence intensity for XCRI (as indicated by the histogram shift) 
suggesting that these cells express high levels of XCR I (Figure 2.7j, 2.7k). 
interestingly, flow cytometry also showed two distinct XCRI-positive cell 
populations in H357 cells with one population expressing higher levels than the other 
(as shown by two peaks in the histogram) (Figure 2.7g). This is in harmony with the 
immunocytochemistry results and suggests that XCR I expression in H357 cells is 
different to other cells as they exhibit a mixed population of XCR I -negative, -weakly 
positive and -strongly positive cells. Flow cytometry histograms from a recent paper 
on the role of chemokine receptors in nasopharyngeal carcinoma show the existence 
of distinct cell populations within nasopharyngeal carcinoma cell lines when tested 
for CXCR6 and CCR7 (Ou el cxl., 2006). However, the authors did not comment or 
provide an explanation for this phenomenon. There is a possiblity that chemokine 
receptor expression may be correlated to the cell size or cell cycle with cells in a 
certain stage of the cell cycle expressing higher levels than others. I iowever, whether 
this is so is outside the scope of this study and hence the significance of this mixed 
population expression pattern remains to be determined. 
To summarize, no distinct difference in staining intensity was observed between NOK 
and OCCL by immunocytochernistry. Flow cytornetry results showed that some oral 
cancer cell lines (H357, SCC4, CAL27, FaDu) had more XCRI-positive cells 
compared with NOK, NSK and HGF. However, the TR146 and SCC25 cell lines were 
even less positive for XCRI than normal cells. There does not appear to be a 
consistent change in XCR1 expression in OCCL compared with NOK. 
These results validate the preliminary micro-array data which suggested XCR I 
mRNA is present in NOK and OCCL and confirm XCRI protein expression on 
normal and cancerous oral epithelial cells for the first time. Similarly, the melanoma 
cell line A375P has not been shown to express XCRI. Expression of XCRI on 
epithelial cells has not been reported to date. However, the significance of this 
expression on oral epithelial cells and fibroblasts remains to be elucidated. 
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ii. Protein expression of CXCR1 
The positive control A375P cell line stained for CXCRI and this is in agreement with 
the findings of Varney et al. (Varney et al., 2003). CXCRI staining was observed on 
the cell surface and in the cytoplasm of NOK by Immunocytochemistry. An 
interesting pattern of staining was noticed as there were three distinct cell groups 
negative, weakly-staining and strongly-staining cells for CXCR1. This is somewhat 
different to the findings of Sfakianakis et al. who carried out staining for CXCRI on 
gingival keratinocytes and reported 100% positivity for CXCRI (Sfakianakis, Barr, 
and Kreutzer 2002). Flow cytometry substantiated our results and showed a negative, 
a low expressing and a high expressing positive cell population. CXCRI cell surface 
expression was also detected on NSK which has not been shown previously. More 
NSK cells (approximately 40%) were positive for CXCRI than NOK (20%). 
CXCRI expression was also observed on HGF which has not been reported before. 
HGF exhibited a more uniform CXCRI staining pattern than NOK and staining was 
seen on the cell surface and in the cytoplasm. 
CXCR1 staining was also seen in the OCCL. Like NOK, the H357 cells also showed 
a mixed positive cell pattern and negative, weakly-positive and strongly-positive cells 
were seen. SCC4 cells showed stronger staining intensity than TR146 cells but 
overall, no observable difference in staining intensity was noticed between the normal 
and cancer cells. Flow cytometry confirmed the immunocytochemical results and 
CXCRI expression was detected on the positive controls and all OCCL. Other than 
SCC25, all oral cancer cells had a higher number of CXCRI-positive cells than NOK 
and SCC4, CAL27 and FaDu cells had more positive cells than H357 and TR146. In 
addition H357, TR146, SCC25 and FaDu cells also showed two distinct CXCRI- 
positive populations (a low expressing and a high expressing one). Similar results for 
CXCRI expression have been reported in colonic epithelial cell lines CaCo-2 and HT- 
29 which show two distinct cell populations (Sturm et al., 2005). Watanabe et a!. have 
previously used flow cytometry to study cell surface expression of CXCR I on NA 
and HSC-4 oral cancer cell lines with HSC-4 cells showing higher fluorescence 
intensity but did not report high-expressing and low-expressing cell populations 
(Watanabe et al., 2002). In addition, they did not quantify the percentage of CXCRI- 
positive cells or compare it to NOK. 
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Overall, the results suggest a greater proportion of oral cancer cells than NOK are 
positive for CXCR1. 
iii. Protein expression of CXCR2 
Membranous and cytoplasmic staining for CXCR2 was observed on the positive 
control (A375P cell line) and NOK which is consistent with existing literature 
(Varney et al., 2003; Sfakianakis, Barr, & Kreutzer 2002). Sfakianakis et al. reported 
that 90% of gingival keratinocytes in their study expressed CXCR2. However, their 
results show very weak CXCR2 staining predominantly localized in the perinuclear 
area which differs from our pattern. The significance of this not clear but it may be 
the result of use of different antibodies. Alternatively it may reflect differences in the 
site of origin of the NOK within the oral cavity. Flow cytometry confirmed CXCR2 
expression on NOK cell surface (to date flow cytometry has not been performed for 
CXCR2 on NOK). A higher proportion of NSK were positive for CXCR2 than 
CXCRI. Cell surface expression of CXCR2 has not been reported on NSK and HGF 
to date. No CXCR2 expression was observed on HGF by immunocytochemistry or 
flow cytometry. 
CXCR2 staining by immunocytochemistry was also observed on the positive control 
and OCCL and this was corroborated by flow cytometry. No difference in staining 
intensity was noticed between normal and cancerous oral cells. The staining pattern 
for CXCR2 in H357 cells was different to CXCR1 as no distinct weakly staining and 
strongly staining cells were seen. However, the number of CXCR2-positive cells for 
all cancer cell lines was consistently lower than CXCR1. This is in agreement with 
the findings of Watanabe et al. as they reported lower expression of CXCR2 on NA 
and HSC-4 (OCCL) than CXCR1. No consistent difference in CXCR2 expression was 
noticed between normal and cancer cells in our study as some cancer cells (TR146, 
SCC25) were less positive than NOK. 
All these finding confirm protein expression of XCRI, CXCRI and CXCR2 on 
normal and cancerous oral epithelial cells. Therefore, the next step was to study the 
functionality of the receptors. NOK, H357 and SCC4 cells were chosen for all the 
functional assays. H357 cells show an intermediate number of positive cells (25-70%) 
whereas 90-100% of SCC4 cells are positive for XCRI, CXCR1 and CXCR2. NOK 
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were included to provide a comparison between normal and cancerous cells and they 
also have the least number of XCR1, CXCR I and CXCR2 positive cells (20-40%) out 
of the three chosen cells. 
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3.1 INTRODUCTION 
It \\as shown in the previous chapter that XCRI, CXCRI and CXCR2 are expressed 
on the surface of normal and malignant oral epithelial cells. The next step was to 
establish whether these receptors are functional on the surface of oral epithelial cells. 
For this purpose, four different parameters were studied: signal transduction, 
migration'chemotaxis, invasion and proliferation. NOK, H357 and SCC4 cells were 
chosen for all functional assays. 
The ERK 1'2 (extracellular signal-regulated kinases I and 2) signaling pathway was 
studied for signal transduction. ERKI and 2 are also known as p44 and p42 MAP 
kinases and as both these proteins are highly homologous they are collectively 
referred to as ERK 1'2. The constitutive ERK 1/2 present intracellularly is called total 
ERK 12 and is in an unphosphorylated form. Stimulation of the cascade results in 
phosphorylation of ERK 1/2 leading to activation. This cascade plays a vital role in the 
regulation of cell differentiation, cell physiology and neuronal function (Giovannini 
2006; Lu and Xu 2006; Meloche and Pouyssegur 2007; Yoon and Seger 2006). 
Abnormal ERKI/2 activity has been associated with a number of pathological 
conditions including autoimmune diseases and cancer (Roberts and Der 2007). 
Figure 3.1. Overview of the ERK1/2 pathway. Stimulation of a cell surface receptor (by 
chemokines, growth factors etc. ) activates downstream'Raf' followed by 'MEK' activation. 
MEK activates ERK1/2 which then acts on substrates within the nucleus leading to gene 
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transcription and facilitation of a range of actions including chemotaxis, proliferation and cell 
differentiation. 
The ERK pathway is also involved in the signaling of chemokines including MIP-3u 
(Keates el a1., 2007) and SDF-la (Barbieri et al., 2006) in epithelial cells. 
Furthermore, a previous study has shown signal transduction in response to 
extracellular calcium through the ERKI/2 pathway in normal, pre-malignant and 
cancerous oral epithelial cells (Mukhopadhyay et al., 2004). IL-8 and GRO-u have 
also been shown to signal through the ERKI/2 signaling cascade in Chinese hamster 
ovary (CHO) epithelial cells (Shyamala and Khoja 1998). However whether 
lvmphotactin signals through the ERK 1/2 pathway is not known. 
3.2 AIM 
The aim of this chapter was to establish whether the chemokine receptors XCRI, 
CXCRI and CXCR2 mediate ERKI/2 signal transduction when exposed to their 
respective chernokines (lymphotactin and IL-8). CXCLI/GRO-a was included as it 
signals through CXCR2 only and not through CXCRI (Ahuja and Murphy 1996). 
3.3 EXPERIMENTAL PROTOCOL 
A cell-based ELISA was performed to study the phosphorylation of intracellular 
ERK 1 '2. The following methods were used in conjunction: 
  NOK and OCCL (11357 and SCC4) were cultured to study signal transduction in 
response to lymphotactin, IL-8 and GRO-u. 
  Phorhol 12-myristat 13-acetate (PMA) which is a potent protein kinase C activator 
(Jorgensen et al., 2005; Tepperman, Soper, and Chang 2005) and has also been 
shown to activate the ERKI/2 pathway (Hwang et al., 2007) was used as positive 
control 
  For XCRI, cells were stimulated with lymphotactin whereas for CXCRI and 
CXCR2, IL-8 and GRO-a were used. GRO-a was used since it signals specifically 
through CXCR2 but not through any other receptor. 
  The chemokine CCL25/TECK was used as an irrelevant chemokine control. 
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" Triplicate wells for each cell line and treatment were used in all assays and the 
ELISA was performed on three different occasions. 
3.4 MATERIALS AND METHODS 
3.4.1 CELL CULTURE 
Cells were grown and maintained as described previously. 
3.4.2 ERKI/2 ELISA 
A fast activated cell-based ELISA (FACE) kit (Active Motif, Rixensart, Belgium) 
was used to study ERKI/2 phosphorylation. H357 cells were detached using cell 
dissociation buffer (Sigma) and seeded at a density of 6x103/well in 96-well tissue 
culture plates (Corning, Lowell, MA, USA). Cells were grown to 80% confluence, 
washed with PBS and exposed to serum-free medium (Appendix 10.1.5) for 16h. 
Lymphotactin (100ng/ml) (R&D Systems), IL-8 (100ng/ml) (Sigma) and GRO-a 
(100ng/ml) (Peprotech, Rocky Hill, NJ, USA) were used to stimulate the cells for 
10min before being fixed. TECK/CCL25 (Peprotech) was used as an irrelevant 
chemokine. Phorbol 12-myristat 13-acetate (PMA) (Sigma) was used as positive 
control (50ng/ml) whereas absence of ligands served as negative control. 
Cells were fixed with 2% paraformaldehyde for 20min at RT and washed three times 
with 100µl wash buffer (provided with kit) for 5min with gentle shaking. Wash buffer 
was removed and 100µd quenching buffer (provided with kit) was added for 20min at 
RT. After removal of quenching buffer, cells were washed two more times with wash 
buffer followed by the addition of antibody blocking buffer (provided with kit) for 1h. 
This was followed by the application of 40µl of diluted primary antibody for 
phosphorylated ERKI/2 and total ERKI/2 (in accordance with the manufacturer's 
instructions). The plate was sealed and cells incubated with primary antibody 
overnight at 4°C. 
Primary antibody was removed the next day and cells washed three times as described 
previously. l00µ1 of secondary antibody was added (provided with kit), plate was 
sealed and incubated for 2h at RT with gentle shaking. Secondary antibody was 
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removed and cells washed followed by the addition of 100µI of developing solution 
(provided with kit) to each well. The plate was incubated for 10min at RT protected 
from direct light until the darkest staining wells were medium to dark blue. 100µI of 
stop solution (provided with kit) was added to stop the colour development which 
turned the blue colour to yellow. Absorbance was read on a spectrophotometer within 
5min at 450nm. 
Cells seeded in 96-well tissue culture 
plates, allowed to adhere and serum- 
starved 
Cells stimulated with PMA, Lymphotactin, 
IL-8 and GRO-u for 10 min and 
immediately fixed using paraformadehyde. 
Permeabilisation carried out to allow 
excess to the cell interior. 
Primary antibody against phosphorylated 
and total ERK1/2 added overnight 
Unbound antibody removed by washing. 
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HRP-labelled secondary antibody added. 
Unbound antibody removed by washing. 
R= 
-I .. "fr 
// 
"" 
Substrate solution (TMB) added. HRP 
attached to the secondary antibody 
changes the colour to blue. 
Stop solution (2N H2S04) added which 
" changed the colour to yellow. 
j 
Figure 3.2. O, e-ý e, % of the ERK1)2 cell-based ELISA protocol. 
3.4.3 STATISTICAL ANALYSIS 
Data are presented as means of absorbencies +/- standard deviation (SD). Paired 
student's T-test was used to analyse the statistical significance of the results 
3.5 RESULTS 
3.5.1 1 mphotactin 
i) NON 
Stimulation of NOK with PMA and lymphotactin resulted in a significant increase in 
intracellular ERK 1 '2 phosphorylation compared with unstimulated cells (p<0.000I 
and p. -0.001 respectively) (Figure 3.2). Lymphotactin increased 
ERKI/2 
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phosphorvlation in a dose dependent manner in NOK. The irrelevant chemokine 
CCL25 TECK failed to elicit a response. No significant difference in total ERKI/2 
was observed between any of the different treatments (Figure 3.2). 
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Figure 3.3. ERK1/2 activation in NOK in response to lymphotactin (mean absorbencies + SD) 
(n= average of 3 different experiments done in triplicate, error bars=SD) (Where PMA= 
positive control, TECK= irrelevant chemokine). Similar absorbancies were observed for total 
ERK1/2. Lymphotactin but not TECK increased ERK1/2 phosphorylation in a dose-dependent 
manner but this increase was less than PMA. 
ii) 11357 and SCC4 cells 
Stimulation of H357 and SCC4 cells with PMA (the positive control) caused a highly 
significant increase in ERK1/2 phosphorylation compared with unstimulated cells 
(p<0.000001 and p<0.00001 respectively) (Figure 3.3 and 3.4). Exposure to 
lymphotactin also caused a significant and dose-dependent increase in ERK I /2 
phosphorylation in H357 and SCC4 cells compared with negative controls (p<0.0001 
and p<0.00I respectively). However, this increase was less than the increase observed 
with PMA (Figure 3.3 and 3.4). TECK did not have any effect on ERK 1 /2 activation. 
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Figure 3.4. ERK1/2 activation in H357 cells after lymphotactin stimulation (absorbencies + 
SD) (n= average of 3 different experiments done in triplicate, error bars=SD) (Where PMA= 
positive control, TECK= irrelevant chemokine). Similar absorbancies were observed for total 
ERK1/2. Lymphotactin but not TECK increased ERK1/2 phosphorylation in a dose-dependent 
manner but this increase was less than PMA. 
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Figure 3.5. ERK1/2 activation in SCC4 cells after lymphotactin stimulation (absorbencies ± 
SD) (n=average of 3 different experiments done in triplicate, error bars=SD) (Where PMA= 
positive control, TECK= irrelevant chemokine). Similar absorbancies were observed for total 
ERK1/2. Lymphotactin but not TECK increased ERK1/2 phosphorylation in a dose-dependent 
manner but this increase was less than PMA. 
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iii) Comparison of lymphotactin-mediated ERK1/2 phosphorylation between 
NOK and OCCL 
Pho phorylated ERK I12 levels in H357 and SCC4 (OCCL) were significantly higher 
than NOK at all doses (p<0.05) (Figure 3.5). 
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Figure 3.6. Comparison of lymphotactin mediated ERK1/2 phosphorylation in NOK, H357 and 
SCC4 cells (absorbencies + SD) (n=average of 3 different experiments done in triplicate, error 
bars=SD). ERK112 phosphorylation was higher in the H357 and SCC4 cancer cells at all 
doses including baseline levels. No difference between H357 and SCC4 cells was observed. 
3.5.2 IL-8 
i) NOK 
Exposure to PMA and 1L-8 caused a significant increase in intracellular ERKI/2 
phosphorylation in NOK compared with unstimulated controls (p<0.0001) and this 
effect was dose dependent. No effect was observed with the irrelevant chemokine 
CCL25 TECK (Figure 3.6). 
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Figure 3.7. ERK1/2 activation in NOK after exposure to IL-8 (absorbencies + SD) 
(n=average of 3 different experiments done in triplicate, error bars=SD) (Where PMA= 
positive control, TECK= irrelevant chemokine). Similar absorbancies were observed for total 
ERK1/2. IL-8 but not TECK increased ERK1/2 phosphorylation in a dose-dependent manner 
but this increase was less than PMA. 
ii) H357 and SCC4 cells 
A highly significant increase in ERKI/2 phosphorylation in H357 and SCC4 cells was 
observed after exposure to PMA compared with unstimulated cells (p<0.000001 and 
p<0.00001 respectively) (Figure 3.7 and 3.8). Stimulation of H357 and SCC4 cells 
with IL-8 but not TECK caused a significant increase in ERKI/2 phosphorylation 
compared with negative controls (p<0.001 and p<0.00001 respectively) in a dose 
dependent manner. However, this increase was not as high as observed with PMA. 
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Figure 3.8. ERK1/2 activation in H357 cells after exposure to IL-8 (absorbencies + SD) 
(n=average of 3 different experiments done in triplicate, error bars=SD) (Where PMA= 
positive control, TECK= irrelevant chemokine). Similar absorbancies were observed for total 
ERK1/2. IL-8 but not TECK increased ERK1/2 phosphorylation in a dose-dependent manner 
but this increase was less than PMA. 
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Figure 3.9. ERK1/2 activation in SCC4 cells after exposure to IL-8 (absorbencies + SD) 
(n=average of 3 different experiments done in triplicate, error bars=SD) (Where PMA= 
positive control, TECK= irrelevant chemokine). Similar absorbancies were observed for total 
ERK1/2. IL-8 but not TECK increased ERK1/2 phosphorylation in a dose-dependent manner 
but this increase was less than PMA. 
iii) Comparison of IL-8-mediated ERK1/2 phosphorylation between NOK and 
0CCI. 
As 'p ith I' mphotactin, a significantly higher increase in ERKI/2 phosphorylation was 
observed after IL-8 stimulation of H357 and SCC4 cells compared with NOK at all 
doses (p<0.05) (Figure 3.9). No significant difference was observed between the two 
cancer cell lines. 
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Figure 3.10. Comparison of IL-8 mediated ERK1/2 phosphorylation between NOK, H357 and 
SCC4 cells (absorbencies + SD) (n=average of 3 different experiments done in triplicate, error 
bars=SD) ERK1/2 phosphorylation was higher in the H357 and SCC4 cancer cells at all 
doses including baseline levels. No difference between H357 and SCC4 cells was observed. 
3.5.3 G RO-a 
i) NOK 
GRO-a facilitated a significant up-regulation of intracellular ERKI/2 phosphorylation 
in a dose dependent manner in NOK compared with unstimulated cells (p<0.001). The 
irrelevant chemokine CCL25/TECK did not cause any increase in phosphorylation. 
No difference in total ERK I /2 level between different treatments was observed 
(Figure 3.10). 
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Figure 3.11. ERK1/2 activation in NOK after exposure to GRO-a (absorbencies + SD) 
(n=average of 3 different experiments done in triplicate, error bars=SD) (Where PMA= 
positive control. TECK= irrelevant chemokine). Similar absorbancies were observed for total 
ERK1/2 GRO-a but not TECK increased ERK1/2 phosphorylation in a dose-dependent 
manner but this increase was less than PMA. 
ii) 11357 and SCC4 cells 
titimulation of 11 57 and SCC4 cells with PMA caused a highly significant increase in 
E: RK 12 phosphorylation compared with unstimulated controls (p<0.000001 and 
p--0.00001 respectively) (Figure 3.11 and 3.12). Exposure to GRO-a also significantly 
increased ERK 12 phosphorylation compared with controls (p<0.0001 and p<0.0001 
respectively) in a dose dependent manner but the levels of phosphorylated ERK I/2 
were not as high as seen with PMA. No response was observed with TECK. 
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Figure 3.12. ERK1/2 activation in H357 cells after exposure to GRO-a (absorbencies ± SD) 
(n=average of 3 different experiments done in triplicate, error bars=SD) (Where PMA= 
positive control, TECK= irrelevant chemokine). Similar absorbancies were observed for total 
ERK1/2 GRO-a but not TECK increased ERK1/2 phosphorylation in a dose-dependent 
manner but this increase was less than PMA. 
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Figure 3.13. ERK1/2 activation in SCC4 cells after exposure to GRO-a (absorbencies + SD) 
(n=average of 3 different experiments done in triplicate, error bars=SD) (Where PMA= 
positive control TECK= irrelevant chemokine). Similar absorbancies were observed for total 
ERK1/2 GRO-a but not TECK increased ERK1/2 phosphorylation in a dose-dependent 
manner but this increase was less than PMA. 
iii) Comparison of GRO-a-mediated ERKI/2 phosphorylation between NOK and 
O('('L 
Ixp sure to GRO-a caused a significantly higher increase in ERK 1/2 phosphorylation 
in H357 and SCC4 cells (p<0.05 and p<0.05 respectively) than NOK at all 
concentrations (Figure 3.13). 
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Figure 3.14. Comparison of GRO-a mediated ERK1/2 phosphorylation between NOK, H357 
and SCC4 cells (absorbencies ± SD) (n=average of 3 different experiments done in triplicate, 
error bars=SD) ERK1/2 phosphorylation was higher in the H357 and SCC4 cancer cells at all 
doses including baseline levels. No difference between H357 and SCC4 cells was observed. 
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3.6 U1ýCl tiS1<)\ 
IRK I- .i nal ir: in: duction as studied as the first parameter to determine whether 
XCR I. CXCR I and CXCR2 are functional on oral epithelial cells. As mentioned 
earlier, this pathway is involved in a number of physiological and pathological 
processes including chemokine signaling in epithelial cells (Barbieri et at., 2006, 
Keates ci al.. 2007). The chemokine receptor CXCR4 and its ligand SDF-la have 
been shown to mediate proliferation of tumours through increased activation of the 
ERK 12 cascade (Alsav ed et al., 2007; Barbieri et al., 2006; Scala et al., 2006). 
The I-IRK 12 cascade can influence tumourigenesis in a number of ways. It is 
regulated by the Rat' serine threonine kinases which set off the MAPK/ERK kinase 
(M [K) protein kinases, which then activate ERKI/2. Mutations of Raf in neoplasia 
suggest an important role for this pathway in oncogenesis (Davies et (l., 2002). In 
addition, the ERK 12 pathway is a key downstream effector of Ras which is one of 
the most commonl mutated genes in cancer. Finally, Ras is a critical downstream 
effector of the epidermal growth factor receptor (EGFR), which is up-regulated in a 
range of cancers (Figure 3.13 and 3.14). Activation of ERKI/2 up-regulates 
expression of FGFR ligands, thus providing an autocrine growth mechanism to the 
tumour (Grandis and Sok 2004. Hynes and Lane 2005; Lynch 2004; Stephens et al., 
2004). Therefore. this pathway has been studied intensely with reference to cancer 
treatment. 
i) X('RI, 
Exposure to I%mphotactin significantly increased intracellular ERK 1/2 
phosphor lation in NOK and OCCL in a dose dependent manner. This strongly 
suggests that NCR I is functional on the surface of NOK and OCCL since it is the 
only known receptor for lymphotactin. However, since XCRI was not blocked in 
these experiments by use of an antibody it is possible that lymphotactin may mediate 
I RK 12 phosphors lation through another receptor, as yet unidentified. CCL25/TECK 
%%hich was used as an irrelevant chemokine did not cause a similar increase which 
su gists that the response was specific to lymphotactin. 
Higher baseline leýeIs of phosphoryIated ERK were observed in OCCL coin pared 
!h ('henw king Krrpýors . 
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with NOK at all doses. As explained earlier, one possible explanation is that mutated 
Raf/Ras is present in the cancer cells and this may facilitate downstream activation of 
ERK1/2. Such a response has been documented in a range of cancers such as 
melanoma, lung and ovarian carcinoma (Mercer and Pritchard 2003; Rajagopalan et 
al., 2002; Sieben et al., 2004; Singer et al., 2003; Vos et al., 2003). Mutations of Ras 
have also been shown to play an important role in the pathogenesis of oral cancer 
(Milasin et al., 1994; Sakata 1996). Another possible explanation is that EGFR which 
may be up-regulated in cancer, activates downstream Ras which in turn can influence 
the ERK1/2 pathway. Whether EGFR is up-regulated in the H357 and SCC4 cell lines 
is not known but aberrant expression of EGFR and its ligands have been documented 
in OSCC in vivo and EGFR and its ligands are up-regulated in head and neck 
malignancies and premalignant conditions compared to normal oral mucosa 
(Bankfalvi et al., 2002; Rubin et al., 1996; Rubin et al., 1998; Rubin, Tweardy, and 
Melhem 1998; Rubin, Zeng, and Tweardy 1996; Srinivasan and Jewell 2001). Which 
of these possibilities explains the higher baseline levels of phosphorylated ERK in the 
cancer cell lines compared with NOK is not clear since nothing is known about the 
Raf/Ras mutations or EGFR expression in the cells used in our study. 
To our knowledge, lymphotactin/XCR1 mediated activation of ERK1/2 signaling 
cascade either in lymphoid or non-lymphoid cells has not been shown to date. The 
significance of this signaling in oral epithelial cell regulation will be studied in the 
following chapters. 
ii) CXCR1 and CXCR2 
a) IL-8 
Stimulation with IL-8 up-regulated ERKI/2 phosphorylation in a dose-dependent 
manner in both NOK and OCCL. No such response was seen with TECK/CCL25. 
This suggests that IL-8 acts through CXCR1 and/or CXCR2 on the surface of oral 
epithelial cells to increase ERK1/2. This is in agreement with existing literature as 
IL-8 signaling through ERK1/2 has been shown to induce growth, transcriptional 
activation and migration of endothelial cells in Kaposi's Sarcoma (Wang et al., 2004). 
IL-8 mediated direct activation of ERKI/2 cascade in epithelial cells has also been 
shown previously. IL-8 facilitates phosphorylation of ERK1/2 through both CXCRI 
and CXCR2 transfected in Chinese hamster ovary cells (CHO) (Shyamala and Khoja 
The Chemokine Receptors XCRI, CXCRI and CXCR2 Regulate Oral Epithelial Cell Behaviour 101 
Chapter 3- Signal Transduction 
1998). This phosphorylation is inhibited by the addition of pertussis toxin confirming 
the involvement of G-protein coupled receptors. 
Higher baseline phosphorylated ERK1/2 levels were observed in OCCL compared 
with NOK. This maybe due to the autocrine growth loop of ERK, MEK and EGFR as 
discussed earlier but remains to be determined. 
IL-8 mediated ERKI/2 signaling stimulates proliferation of non-small lung cancer cell 
lines A549 and NCI-H292 in a dose-dependent manner (Luppi et al., 2006). Addition 
of an ERKI/2 inhibitor blocks this effect of IL-8. Interestingly, this IL-8 mediated 
proliferation is also blocked when an EGFR tyrosine kinase inhibitor or an anti-EGFR 
blocking antibody is used. This suggests that transactivation of EGFR can augment 
IL-8 facilitated ERKI/2 signaling and hence proliferation of cancer cells (Luppi et al., 
2006). We observed higher baseline levels of ERK in OCCL compared with normal 
cells which suggests higher constitutive ERK activity in OCCL. 
b) GRO-a 
Exposure of NOK and OCCL to GRO-a also caused a significant increase in ERK1/2 
phosyphorylation and activation. The irrelevant chemokine TECK did not have any 
effect. This suggests that GRO-a acts on oral epithelial cells through CXCR2 which is 
its only known receptor. 
GRO-a mediated ERK1/2 activation in epithelial cells has already been reported. 
Exposure to GRO-a leads to phosphorylation of ERKI/2 in CHO cells stably 
transfected with CXCR2 whereas addition of pertussis toxin blocks this response 
confirming the involvement of a G-protein coupled receptor (Shyamala and Khoja 
1998). In addition, ERK1/2 activation by GRO-a has been shown in lymphoid cells. 
Airway smooth muscle cells release GRO-a which mediates neutrophil chemotaxis. 
Addition of PD-98059 (an ERK inhibitor) inhibits GRO-a secretion from airway 
smooth muscle cells suggesting that GRO-a release involves the ERKI/2 cascade 
(Issa et a!., 2006). 
To summarise, stimulation of NOK and H357 and SCC4 oral cancer cell lines with 
IL-8 and GRO-a, causes a significant increase in intracellular ERK1/2 
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phosphorylation. This suggests that CXCRI and CXCR2 mediate activation of 
ERK1/2 in oral epithelial cells when stimulated with their respective chemokines. 
Higher levels of phosphorylated ERK1/2 are observed in unstimulated and stimulated 
oral cancer cells than normal at all concentrations which suggests a potential role for 
ERK1/2 in the biology of oral cancer. However, more work needs to be done to 
establish the precise role of the ERK1/2 signaling cascade in this regard. 
At present it is not clear whether the activation of ERK following IL-8 exposure is 
due to signaling through CXCRI or CXCR2 or both. However it is clear that 
signaling through CXCR2 is able to activate ERK1/2 since exposure to GRO-a 
increases ERK1/2 and CXCR2 is its only known receptor. 
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Chapter 4- XCRI, CXCRI and CXCR2 in Oral Epithelial Cell Migration and Invasion 
4.1 INTRODUCTION 
Previous chapters have shown that XCR1, CXCR1 and CXCR2 are expressed on normal 
and cancerous oral epithelial cells at mRNA and protein level and that they facilitate 
activation of the ERK1/2 signaling cascade when stimulated with their respective ligands. 
In order to determine whether XCR1, CXCR1 and CXCR2 are functional on oral 
epithelial cells, the effects of stimulation on cell migration and invasion were also 
investigated. 
Cell migration and invasion are fundamental aspects of wound healing and tumour 
metastasis. A wide range of mechanisms appear to be involved in these processes ranging 
from alteration in expression and/or behaviour of cytokines, growth factors and adhesion 
molecules. A role for chemokines and their receptors in cell migration and invasion has 
been established in a range of cancers (Kim et al., 2006; Kleeffet al., 1999; Liang et al., 
2004; Moore 2001; Muller et al., 2001; Scala et al., 2006; Scotton et al., 2001; Zhang et 
al., 2007; Zlotnik 2006). To date, XCRI/lymphotactin interaction has not been shown to 
mediate migration or invasion of epithelial cells. IL-8 and GRO-a are better characterised 
than lymphotactin in that regard as they have previously been shown to facilitate 
epithelial cell migration (as discussed later in Section 4.6). However, very little is known 
about the individual roles of CXCR1 or CXCR2 in IL-8 or GRO-a mediated migration 
and invasion. 
4.2 AIM 
The aim of this chapter was to establish the role of the chemokine receptors XCR1, 
CXCR1 and CXCR2 in migration and invasion of oral epithelial cells. 
4.3 EXPERIMENTAL PROTOCOL 
  NOK, H357 and SCC4 cells were used in these assays. 
  Migration assays were performed using Transwell® inserts in 24 well tissue culture 
plates to study the role of XCR1, CXCR1 and CXCR2 in chemotaxis of oral cells 
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towards lymphotactin, IL-8 and GRO-a. 
  BD biocoat invasion chambers (coated with matrigel) were used to study the invasion 
of cells towards lymphotactin, IL-8 and GRO-a. 10% foetal bovine serum (FBS) was 
used as positive control in invasion studies. 
  Blocking antibodies for XCR, CXCR1 and CXCR2 were also used in the assays to 
study the individual role of the receptors in migration and invasion 
  CCL25/TECK was used as an irrelevant chemokine in all assays. CXCR1 was used as 
an irrelevant antibody in assays for XCR1/lymphotactin and GRO-a whereas XCRI 
was used as an irrelevant antibody for IL-8 assays. 
  Triplicate wells for each treatment and cell type were used in every migration and 
invasion assay. Assays were repeated three times on different occasions. 
4.4 MATERIALS AND METHODS 
4.4.1 CELL CULTURE 
Cells were grown and maintained as described previously. 
4.4.2 MIGRATION ASSAY 
Chemotaxis assays were performed using Transwell® insert polycarbonate membranes 
(8µm pore size) (Coming, Lowell, MA, USA) in 24-well tissue culture plates. The 
undersides of the inserts were coated with fibronectin (Sigma)(10µg/ml) via a lh 
incubation in a CO2 incubator. The inserts were blocked with migration buffer 
(DMEM: F12,3: 1 with 0.5% BSA; filter sterilized) by another Ih incubation. 
Cells were detached from T75cm2 tissue culture flasks using a non-enzymatic cell 
dissociation solution (Sigma) and re-suspended in migration buffer. Some cells were 
incubated with XCR1 (Lifespan), CXCR1 and CXCR2 antibodies (R&D Systems) 
(20µg/ml) or an irrelevant antibody for 30min at RT before being used in the assay. The 
same concentration of antibodies was used as for immunocytochemistry and flow 
cytometry for consistency. Also, the product details suggested these concentrations to be 
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optimal for receptor neutralisation. (x105 cells were seeded in the top compartment 
whereas lv mphotactin (R&D Systems), IL-8 (Sigma) and GRO-a (Peprotech) (100ng/ml) 
were added to the lower chamber. The control wells received no lymphotactin or an 
irrelevant chemokine CCL25/TECK (Peprotech) (100ng/ml). 
Cells were allowed to migrate for 4h in a CO, incubator. The inserts were fixed in 10% 
lormalin for I0min and stained in 0.5% crystal violet for l0min at RT. The inserts were 
rinsed briefly in water and non-migratory cells on the upper membrane surface removed 
with a cotton swab. The membranes were cut and mounted on slides using DYX. 
Migrated cells in five random fields were counted using a light microscope for each 
membrane and mean number of cells per assay calculated. All assays were performed in 
triplicate. Data Nv as expressed as migration index. 
Migration Index = Number of cells migrating to fibronectin x 100 
Number of cells migrating to test substance 
Transwell inserts coated with Fibronectin. 
............. . 
Fibronectin 
1h incubation 
Aim 
Blocked using Migration Buffer. 
 uIuIllsollUu  
Migration buffer 
DMEM + 0.5% BSA 
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Ih incubation 
Single cell suspensions prepared. 1 x105 
cells placed on top of the membrane. Test 
substances were placed in the bottom half. 
4h incubation 
Cells fixed after four hours. Stained using 
crystal violet. 
,... i Cells on the upper surface removed. 
Membranes cut, mounted and viewed 
under a microscope. 
Figure 4.1. Overview of migration/chemotaxis assay. 
4.4.3 INVASION ASSAY 
In, asion assays were performed using Becton Dickinson biocoat invasion chambers 
(iatrigel-coated) (BD Biosciences, Bedford, MA, USA) to study the effect of 
lymphotactin on epithelial cell invasion. The layer of matrigel matrix serves as a 
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reconstituted basement membrane in vitro. It occludes the membrane pores thereby 
blocking non-invasive cells. By contrast, invasive cells (malignant or non-malignant 
cells) are able to detach themselves and migrate through the membrane. NOK, 11357 and 
SCC4 cell lines were used (as they express different positivity for XCRI) to study 
whether invasive capability of the cells has a correlation with receptor positivity. 
Figure 4.2. Matrigel-coated invasion chamber in a 24-well tissue culture plate. The test 
chemokine is placed in the bottom half whereas the cells are placed on top of the matrigel-coated 
membrane and allowed to invade for 22 hours. 
Invasion chambers were brought to ambient temperature and re-hydrated using warn 
DMEM (In%itrogen) for two hours in a CO2 incubator at 37°C. Cells were serum-starved 
overnight. washed and re-suspended in serum free medium at 50x103 per nil. For some of 
the wells, cells were incubated with XCRI antibody (20µg/ml) and an irrelevant antibody 
(CXCRI) for 30nlln at RT before being used. Medium in upper compartment was 
removed and replaced with 500µI of cell suspension. Lymphotactin (R&D Systems), IL- 
8 (Signa), GRO-a (Peprotech) or an irrelevant chemokine TECK (Peprotech)(100ng/ml) 
were added to the bottom half and 10% serum was used as positive control. The invasion 
chambers were incubated for 20h, fixed in formalin and stained using 0.5% crystal violet. 
Chambers were washed and remaining non-invasive cells on the upper surface were 
wiped off using a cotton swab. The matrigel membranes were cut and mounted on slides 
using DI X. Number of invasive cells in five random fields per membrane was counted 
using a light microscope and mean number of cells per assay calculated. All assays were 
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performed in triplicate and performed three times. Data was expressed as mean number 
of invasive cells per assay. 
4.4.4 STATISTICAL ANALYSIS 
Data are presented as means +/- SD. Paired student's T test was used to determine the 
significance of the results obtained from the migration and invasion assays. A p-value of' 
<0.05 as considered significant. 
4.5 RESULTS 
4.5.1 XCRI / LYMPHOTACTIN 
4.5.1.1 Migration towards h mphotactin 
i) NOK 
Addition of lymphotactin resulted in a significant increase (30%) in migration of NOK 
compared with fibronectin alone (p<0.05). No increase in migration was observed with 
the irrelevant chemokine TECK. Pre-incubation of cells with XCRI antibody caused a 
significant decrease in lymphotactin-mediated migration (p<0.05) but did not reduce it to 
the control level. The irrelevant antibody CXCRI failed to have any effect. (Figure 4.3). 
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Figure 4.3. Percentage increase in migration of NOK towards fibronectin in the presence of 
lymphotactin (n=average of 3 different experiments done in triplicate, error bars=SD) (Where FN- 
fibronectin, TECK=irrelevant chemokine, CXCR1=irrelevant antibody). Lymphotactin caused a 
significant increase in migration of NOK towards fibronectin and this effect was significantly 
reduced when an XCR1 antibody was added. The irrelevant chemokine TECK and the irrelevant 
antibody CXCR1 did not have any effect. 
ii) 1-1357 and SCC4 
A similar response was observed in H357 and SCC4 cells as their migration increased 
significantly (46.3% and 56.3% respectively) towards lymphotactin compared with 
fibronectin alone (p<0.0001 and p<0.0001 respectively) (Figure 4.4 and 4.5). Addition of 
XCR I antibody resulted in a significant reduction in migration in 11357 and SCC4 cells 
(p<0.00I and p<0.00l respectively) but migration was not reduced to control levels. The 
irrelevant controls TECK or CXCRI did not have any effect. 
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Figure 4.4. Percentage increase in migration of H357 cells towards fibronectin in the presence of 
lymphotactin (n=average of 3 different experiments done in triplicate, error bars=SD) (where FN- 
fibronectin, TECK=irrelevant chemokine, CXCR1=irrelevant antibody). Lymphotactin caused a 
significant increase in migration of NOK towards fibronectin and this effect was significantly 
reduced when an XCR1 antibody was added. The irrelevant chemokine TECK and the irrelevant 
antibody CXCR1 did not have any effect. 
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Figure 4.5. Percentage increase in migration of SCC4 cells towards fibronectin in the presence 
of lymphotactin (n=average of 3 different experiments done in triplicate, error bars=SD) (where 
FN- fibronectin, TECK=irrelevant chemokine, CXCR1 =irrelevant antibody). Lymphotactin caused 
a significant increase in migration of NOK towards fibronectin and this effect was significantly 
reduced when an XCR1 antibody was added. The irrelevant chemokine TECK and the irrelevant 
antibody CXCR1 did not have any effect. 
iii) Comparison of XCRI/lymphotactin mediated migration between NOK and 
OCCL 
Significantly more H357 cells than NOK migrated towards lymphotactin (p<0.0001 and 
p<0.0000I respectively). SCC4 cells were more migratory towards lymphotactin than 
11357 cells (p<0.000I) (Figure 4.6). 
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Figure 4.6. Comparison of percentage increase in migration of NOK, H357 and SCC4 cells in the 
presence of lymphotactin + fibronectin compared with fibronectin alone (n=average of 3 different 
experiments done in triplicate, error bars=SD). SCC4 cells were the most migratory towards 
lymphotactin, followed by H357 whereas NOK were the least migratory. 
An increase of 56.3% in lymphotactin mediated migration of SCC4 cells was seen 
compared with 48.3% in H357 cells. This correlates well with the expression data as a 
higher number of SCC4 express XCRI (>90%) than H357 cells (60%). The percentage 
increase in migration was lowest for NOK (31.3%) which are the least XCR ]-positive of' 
the three tested cells. The relationship between receptor expression and the migratory 
response of NOK, 1-1357 and SCC4 cells is shown in Figure 4.7. 
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Figure 4.7. Relationship between % XCR1-positive cells and migration towards lymphotactin. 
Extent of XCR1 expression appeared to correlate with the migratory ability towards lymphotactin. 
SCC4 cells (with highest XCR1 positivity) showed highest migration towards lymphotactin 
followed by H357 (intermediate XCR1 expression). NOK were the least migratory. 
4.5.1.2 Invasion towards lymphotactin 
i) NOK 
The number of NOK that invaded towards lymphotactin was significantly lower than the 
positive control FBS (p<0.00001) but was significantly higher than the background 
(p<0.000I ). Very little invasion was observed in negative control or in response to '1'{. ('K 
(Figure 4.8). 
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Figure 4.8. Invasion of NOK towards lymphotactin (n=average of 3 different experiments done in 
triplicate, error bars=SD) (where positive= 10% FBS, TECK= irrelevant chemokine, CXCR1= 
irrelevant antibody). Lymphotactin caused a significant increase in invasion of NOK and this effect 
was significantly reduced when an XCR1 antibody was added. The irrelevant chemokine TECK 
and the irrelevant antibody CXCR1 did not have any effect. 
Administration of XCRI blocking antibody almost completely abolished this 
lymphotactin-mediated invasion (p<0.000I) but did not reduce it to control levels. No 
effect was observed with the irrelevant control antibody CXCR I (Figure 4.8). 
ii) H357 and SCC4 cells 
Invasion of H357 and SCC4 cells was also significantly enhanced in the presence of IRS 
and lymphotactin (p<0.0001 and p<0.000I respectively) compared with the background 
(Figure 4.9 and 4.10). Pre-incubation of 11357 and SCC4 cells with XCRI antibody 
resulted in a significant reduction in invasion (p<0.0000I and p<0.000I respectively) but 
did not reduce it to the level of background. The irrelevant chemokine 'I'FCK and the 
irrelevant antibody CXCR I did not exert any influence on invasion. 
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Figure 4.9. Invasion of H357 cells towards lymphotactin (n=average of 3 different experiments 
done in triplicate, error bars=SD) (where positive= 10% FBS, TECK= irrelevant chemokine, 
The Chemokine Receptors XCRI, I and ('. 1('R2 Regulate Oral Epithelial ('ell Behaviour 115 
Charter 4- XCRI, ('X('RI und ('. 1CR? in Oral Epithelial ('ell , Migration unc/ 
/nrasiun 
CXCR1= irrelevant antibody). Lymphotactin caused a significant increase in invasion of NOK and 
this effect was significantly reduced when an XCR1 antibody was added. The irrelevant 
chemokine TECK and the irrelevant antibody CXCR1 did not have any effect. 
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Figure 4.10. Invasion of SCC4 cells towards lymphotactin (n=average of 3 different experiments 
done in triplicate, error bars=SD) (where positive= 10% FBS, TECK= irrelevant chemokine, 
CXCR1= irrelevant antibody). Lymphotactin caused a significant increase in invasion of NOK and 
this effect was significantly reduced when an XCR1 antibody was added. The irrelevant 
chemokine TECK and the irrelevant antibody CXCR1 did not have any effect. 
iii) Comparison of XCRI/Iymphotactin mediated invasion between NOK and OCCL 
Comparison of invasion between NOK, 11357 and SC('4 showed that the number of 
SCC4 cells invading towards lymphotactin was significantly higher than 11357 cells 
(p<0.0001) which was significantly greater than the number of NOK (p<0.000I ) (Figure 
4.11). 
The Chemokine Receptors 
. 
A('RI, C. l'('RI und ('. l('R2 Rcgulale Oiul Ljýitheliu/Cc'l/ 13chnrir, nr 
116 
Chapter 4- XCRI, CXCR/ and CXCR2 in Oral Epithelial Cell : Vigralion and Invasion 
Lptn + XCRI 
Lptn 
Negative 
H 
40 60 
Invasive cells/field 
SCC4 
H357 
NOK 
80 100 
Figure 4.11. Comparison of invasion of NOK, H357 and SCC4 cells towards lymphotactin n= 
average of 3 different experiments done in triplicate, error bars=SD). Invasion towards 
lymphotactin was highest for SCC4 cells followed by H357 whereas NOK were the least invasive. 
This is in agreement with XCRI expression data as more than 90% of' SCC4 cells are 
positive for XCRI (as shown by flow cytometry) whereas fewer 11357 cells express 
XCR I. The NOK are the least positive for XCRI and the least invasive towards 
lymphotactin (Figure 4.12). 
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Figure 4.12. The relationship between % XCR1-positive cells and the number of cells that 
invaded towards lymphotactin. Extent of XCR1 expression appeared to correlate with invasion 
towards lymphotactin. SCC4 cells (with highest XCR1 positivity) showed highest invasion towards 
lymphotactin followed by H357 (intermediate XCR1 expression). NOK were the least invasive. 
4.5.2 CXCR1 AND CXCR2 / IL-8 
4.5.2.1 Migration towards IL-8 
i) NOK 
Exposure of NOK to IL-8 lead to a significant increase (36%) in migration compared 
with fibronectin alone (p<0.005) whereas no migration was observed with the irrelevant 
chemokine TECK (Figure 4.13). Pre-incubation of cells with CXCRI or CXCR2 
antibody individually significantly decreased migration (p<0.005) while the irrelevant 
antibody XCRI failed to do so. However, when both CXCRI and CXCR2 antibodies 
were used in combination, no further decrease was observed compared with CXCR I or 
CXCR2 on their own. 
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Figure 4.13. Percentage increase in migration of NOK towards fibronectin in the presence of IL-8 
(n=average of 3 different experiments done in triplicate, error bars=SD) (where FN= fibronectin, 
TECK= irrelevant chemokine, XCR1= irrelevant antibody). IL-8 caused a significant increase in 
migration of NOK and this effect was significantly reduced when CXCR1 or CXCR2 antibody was 
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added (alone and in combination). The irrelevant chemokine TECK and the irrelevant antibody 
XCR1 did not have any effect. 
ii) 11357 and SCC4 cells 
Migration of 11357 and SCC4 cells also increased significantly (47.2% and 74 2% 
respectively) in the presence of IL-8 compared with lihronectin alone (p<0.000001 and 
p<0.001 respectively) (Figure 4.14 and 4.15). As with NOK, the irrelevant chemokinc 
TECK failed to increase migration. 
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Figure 4.14. Percentage increase in migration of H357 cells towards fibronectin in the presence 
of IL-8 (n=average of 3 different experiments done in triplicate, error bars=SD) (where FN= 
fibronectin, TECK= irrelevant chemokine, XCR1= irrelevant antibody). IL-8 caused a significant 
increase in migration and this effect was significantly reduced when CXCR1 or CXCR2 antibody 
was added (alone and in combination). The irrelevant chemokine TECK and the irrelevant 
antibody XCR1 did not have any effect. 
For both H357 and SCC4 cells, addition of CXCR I (p<p. 000l and p<0.001 respectively) 
or CXCR2 antibody (p<0.000I and p<0.000I respectively) facilitated a significant 
decrease in migration but did not reduce it to the control levels. Pic-incubation with 
CXCRI and CXCR2 antibodies in combination did not cause any additional reduction in 
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migration compared to the individual antibodies. The irrelevant antibody X(R I had no 
effect on migration (Figure 4.14 and 4.15). 
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Figure 4.15. Percentage increase in migration of SCC4 cells towards fibronectin in the presence 
of IL-8 (n=average of 3 different experiments done in triplicate, error bars=SD) (where FN= 
fibronectin, TECK= irrelevant chemokine, XCR1= irrelevant antibody). IL-8 caused a significant 
increase in migration and this effect was significantly reduced when CXCR1 or CXCR2 antibody 
was added (alone and in combination). The irrelevant chemokine TECK and the irrelevant 
antibody XCR1 did not have any effect. 
iii) Comparison of IL-8 mediated migration between NOK and OCCL 
As for lymphotactin, the number of SCC4 cells that migrated towards ll. -8 was 
significantly higher than the number of 11357 cells (p<0.00000I ). Similarly significantly 
more I1357 cells than NOK migrated towards IL-8 (p<O. 01) (Figure 4.16). 
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Figure 4.16. Comparison of percentage increase in migration of NOK and OCCL towards IL-8 
(n=average of 3 different experiments done in triplicate, error bars=SD). Migration of cells was 
significantly increased in the presence of IL-8 compared with fibronectin alone. SCC4 cells 
showed the highest migration followed by H357 cells while NOK were the least migratory. 
Addition of CXCR1 or CXCR1 antibody (alone and in combination) significantly reduced this 
migration. 
The relationship between the percentage of CXCRI and CXCR2 positive cells and the 
percentage increase in migration is shown in Figures 4.17 and 4.18 respectively. I)itlerent 
patterns were observed for CXCRI and CXCR2 as CXCR I expression showed a more 
direct relationship with percentage expression of migrating cells than CXCR2. 
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Figure 4.17. Correlation between CXCR1 expression and migration of cells towards IL-8. Extent 
of CXCR1 expression appeared to correlate with the migratory ability towards IL-8. SCC4 cells 
(with highest CXCR1 positivity) showed highest migration towards IL-8 followed by H357 
(intermediate CXCR1 expression). NOK were the least migratory. 
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Figure 4.18. Correlation between CXCR2 expression and migration of cells towards IL-8. Extent 
of CXCR2 expression did not correlate very well with the migratory ability towards IL-8 (compared 
with CXCR1). SCC4 cells (with highest CXCR2 positivity) showed highest migration towards IL-8. 
H357 and SCC4 cells had similar CXCR2 positivity but greater migration was seen in H357 cells 
compared with NOK. 
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4.5.2.2 Invasion towards IL-8 
i) NOK 
Invasion of NOK was significantly increased towards FBS (p<0.001) and IL-8 
(p<0.0001) but not towards TECK (Figure 4.19). Addition of CXCRI or CXCR2 
antibody on their own resulted in significantly diminished invasion (p<0.0005) but did 
not reduce it to the control levels. No additional decrease was observed when both 
antibodies were used in combination. The irrelevant XCRI antibody did not cause any 
decrease in invasion. 
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Figure 4.19. Invasion of NOK towards IL-8 (n=average of 3 different experiments done in 
triplicate, error bars=SD) (where positive= 10% FBS, TECK= irrelevant chemokine, XCR1= 
irrelevant antibody). IL-8 caused a significant increase in invasion of NOK and this effect was 
significantly reduced when CXCR1 or CXCR2 antibody was added (alone and in combination). 
The irrelevant chemokine TECK and the irrelevant antibody XCR1 did not have any effect. 
ii) H357 and SCC4 cells 
A similar response was observed in H357 and SCC4 cells, Exposure of H357 and SCC4 
cells to FBS (p<0.00001) and IL-8 (p<0.0000001 and p<0.0001) significantly enhanced 
invasion compared with negative controls (Figures 4.20 and 4.21). In both H357 and 
SCC4 cells administration of CXCRI (p<0.00001 and p<0.01 respectively) or CXCR2 
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(p<0.00001 and p<0.01 respectively) blocking antibodies individually or in combination 
(p<0.000001 and p<0.0001 respectively) significantly reduced invasion but did not 
reduce it to control levels. The reduction in invasion of H357 with CXCRI antibody was 
significantly higher than CXCR2 (p<0.01) whereas no such effect was observed in the 
SCC4 cells (Figure 4.20). The irrelevant chemokine TECK or the irrelevant antibody 
XCRI failed to elicit any response. 
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Figure 4.20. Invasion of H357 cells towards IL-8 (n=average of 3 different experiments done in 
triplicate, error bars=SD) (where positive= 10% FBS, TECK= irrelevant chemokine, XCR1= 
irrelevant antibody). IL-8 caused a significant increase in invasion of NOK and this effect was 
significantly reduced when CXCR1 or CXCR2 antibody was added (alone and in combination). 
The irrelevant chemokine TECK and the irrelevant antibody XCR1 did not have any effect. 
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Figure 4.21. Invasion of SCC4 cells towards IL-8 (n=average of 3 different experiments done in 
triplicate, error bars=SD) (where positive= 10% FBS, TECK= irrelevant chemokine, XCR1= 
irrelevant antibody). IL-8 caused a significant increase in invasion of NOK and this effect was 
significantly reduced when CXCR1 or CXCR2 antibody was added (alone and in combination). 
The irrelevant chemokine TECK and the irrelevant antibody XCR1 did not have any effect. 
iii) Comparison of CXCRI-CXCR2/IL-8 mediated invasion between NOK and 
OCCL 
The number of SCC4 cells that invaded towards IL-8 was significantly more than H357 
cells (p<0.01). Invasion was lowest for NOK (Figure 4.22). 
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Figure 4.22. Comparison of invasion of NOK, H357 and SCC4 cells towards IL-8 (n=average of 3 
different experiments done in triplicate, error bars=SD). Invasion of cells was significantly 
increased in the presence of IL-8 compared with controls. SCC4 cells showed the highest 
invasion followed by H357 cells while NOK were the least invasive. Addition of CXCR1 or CXCR1 
antibody (alone and in combination) significantly reduced this effect. 
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This is in agreement with CXCRI and CXCR2 expression data. More SCC4 cells are 
positive for CXCRI and CXCR2 compared with NOK and H357 cells and showed the 
highest number of cells that invaded towards IL-8. 
The correlation between CXCRI and CXCR2 expression and the number of cells that 
invaded towards IL-8 is shown in Figure 4.23 and 4.24. 
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Figure 4.23. Relationship between CXCR1 expression and invasion of cells towards IL-8. Extent 
of CXCR1 expression appeared to correlate with the invasion towards IL-8. SCC4 cells (with 
highest CXCR1 positivity) showed highest invasion towards IL-8 followed by H357 (intermediate 
CXCR1 expression). NOK were the least invasive. 
For CXCRI, a direct relationship was observed between the number of CXCRI positive 
cells and the number of cells that invaded towards IL-8 (Figure 4.25). 
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Figure 4.24. Relationship between CXCR2 expression and invasion of cells towards IL-8. Extent 
of CXCR2 expression did not correlate very well with the invasion towards IL-8 (compared with 
CXCR1). SCC4 cells (with highest CXCR2 positivity) showed highest invasion towards IL-8. H357 
and SCC4 cells had similar CXCR2 positivity but greater invasion was seen in H357 cells 
compared with NOK. 
The results were very different for CXCR2. NOK and H357 cells have a similar 
percentage of CXCR2-positive cells however more H357 cells than NOK invaded 
towards IL-8 (Figure 4.24). 
4.5.3 CXCR2 / GRO-a 
4.5.3.1 Migration towards GRO-a 
i) NOK 
Migration of NOK increased significantly by 45% in the presence of GRO-a compared 
with fibronectin alone (p<0.00001). Pre-incubation of cells with CXCR2 antibody caused 
a significant decrease in this migration (p<0.001) but did not reduce it to control levels. 
TECK and the irrelevant antibody CXCRI failed to elicit any response (Figure 4.25). No 
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further decrease was observed compared to CXCR2 when both CXCRI and CXCR2 
antibodies were used in combination. 
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Figure 4.25. Percentage increase in migration of NOK towards fibronectin in the presence of 
GRO-a (n=average of 3 different experiments done in triplicate, error bars=SD) (where TECK= 
irrelevant chemokine, CXCR1= irrelevant antibody). GRO-a caused a significant increase in 
invasion of NOK and this effect was significantly reduced when CXCR2 antibody was added. The 
irrelevant chemokine TECK and the irrelevant antibody CXCR1 did not have any effect. 
ii) H357 and SCC4 cells 
Migration of H357 and SCC4 cells increased significantly (by 45% and 59.3% 
respectively) in the presence of GRO-a compared with fibronectin alone (p<0.01 and 
p<0.000I respectively) (Figure 4.26 and 4.27). Pre-incubation with CXCR2 but not 
CXCRI antibody significantly reduced migration of H357 and SCC4 cells towards GRO- 
a (p<0.05 and p<0.01 respectively) but failed to reduce it to control levels. No further 
reduction in migration compared to CXCR2 was observed when both CXCRI and 
CXCR2 antibodies were used in combination. No migration was seen in response to 
TECK. 
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Figure 4.26. Migration of H357 cells towards fibronectin in the presence of GRO-a (n=average of 
3 different experiments done in triplicate, error bars=SD) (where TECK= irrelevant chemokine, 
CXCR1= irrelevant antibody). GRO-a caused a significant increase in invasion of NOK and this 
effect was significantly reduced when CXCR2 antibody was added. The irrelevant chemokine 
TECK and the irrelevant antibody CXCR1 did not have any effect. 
70 
Figure 4.27. Migration of SCC4 cells towards fibronectin in the presence of GRO-a (n=average of 
3 different experiments done in triplicate, error bars=SD) (where TECK= irrelevant chemokine, 
CXCR1= irrelevant antibody). GRO-a caused a significant increase in invasion of NOK and this 
effect was significantly reduced when CXCR2 antibody was added. The irrelevant chemokine 
TECK and the irrelevant antibody CXCR1 did not have any effect. 
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iii) Comparison of CXCR2/GRO-a mediated migration between NOK and OCCL 
Comparison of migration of NOK, 11357 and SCC4 cells towards GRO-a revealed no 
difference between NOK and 11357 cells compared with fibronectin alone. However, 
migration of SCC4 cells was significantly higher than both NOK and H357 (p<0.00001 
and p<0.0I respectively) (Figure 4.28). 
. 
ýý .ý 
--ý 
FN 
0 10 20 30 40 50 60 70 
% Increase in migration 
Figure 4.28. Comparison of percentage increase in migration of NOK, H357 and SCC4 cells 
towards GRO-a + fibronectin compared with fibronectin alone (n=average of 3 different 
experiments done in triplicate, error bars=SD). GRO-a mediated migration was highest in SCC4 
cells whereas NOK and H357 migrated to a similar extent. Addition of CXCR2 antibody 
significantly reduced GRO-a mediated migration. 
The relationship between percentage of CXCR2 positive cells and the percentage increase 
in migration is shown in Figure 4.29. NOK and H357 showed almost identical CXCR2 
expression and migration whereas more SCC4 cells were CXCR2 positive and their 
17ir ('hemokinr Receplurs . 
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migration was greater. 
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Figure 4.29. Relationship between CXCR2 expression and migration of cells towards GRO-a. 
Extent of CXCR2 expression appeared to correlate with the migration towards GRO-a. SCC4 
cells (with highest CXCR2 positivity) showed highest migration towards GRO-a. H357 and NOK 
had similar CXCR2 expression and migrated to a similar extent. 
4.5.3.2 Invasion towards GRO-a 
i) NOK 
Invasion of NOK was significantly enhanced in the presence of FBS and GRO-a 
compared with negative controls (p<0.000001). Addition of CXCR2 but not CXCRI 
antibody significantly decreased invasion towards GRO-a (p<0.0000I) but did not reduce 
it to control levels (Figure 4.30). 
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Figure 4.30. Invasion of NOK towards GRO-a (n=average of 3 different experiments done in 
triplicate, error bars=SD) (where positive= 10% FBS, TECK= irrelevant chemokine, CXCR1= 
irrelevant antibody). GRO-a caused a significant increase in invasion of NOK and this effect was 
significantly reduced when CXCR2 antibody was added. The irrelevant chemokine TECK and the 
irrelevant antibody CXCR1 did not have any effect. 
Combination of CXCRI and CXCR2 antibodies did not cause further reduction in 
invasion compared with CXCR2. No invasion was seen in response to TECK (Figure 
4.30). 
ii) H357 and SCC4 cells 
FBS and GRO-a also caused a significant increase in invasion of 11357 (p<0.0000001 
and p<0.00001 respectively) and SCC4 cells (p<0.00001 and p<0.0001 respectively) 
compared with negative controls whereas TECK failed to do so (Figure 4.31 and 4.32). 
Addition of CXCR2 antibody decreased GRO-a mediated invasion significantly in both 
H357 and SCC4 cells (p<0.0001 and p<0.0001 respectively) but did not reduce it to 
control levels. 
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Figure 4.31. Invasion of H357 cells towards GRO-a (n=average of 3 different experiments done 
in triplicate, error bars=SD) (where positive= 10% FBS, TECK= irrelevant chemokine, CXCR1= 
irrelevant antibody). GRO-a caused a significant increase in invasion of NOK and this effect was 
significantly reduced when CXCR2 antibody was added. The irrelevant chemokine TECK and the 
irrelevant antibody CXCR1 did not have any effect. 
Use of CXCRI and CXCR2 antibodies in combination did not cause any further 
reduction in invasion compared with CXCR2. No decrease in invasion was seen with the 
irrelevant CXCR I antibody (Figure 4.31 and 4.32). 
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Figure 4.32. Invasion of SCC4 cells towards GRO-a (n=average of 3 different experiments done 
in triplicate, error bars=SD) (where positive= 10% FBS, TECK= irrelevant chemokine, CXCR1= 
irrelevant antibody). GRO-a caused a significant increase in invasion of NOK and this effect was 
significantly reduced when CXCR2 antibody was added. The irrelevant chemokine TECK and the 
irrelevant antibody CXCR1 did not have any effect. 
iii) Comparison of CXCR2/GRO-a mediated invasion between NOK and OCCL 
More SCC4 cells were invasive towards GRO-a than 11357 (p<0.00001) whereas the 
number of invasive H357 cells was slightly higher than NOK (p<0.01) (Figure 4.33). 
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Figure 4.33. Comparison of invasion of NOK, H357 and SCC4 cells towards GRO-a (n=average 
of 3 different experiments done in triplicate, error bars=SD). GRO-a mediated invasion was 
highest in SCC4 cells whereas NOK and H357 invaded to a similar extent. Addition of CXCR2 
antibody significantly reduced GRO-a mediated invasion. 
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NOK and 1357 cells exhibited identical CXCR2 expression but more 11357 cells invaded 
towards GRO-a than NOK. The relationship between percentage of CXCR2 positive cells 
and number of invasive cells towards GRO-a is shown in Figure 4.34. 
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Figure 4.34. Correlation between CXCR2 expression and invasion of cells towards GRO-a. 
Extent of CXCR2 expression appeared to correlate with the invasion towards GRO-a. SCC4 cells 
(with highest CXCR2 positivity) showed highest invasion towards GRO-a. H357 and NOK had 
similar CXCR2 expression and invaded to a similar extent. 
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4.6 DISCUSSION 
Migration and invasion assays were performed to study the role of XCRI, CXCRI and 
CXCR2 in oral epithelial cell chemotaxis and invasion. The results suggest that XCRI. 
CXCRI and CXCR2 may mediate migration and invasion of normal and cancerous oral 
epithelial cells when stimulated with their respective ligands. 
i) XCRI and lymphotactin 
Migration of NOK and OCCL (H357 and SCC4) towards fibronectin was significantly 
enhanced in the presence of lymphotactin, but not TECK. Application of an anti-XCRI 
antibody, but not CXCRI antibody, resulted in a significant decrease in this migration 
suggesting that the migration is mediated through XCRI. However, the XCRI blocking 
antibody did not completely abolish the migration or bring it down to the level of 
negative control. There may be a number of explanations for this. One is that the 
concentration of blocking antibody was not sufficient to block all XCRI receptors on the 
cells. Second, since the role and interaction of XCRI and lymphotactin on epithelial cells 
are not yet fully characterized, it is a possibility that lymphotactin may be signaling 
through a receptor not yet identified. However, migration of cells towards lymphotactin 
appeared proportional to the number of XCRI expressing cells in the different cell 
populations used. Significantly more SCC4 cells (>90% XCRI positive) migrated 
towards lymphotactin compared with 11357 (60% XCRI positive) whereas NOK (30% 
XCRI positive) were the least migratory. This shows that a relationship exists between 
the number of XCRI positive cells and the migratory capability towards lymphotactin 
and further suggests that lymphotactin mediates its effects through XCRI. 
Similar results were obtained for invasion assays. Exposure to lymphotactin caused a 
significant and specific increase in invasion of H357 and SCC4 cells, since no response to 
TECK was seen. Invasion of a few NOK towards lymphotactin was also observed. 
Administration of an XCRI antibody significantly reduced this invasion to a much 
greater extent than migration but still failed to bring it back to control levels. No response 
was seen to the irrelevant CXCRI antibody or TECK. Like migration, a direct 
relationship between the number of XCRI positive cells and the number of invasive cells 
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was observed as significantly more SCC4 cells invaded towards lymphotactin than H357 
followed by NOK. Keratinocytes are known to migrate and invade in vivo during wound 
healing and a previous study has shown invasion of normal human keratinocytes in vitro 
(Livant et al., 2000). However, this group did not describe the location of origin of the 
keratinocytes used in their study. 
To summarize, these results show that XCRI is functional on the surface of oral epithelial 
cells and these cells respond to lymphotactin by migrating and invading. The significance 
of Ivmphotactin's role in oral epithelial cell migration and invasion and its potential 
implications will be discussed later in Chapter 9. 
ii) CXCR1, CXCR2 and IL-8 
Migration of NOK and OCCL was significantly enhanced in the presence of IL-8. 
Addition of anti-CXCRI or -CXCR2 antibody on its own reduced migration to a similar 
extent but no further decrease was observed when a combination of both antibodies was 
used. These findings are in agreement with those of Watanabe el al., who studied the 
migration of oral cancer cell lines NA and HSC-4 towards IL -8 and reported a significant 
increase in migration of cells in the presence of IL-8 (Watanabe ef al., 2002). This group 
also used CXCRI and CXCR2 blocking antibodies in their migration assays and reported 
that almost an identical reduction was observed with CXCRI or CXCR2 antibody and 
only partial inhibition of migration could be achieved. Our results suggest that migration 
in response to IL-8 is mediated through both CXCRI and CXCR2. 
Comparison of the three cell types indicated a direct relationship between overall number 
of receptor positive cells and the chernotactic response. More SCC4 cells than H357 
migrated towards IL-8 whereas NOK were the least migratory. A direct relationship 
between the percentage positive CXCRI population and the percentage increase in 
migration of NOK, 11357 and SCC4 cells was observed. However, the same was not true 
for CXCR2. Although approximately 30% of NOK and 14357 are positive for CXCR2, 
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the percentage increase in migration was higher for H357 cells (45%) than NOK (35%). 
This may be explained by Figure 4.35. 
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Figure 4.35. Percentage positivity for CXCR1 and CXCR2 in NOK, H357 and SCC4 cells. 20% of 
NOK are positive for CXCR1 and 30% for CXCR2. For H357 cells, 75% and 30% are positive for 
CXCR1 and CXCR2 respectively. Whereas for SCC4 cells, 100% and 90% are positive for 
CXCR1 and CXCR2 respectively. 
Since more H357 cells are positive for CXCRI than NOK (75% compared with 20% for 
NOK) CXCRI might play a more important role than CXCR2 in these experiments as 
more CXCR I receptors will be available to mediate the effects of IL-8. 
The Chemokine Receptors XCRI, C XCRI and XCR2 Regulate Oral Epithelial Cell Behaviour 138 
Chapter 4-XCRI, CXCRI and CXCR2 in Oral Epithelial Cell Migration and Invasion 
As mentioned earlier, no further reduction in migration was observed when CXCR1 and 
CXCR2 antibodies were used in combination with any of the cells. This suggests that 
CXCR1 and CXCR2 may be co-expressed on the same cells rather than on separate cells. 
This is certainly the case for the SCC4 cell line because almost 100% are positive for 
CXCR1 and 90% are positive for CXCR2. Whether it is true for H357 and NOK cells is 
not clear. Preliminary FACS analysis (fluorescence activated cell sorting) suggested this 
may be the case (results not shown) but further work needs to be done to establish 
whether the receptors are co-expressed particularly on NOK and OCCL. 
It is also worth commenting on the finding that for SCC4 cells which almost all co- 
express CXCRI and CXCR2 there was an equal reduction in migration in response to 
antibodies against CXCRI and CXCR2 separately and in combination. If migration is 
induced through both receptors equally, migration would not be expected to be reduced in 
the presence of just one antibody because the other receptor would be available to 
mediate migration. However in the presence of both blocking antibodies migration should 
have been greatly reduced. These findings suggest that interaction between receptors may 
be important in mediating migration. Clearly dissecting out the relative contributions of 
CXCR1 and CXCR2 in mediating migration will require further study. 
Individual roles of CXCRI and CXCR2 have previously been studied in IL-8 induced 
migration. Antibody inhibition studies have shown that chemotaxis of epithelial cells in 
colon carcinoma and endothelial cells in melanoma is mediated through CXCRI (Bates, 
DeLeo, III, and Mercurio 2004; Ramjeesingh, Leung, and Siu 2003) as CXCRI blocking 
antibody caused a much greater reduction in migration than CXCR2. However, higher 
CXCRI expression was exhibited by cells in both cases after stimulation. This suggests 
that the greater reduction in migration with CXCRI antibody may only be due to greater 
expression of CXCRI compared with CXCR2. In contrast, migration of human vein 
umbilical endothelial cells (HUVEC) and human dermal microvascular endothelial cells 
(HMEC) towards IL-8 is mediated through CXCR2 (Li et al., 2005). This group did not 
study the cell surface expression of CXCRI or CXCR2 on HMECs and therefore it is 
possible that more HMECs are positive for CXCR2 than CXCRI. Colonic epithelial cell 
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lines CaCo-2 and HT-29 show very weak expression of CXCR2 compared with CXCRI 
and their migration in chemotaxis/wound assays is mediated through CXCRI (Sturm et 
al., 2005). They also reported that addition of a CXCRI antibody significantly reduced 
migration towards IL-8 but even extensive doses of CXCRI do not block the migration 
completely. This is similar to our findings as addition of both antibodies individually or 
in combination failed to reduce migration to the control level. It is also possible that IL-8 
may have the potential to act through other pathways. 
IL-8 also stimulated invasion of NOK, H357 and SCC4 cells. Invasion was decreased 
after addition of CXCR1 or CXCR2 antibody individually and in combination. This 
suggests that like migration, invasion may be mediated through both receptors. A direct 
relationship between the percentage positive CXCR1 cells and number of invasive cells 
was seen in NOK, H357 and SCC4 cells. The same was not true for CXCR2. Even 
though similar proportions of NOK and H357 are positive for CXCR2 (30%) a much 
higher number of H357 cells than NOK invaded towards IL-8. As discussed above this 
may be explained by the much higher percentage of CXCRI-positive than CXCR2- 
postive H357 cells. 
A different effect of the blocking antibodies on invasion of H357 cells compared with the 
SCC4 cells and NOK was seen. Interestingly a greater reduction in invasion occurred 
with antibodies against CXCR1 than CXCR2 and addition of both antibodies in 
combination significantly reduced invasion compared with CXCR2 but not CXCRI. This 
may be explained by the fact that more H357 cells are positive for CXCRI than CXCR2 
(see above). However such an effect was not seen with antibodies against CXCR1 and 
CXCR2 on the migration of H357 cells. Clearly the difference in the percentage of 
CXCR1 and CXCR2 positive cells is not the only explanation. A further difference 
between the effects of blocking antibodies on migration and invasion was observed as 
antibodies were more effective in invasion than migration assays and reduced invasion 
almost to control levels. One possible explanation for this could be the design of the two 
experiments. The migration assays were less sensitive than invasion assays as a large 
number of cells migrated towards fibronectin even in the absence of the chemokines. In 
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invasion assays, fibronectin was not employed and cells (serum starved overnight) were 
allowed to invade only towards the chemokines for 22 hours. Therefore the improved 
blocking efficiency in invasion assays may just be due to greater sensitivity of the 
invasion assays. 
A role for IL-8 in cancer cell migration and invasion has previously been reported by a 
number of groups. IL-8 facilitates chemotaxis and invasion in a number of cancer cells 
including ovarian (So et al., 2004), breast (Kim et al., 2005; Yao et al., 2007; Youngs et 
al., 1997) colon (Li, Varney, and Singh 2001), gastric (Kitadai et al., 2000) pancreatic 
(Kuwada et al., 2003) and hepatocellular cancer (Kubo et al., 2005). All these findings 
suggest that both CXCR1 and CXCR2 can facilitate migration or invasion in response to 
IL-8. The possible implications of the interaction between CXCR1, CXCR2 and IL-8 in 
oral epithelial cell behaviour will be discussed later. 
iii) CXCR2 and GRO-a 
GRO-a was used for comparison with IL-8 in migration and invasion assays as it only 
signals through CXCR2 and not CXCRI. Migration and invasion of cells was 
significantly enhanced in the presence of GRO-a. Use of an anti-CXCR2 antibody but not 
CXCRI antibody resulted in a significant decrease in migration. When antibodies against 
CXCRI and CXCR2 were used in combination no further decrease in migration was 
observed compared with CXCR2 which is in agreement with the literature as GRO-a 
signals through CXCR2 and not through CXCR1. A role for GRO-a in epithelial cell 
migration and invasion has been shown in uveal melanoma (Woodward et al., 2002), 
colon carcinoma (Li, Varney, and Singh 2004) and breast cancer cell lines (Li and Sidell 
2005; Youngs et al., 1997). However, the role of GRO-a in oral epithelial migration or 
invasion has not been reported to date. The above mentioned findings suggest that GRO- 
a can facilitate migration and invasion of oral epithelial cells and its effects are mediated 
principally through CXCR2. 
To summarize, these results show that IL-8 is able to stimulate migration and invasion of 
both normal and malignant epithelial cells and these effects appear to be mediated by 
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both CXCR1 and CXCR2. The relative contribution of these receptors appears to depend 
on the proportion of receptor positive cells and differs between cell types. The response 
of the SCC4 and H357 cell lines to IL-8 is greater than that of NOK and this also appears 
to relate to the percentage of positive cells. There is a suggestion that interaction between 
receptors may be important at least in the migration and invasion of SCC4 cells. 
GRO-a also facilitates chemotaxis and invasion of normal and cancerous oral epithelial 
cells. Higher migration and invasion are observed in OCCL compared with NOK and 
GRO-a appears to mediate these effects through CXCR2. 
The implications of these findings in the regulation of oral epithelial cell behaviour in 
vivo will be discussed in detail in Chapter 9. 
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Chapter 5- Role ofXCRI, CXCRland CXCR2 in Oral Epithelial Cell Proliferation 
5.1 INTRODUCTION 
Previous chapters have shown that in addition to facilitating cell migration and 
invasion, lymphotactin, IL-8 and GRO-a can also activate the ERK1/2 signaling 
cascade in oral epithelial cells and this may be mediated through their respective 
receptors XCR1, CXCR1 and CXCR2. The ERK1/2 pathway plays an important role 
in a range of physiological and pathological processes. A strong association between 
ERK1/2 activation and proliferation of cells has also been reported (Barbieri et al., 
2006; Luppi et al., 2006). Therefore, the next parameter to establish functional 
expression of XCRI, CXCR1 and CXCR2 was to study their role in oral epithelial 
cell proliferation. 
5.2 AIM 
The aim of this chapter was to establish the role of the chemokine receptors XCR1, 
CXCR1 and CXCR2 (and their ligands) in the proliferation of normal and malignant 
oral epithelial cells. 
5.3 EXPERIMENTAL PROTOCOL 
" NOK and OCCL (H357 and SCC4) were cultured in 96 well tissue culture plates 
to study proliferation in response to lymphotactin, IL-8 and GRO-a. 
" Proliferation assays were performed using CeilTitre 96® aqueous one solution 
cell proliferation reagent (Promega). 
  Negative controls did not receive any of the chemokines whereas TECK/CCL25 
was used as an irrelevant control chemokine. 
  CXCRI was used as an irrelevant antibody for lymphotactin and GRO-a whereas 
XCRI was used for IL-8. 
  Triplicate wells for each treatment and cell type were used in every experiment. 
All proliferation assays were performed three times. 
5.4 MATERIALS AND METHODS 
5.4.1 CELL CULTURE 
Cells were grown and maintained as described previously. 
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5.4.2 PROLIFERATION ASSAY 
The CellTitre 960 aqueous one solution cell proliferation reagent (Promega) was used 
to study proliferation. It contains the MTS tetrazolium compound [3-(4,5- 
dimethylthiazol-2-yl)-5-(3-carboxymethophenyl)-2- (4-sulfophenyl)- 2H- tetrazolium. 
MTS is bio-reduced by cells into a coloured formazan product by NADPH or NADH 
produced by enzymes in metabolically active cells thus providing an indirect account 
of the number of cells. 
Cells were detached using cell dissociation buffer (Sigma) and seeded at a density of 
2x103/well in 96 well plates (Corning). Cells were allowed to adhere overnight, 
medium was aspirated and cells washed with PBS. Lymphotactin (R&D Systems), IL- 
8 (Sigma) and GRO-a (Peprotech) were diluted to a concentration of I00ng/ml in 
serum-free medium (Appendix 10.1.5) and cells were incubated for 72h. In addition to 
the ligands, antibodies against XCR1, CXCRI and CXCR2 were also added to some 
wells to study the individual role of these receptors in lymphotactin-, IL-8- and GRO- 
a-mediated cell proliferation. For receptor blocking, cells were incubated with 
antibodies against XCRI, CXCR1 and CXCR2 (20µg/ml) in serum-free medium at 
37'Cfor at least Ih before addition of the chemokines. Absence of ligands served as 
the negative control whereas keratinocyte growth medium (KGM) (Appendix 10.1) 
was used as the positive control. All treatments were performed in triplicate wells. 
After 72 hours, 20µl of MTS was added to each well and incubated in a CO2 
incubator for 30-60 min. Absorbance was recorded at 492nm using a 
spectrophotometer and plotted against the concentration of the chemokines. A 
standard curve for each assay determined the number of cells. 
5.4.3 STATISTICAL ANALYSIS 
Averages and standard deviations were calculated from the obtained values of all 
samples and paired Student's T-test was used to analyze the significance of cell 
proliferation in response to lymphotactin, IL-8 and GRO-a compared with negative 
control. Data was expressed as increase in cell number relative to unstimulated cells. 
A p-value of less than 0.05 was considered significant. 
The Chemokine Receptors XCRI, CXCRI and CXCR2 Regulate Oral Epithelial Cell Behaviour 145 
Chapter? - Role ofXCR/, CYCRI and CVCR2 in Oral Epithelial Cell Proberation 
5.5 RESULTS 
5.5.1 Role of XCR1/lymphotactin in proliferation 
i) NOK 
Keratinocvte growth medium (KGM) (used as positive control) caused a highly 
significant increase in proliferation of NOK (p<0.0001). Stimulation of NOK with 
lymphotactin but not TECK caused a significant increase in proliferation compared 
with the negative control (p<0.01). Addition of XCRI antibody significantly 
diminished this lymphotactin-mediated proliferation (p<0.01) but failed to bring it 
back to the negative control level. No reduction in proliferation was seen with the 
irrelevant antibody CXCR1 (Figure 5.1). 
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Figure 5.1. Lymphotactin-mediated proliferation of NOK compared with unstimulated cells 
(means + SD) (n=average of 3 different experiments done in triplicate, error bars=SD). The 
positive control (KGM) and lymphotactin caused a significant increase in proliferation 
compared with unstimulated cells. Addition of an antibody against XCR1 significantly reduced 
the lymphotactin-mediated proliferation but did not reduce it to the control levels. The 
irrelevant chemokine TECK and the irrelevant antibody CXCR1 did not have any affect. 
ii) H357 and SCC4 cells 
Exposure to KGM significantly increased proliferation of OCCL (H357 and SCC4 
cells) (p<0.001 and p<0.001 respectively). Lymphotactin also increased proliferation 
of H357 and SCC4 cells (p<0.001 and p<0.001 respectively) whereas addition of 
XCRI antibody significantly reduced lymphotactin mediated proliferation (p<0.001 
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and p<0.0001 respectively). The irrelevant chemokine TECK and the irrelevant 
antibody CXCR I did not have any effect (Figure 5.2 and 5.3). 
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Figure 5.2. Lymphotactin-mediated proliferation of H357 cells compared with unstimulated 
cells (means ± SD) (n=average of 3 different experiments done in triplicate, error bars=SD). 
The positive control (KGM) and lymphotactin caused a significant increase in proliferation 
compared with unstimulated cells. Addition of an antibody against XCR1 significantly reduced 
the lymphotactin-mediated proliferation but did not reduce it to the control levels. The 
irrelevant chemokine TECK and the irrelevant antibody CXCR1 did not have any affect. 
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Figure 5.3. Lymphotactin-mediated proliferation of SCC4 cells compared with unstimulated 
cells (means ± SD) (n=average of 3 different experiments done in triplicate, error bars=SD). 
The positive control (KGM) and lymphotactin caused a significant increase in proliferation 
compared with unstimulated cells. Addition of an antibody against XCR1 significantly reduced 
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the lymphotactin-mediated proliferation but did not reduce it to the control levels. The 
irrelevant chemokine TECK and the irrelevant antibody CXCR1 did not have any affect. 
iii) Comparison of XCRI/lymph otactin mediated proliferation between NOK 
and OCCL 
Proliferation in response to lymphotactin was significantly higher in H357 and SCC4 
cells compared with NOK (p<0.05 and p<0.01 respectively). Addition of XCRI 
antibody significantly decreased proliferation of NOK and OCCL and reduced it to 
similar levels in all cells (Figure 5.4). 
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Figure 5.4. Comparison of XCR1llymphotactin-mediated proliferation between NOK, H357 
and SCC4 cells (means + SD) (n=average of 3 different experiments done in triplicate, error 
bars=SD) Lymphotactin caused a significant increase in the proliferation of NOK, H357 and 
SCC4 cells and addition of an XCR1 antibody significantly reduced lymphotactin-mediated 
proliferation. NOK were less proliferative than H357 and SCC4 cells but no significant 
difference was seen between the H357 and SCC4 cells. 
5.5.2 Role of CXCR1, CXCR2 / IL-8 in proliferation 
i) NOK 
Proliferation of NOK was significantly increased after stimulation with KGM and IL- 
8 (p<0.0001 and p<0.001 respectively). Addition of CXCRI or CXCR2 antibody 
significantly decreased proliferation (p<0.01 and p<0.01 respectively) but did not 
reduce it to the control level (Figure 5.5). 
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Figure 5.5. IL-8-mediated proliferation of NOK compared with unstimulated cells (means + 
SD) (n=average of 3 different experiments done in triplicate, error bars=SD). The positive 
control (KGM) and IL-8 caused a significant increase in proliferation compared with 
unstimulated cells. An antibody against CXCR1 or CXCR2 significantly reduced the IL-8- 
mediated proliferation but did not reduce it to the control levels. Addition of both CXCR1 and 
CXCR2 antibodies on combination further reduced proliferation compared with CXCR2 
antibody alone but not with CXCR1. The irrelevant chemokine TECK and the irrelevant 
antibody XCR1 did not have any affect. 
When both CXCRI and CXCR2 antibodies were used in combination, a further 
decrease in NOK proliferation was observed compared with CXCR2 alone (p<0.05) 
but not with CXCRI. The irrelevant chemokine TECK and CXCRI antibody did not 
have any influence on proliferation (Figure 5.5). 
ii) H357 and SCC4 cells 
KGM and IL-8 significantly increased proliferation of H357 (p<0.00I and p<0.01 
respectively) and SCC4 cells (p<0.00I and p<0.0001 respectively). A significant 
decrease in IL-8 mediated proliferation of H357 and SCC4 cells was noticed when 
either CXCRI or CXCR2 antibody was added (p<0.05 and p<0.001 respectively). 
When both antibodies were used in combination, proliferation of E1357 and SCC4 
cells was decreased further compared with CXCR2 alone, but not with CXCRI 
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antibody (p<0.05). No response was seen when the irrelevant controls TECK or 
XCR I antibody were used. (Figure 5.6 and 5.7) 
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Figure 5.6. IL-8-mediated proliferation of H357 cells compared with unstimulated cells 
(means + SD) (n=average of 3 different experiments done in triplicate, error bars=SD). The 
positive control (KGM) and IL-8 caused a significant increase in proliferation compared with 
unstimulated cells. An antibody against CXCR1 or CXCR2 significantly reduced the IL-8- 
mediated proliferation but did not reduce it to the control levels. Addition of both CXCR1 and 
CXCR2 antibodies on combination further reduced proliferation compared with CXCR2 
antibody alone but not with CXCR1. The irrelevant chemokine TECK and the irrelevant 
antibody XCR1 did not have any affect. 
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Figure 5.7. IL-8-mediated proliferation of SCC4 cells compared with unstimulated cells 
(means ± SD) (n=average of 3 different experiments done in triplicate, error bars=SD). The 
positive control (KGM) and IL-8 caused a significant increase in proliferation compared with 
unstimulated cells. An antibody against CXCR1 or CXCR2 significantly reduced the IL-B- 
mediated proliferation but did not reduce it to the control levels. Addition of both CXCR1 and 
CXCR2 antibodies on combination further reduced proliferation compared with CXCR2 
antibody alone but not with CXCR1. The irrelevant chemokine TECK and the irrelevant 
antibody XCR1 did not have any affect. 
iii) Comparison of CXCR1-CXCR2/IL-8 mediated proliferation between NOK 
and OCCL 
Comparison of NOK and OCCL showed that IL-8 facilitated a significantly higher 
increase in proliferation of H357 and SCC4 cells compared with NOK (p<0.05 and 
p<0.01 respectively) (Figure 5.8). 
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Figure 5.8. Comparison of CXCR1, CXCR2 / IL-8 mediated proliferation (means + SD) 
(n=average of 3 different experiments done in triplicate, error bars=SD). IL-8 caused a 
significant increase in the proliferation of NOK, H357 and SCC4 cells and addition of a 
CXCR1 or CXCR2 antibody significantly reduced IL-8-mediated proliferation. When both 
CXCR1 and CXCR2 antibodies were used a further reduction in proliferation was seen 
compared with CXCR2 but not with CXCR1 antibody. NOK were less proliferative than H357 
and SCC4 cells but no significant difference was seen between the H357 and SCC4 cells. 
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A significant reduction in this proliferation was observed when CXCRI or CXCR2 
antibodies were used individually or in combination (Figure 5.8). 
5.5.3 Role of CXCR2 / GRO-a in proliferation 
i) NOK 
A significant increase in the number of NOK was seen after addition of KGM and 
GRO-a indicating that it facilitates proliferation of these cells (p<0.000I). TECK 
failed to induce such a response. Addition of CXCR2 antibody significantly decreased 
proliferation (p<0.001) but did not reduce it to the control level. CXCRI antibody on 
its own or in combination with CXCR2 did not reduce proliferation (Figure 5.9). 
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Figure 5.9. GRO-a mediated proliferation of NOK compared with unstimulated cells (means + 
SD) (n=average of 3 different experiments done in triplicate, error bars=SD). The positive 
control (KGM) and GRO-a caused a significant increase in proliferation compared with 
unstimulated cells. Addition of an antibody against CXCR2 significantly reduced the GRO-a- 
mediated proliferation but did not reduce it to the control levels. The irrelevant chemokine 
TECK and the irrelevant antibody CXCR1 did not have any affect. 
ii) H357 and SCC4 cells 
FI X57 and SCC4 cells also showed a significant increase in proliferation after 
stimulation with KGM (p<0.001 and p<0.001 respectively) and GRO-a (p<0.01 and 
p<0.0001 respectively) compared with negative control. TECK failed to induce 
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proliferation. The proliferation of H357 and SCC4 cells was significantly reduced 
when anti-CXCR2 antibody was added (p<0.001 and p<0.001). No reduction in 
proliferation was observed with the CXCR I antibody (Figure 5.10 and 5.11). 
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Figure 5.10. GRO-a mediated proliferation of H357 cells compared with unstimulated cells 
(means ± SD) (n=average of 3 different experiments done in triplicate, error bars=SD). The 
positive control (KGM) and GRO-a caused a significant increase in proliferation compared 
with unstimulated cells. Addition of an antibody against CXCR2 significantly reduced the 
GRO-a-mediated proliferation but did not reduce it to the control levels. The irrelevant 
chemokine TECK and the irrelevant antibody CXCR1 did not have any affect. 
14000 
12000 
. 92 E 
10000 
d V 
8000 
6000 
4000 
d 
1° 2000 
0 
0 
Figure 5.11. GRO-a mediated proliferation of SCC4 cells compared with unstimulated cells 
(means ± SD) (n=average of 3 different experiments done in triplicate, error bars=SD). The 
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positive control (KGM) and GRO-a caused a significant increase in proliferation compared 
with unstimulated cells Addition of an antibody against CXCR2 significantly reduced the 
GRO-a-mediated proliferation but did not reduce it to the control levels. The irrelevant 
chemokine TECK and the irrelevant antibody CXCR1 did not have any affect. 
iii) Comparison of CXCR2/ CRO-a mediated proliferation between NOK and 
OCC I. 
StiinuI ttion v6th GRO-a caused a significantly higher increase in the proliferation of 
11357 and SCC4 cells compared with NOK (p<0.05 and p<0.01 respectively). 
Ilowwever, no difference in proliferation between H357 and SCC4 cells was observed. 
C'XC'R2 antibody caused a significant reduction in proliferation of all cells (Figure 
5.12). 
Figure 5.12. Comparison of CXCR2 / GRO-a mediated proliferation (n=average of 3 different 
experiments done in triplicate, error bars=SD). GRO-a caused a significant increase in the 
proliferation of NOK, H357 and SCC4 cells and addition of a CXCR2 antibody significantly 
reduced GRO-a-mediated proliferation. NOK were less proliferative than H357 and SCC4 
cells but no significant difference was seen between the H357 and SCC4 cells. 
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5.6 DISCUSSION 
The aim of this chapter was to establish the role, if any of XCRI, CXCRI and 
CXCR2 in the proliferation of oral epithelial cells. Exposure to lymphotactin, IL-8 
and GRO-a increased proliferation of normal and cancerous cells and this 
proliferation was significantly decreased after addition of antibodies against their 
respective receptors. This suggests that XCRI, CXCRI and CXCR2 mediate 
proliferation of oral epithelial cells when exposed to their respective ligands. 
i) XCR1 and lymphotactin 
Lymphotactin has only been reported to stimulate proliferation of CD8+ 'f 
lymphocytes to date (Cerdan et at., 2004). The findings from this chapter suggest that 
lymphotactin can also act as a proliferative agent and trigger the growth of oral 
epithelial cells. This effect appears specific since no such effect is observed when an 
irrelevant chemokine TECK is used. Addition of an antibody against XCRI 
significantly inhibits proliferation although it did not reduce it to control level. This 
suggests that the effects of lymphotactin are mediated by XCRI which has the 
potential to facilitate proliferation of normal and cancerous oral epithelial cells. A 
significantly higher number of OCCL than NOK was seen after exposure to the 
positive control and lymphotactin. This is most likely because a larger proportion of 
the H357 and SCC4 than NOK are positive for XCR 1. It may also reflect the greater 
proliferative capacity of malignant cells. However, no difference in proliferation was 
observed between H357 (60% XCRI positive) and SCC4 cells (99% XCRI positive) 
after lymphotactin stimulation. Why this is so is not clear particularly when 
significantly more SCC4 than H357 migrate and invade in response to lymphotactin. 
lt may be that XCRI is not as important in proliferation as in migration or invasion. 
Although this chapter suggests that lymphotactin mediates both normal and malignant 
epithelial cell proliferation through XCRI in vitro the significance of these findings in 
vivo is not clear. 
ii) CXCRI, CXCR2 and IL-8 
Exposure to IL-8 also caused a significant increase in proliferation of normal as well 
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as cancerous oral cells. However, the proliferative response was greater in OCCL than 
NOK. Administration of CXCRI and CXCR2 antibodies individually resulted in a 
significant reduction in proliferation but failed to reduce it to control levels. This 
suggests that proliferation is mediated through both CXCR1 and CXCR2. 
Interestingly a further reduction in proliferation was observed when both CXCR1 and 
CXCR2 antibodies were used in combination but was only significant compared with 
CXCR2 and not with CXCR1. This reduction occurred with NOK and both H357 and 
SCC4 cell lines. These results suggest that for all cells CXCRI may be more 
important in mediating the effects of proliferation than CXCR2. This is particularly 
true of NOK which are only 20% positive for CXCRI but 30% positive for CXCR2. 
Although more SCC4 cells are positive for CXCRI than H357 cells (75% and 90% 
respectively) no difference in proliferation was observed between the two cell lines. 
Why this is so is not clear but it may be that the cells were proliferating maximally in 
the assay conditions and no further increases were possible. 
The role of IL-8 in proliferation of oral epithelial cells has also been studied 
previously. In contrast to our results, Watanabe et al., reported no increase in oral 
cancer cell proliferation after stimulation with IL-8 (Watanabe et al., 2002). A 
possible explanation may be that the two oral cancer cell lines (NA and HSC-4) used 
in their study are different to the ones in ours and there may be heterogeneity in 
response. An indirect association between IL-8 expression and proliferation in 
periodontitis has been shown as basal keratinocytes expressing IL-8 in vivo are more 
positive for PCNA/cyclin (a proliferation marker) compared with controls (Jarnbring, 
Gustafsson, and Klinge 2000) suggesting that IL-8 may facilitate proliferation of oral 
epithelial cells. However, this group did not study the expression of CXCRI and 
CXCR2 on oral epithelial cells and also did not show any direct influence of IL-8 on 
cell proliferation. 
A role for IL-8 in epithelial cell proliferation has been reported by a number of 
groups. IL-8 induces proliferation of a range of cancer cells in vitro including prostate 
(Araki et al., 2007; Murphy et al., 2005), melanoma (Lazar-Molnar et al., 2000; 
Varney et al., 2003), lung (Luppi et al., 2006; Zhu et al., 2004), colon (Li, Varney, 
and Singh 2001), breast (Yao et al., 2007), hepatocellular (Akiba et al., 2001) and 
epidermoid cancer cells (Metzner et al., 1999). However, other groups have reported 
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contrasting results as IL-8 does not induce in vitro proliferation in hepatocellular 
(Kubo et al., 2005), pancreatic cancer cells (Kuwada et al., 2003) and intestinal 
epithelial cells (Sturm et al., 2005). Individual roles of CXCR1 and CXCR2 in IL-8 
mediated proliferation have also been studied. Murphy et al., reported that IL-8 
induced proliferation in prostate cancer is mediated through CXCRI and CXCR2 as 
addition of either antibody leads to significant decrease in proliferation (Murphy et 
al., 2005). Varney et al., reported similar findings for malignant melanoma (Varney et 
al., 2003). However, Akari et al., showed that proliferation in response to IL-8 in 
prostate cancer is mediated through CXCRI and not CXCR2 (Araki et al., 2007). On 
the other hand, Metzner et al., showed that IL-8 mediated proliferation in epidermoid 
carcinoma is mediated through CXCR2 only (Metzner et al., 1999). These differences 
between our findings and other groups could be explained by the use of different 
CXCRI and CXCR2 antibodies in these studies which might have affected the results. 
Another possibility could be that IL-8 exerts differential effects on different cells and 
that its signaling through CXCR1 or CXCR2 depends upon the expression of the 
receptors as some cells are more positive for CXCRI than CXCR2 and vice versa. 
iii) CXCR2 and GRO-a 
Addition of GRO-a also significantly increased proliferation of NOK and OCCL. As 
observed with IL-8, H357 and SCC4 cells showed more proliferation than NOK. 90% 
of SCC4 cells are positive for CXCR2 compared to 30% for H357. However, no 
significant difference between the proliferation of H357 and SCC4 cells was 
observed. This suggests that the cancer cells may possess an intrinsic ability to 
proliferate more compared to normal cells and their proliferation may be influenced 
by additional factors. To date, a role for GRO-a in oral epithelial cell proliferation has 
not been reported. However, it has been shown to mediate cell proliferation in 
malignant melanoma (Lazar-Molnar et al., 2000), colon carcinoma (Li, Varney, and 
Singh 2004), epidermoid (Metzner et al., 1999) and oesophageal carcinoma (Wang et 
al., 2006). GRO-a also stimulates proliferation of skin keratinocytes and plays an 
important role in wound healing (Rennekampff et al., 1997; Steude, Kulke, and 
Christophers 2002). 
In summary these findings show that IL-8 stimulates proliferation of both NOK and 
OCCL and CXCRI may be more important than CXCR2 in mediating these effects. 
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However CXCR2 is important in mediating the effects of GRO-a on the proliferation 
of both NOK and OCCL. The proliferation of NOK to both IL-8 and GRO-a is less 
than the response of the OCCL. 
Proliferation is a hall mark of a wide range of physiological and pathological 
processes (including epithelial cell turnover, wound healing and cancer) and the 
significance of these findings in these physiological and pathological scenarios will be 
discussed in Chapter 9. 
Although the results on CXCR1 and CXCR2 were interesting it was not feasible to 
carry on studying all three receptors due to time constraints. Since XCR1 expression 
on epithelial cells has never been shown before, the results obtained for XCR1 and its 
ligand lymphotactin are potentially exciting. Therefore, it was decided to focus the 
study on further exploration of the role of XCR1 and lymphotactin in the regulation 
on oral epithelial cell behaviour. 
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Chapter 6- In vivo Expression ofXCRI and Lymphotactin 
6.1 INTRODUCTION 
The results from chapters 2-5 have not only shown that XCRI is expressed on oral 
epithelial cells in vitro but that it is functional and mediates proliferation, migration 
and invasion. However, the significance of these findings in vivo is not known. For 
that reason, the next step was to study whether XCRI is expressed in vivo in normal 
and diseased oral mucosa and furthermore to determine the source of lymphotactin, if 
any in oral mucosa. 
In vivo expression of XCR1 on non-lymphoid cells has been reported only on 
fibroblast-like synoviocytes in rheumatoid synovium (Blaschke et al., 2003) and 
recently in melanocytic lesions (Seidl et a!., 2007). On the other hand, Lymphotactin 
expression in vivo has only been shown in infiltrating lymphocytes, dendritic cells and 
mononuclear cells in rheumatoid arthritis and Crohn's disease (Blaschke et a!., 2003; 
Middel et al., 2001) and in mouse epidermal intraepithelial lymphocytes (IEL) 
(Boismenu et al., 1996). Whether it is produced in the oral mucosa is not known. 
6.2 AIM 
The aim of this chapter was to study and establish the in vivo expression of XCRI and 
the source of lymphotactin in normal and diseased oral mucosa. 
6.3 EXPERIMENTAL PROTOCOL 
  Expression of XCRI and lymphotactin in normal oral epithelium was subjectively 
compared with expression in oral cancer. Expression was also studied in 
dysplasia, lichen planus and ulcers to observe if the presence or absence of an 
inflammatory infiltrate had any influence on expression. Paraffin-embedded tissue 
blocks of normal oral mucosa, OSCC, dysplasia, lichen planus and non-specific 
ulceration were obtained from the departmental tissue archive (Department of 
Oral Pathology, University of Sheffield) and 4µm serial sections were cut. 
  An immunoperoxidase technique was employed. A Vectastain Elite ABC kit 
(Vector Laboratories, Burlingame, CA, USA) was used in accordance with the 
manufacturer's instructions for this purpose. 
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  Staining was performed at least three times on each sample on three different 
occasions. 
6.4 MATERIALS AND METHODS 
6.4.1 IMMUNOHISTOCHEMISTRY 
Serial sections were cut from three cases of normal oral mucosa, oral lichen planus, 
dysplasia, eight cases of OSCC and two cases of non-specific ulceration. 
Mononuclear cells were isolated from blood, fixed, clotted, embedded in paraffin and 
used as positive control (Appendix 10.3 and 10.4). 2% hydrogen peroxide in methanol 
was used to block endogenous peroxidase. For XCR1, antigen retrieval was 
performed by heating the tissue sections in citrate buffer (pH 6.0) in a microwave for 
8min whereas sections were heated for 12min for lymphotactin. Polyclonal anti- 
human XCR1 antibody (Lifespan) (1: 500 dilution) and polyclonal anti-human 
lymphotactin antibody (Peprotech) (1: 25 dilution) were added overnight at 4°C. 
Rabbit serum served as negative control for XCR1 whereas for lymphotactin antibody 
was pre-absorbed with recombinant lymphotactin (R&D Systems) before application. 
A Vector NovaRed substrate kit (Vector Laboratories) was used to visualize 
peroxidase activity resulting in a red-brown positive reaction. Sections were 
counterstained with haematoxylin, dehydrated and mounted in DPX. 
At least three serial sections for each sample were stained on different occasions. 
6.5 RESULTS 
6.5.1 ISOLATED MONONUCLEAR CELLS 
Strong expression of XCRI was seen in stimulated mononuclear cells. Staining was 
observed in lymphocytes and neutrophils but not in monocytes. Expression was 
observed on the cell surface as well as in the cytoplasm. No expression of 
lymphotactin was observed (Figure 6.1). 
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Figure 6.1. Immunohistochemical expression of XCR1 and lymphotactin in isolated 
mononuclear cells (x60 magnification) (Representative sample). No staining was seen in 
The ('hemoldne Receptors XCRI, CXCRI and CXCR2 Regulate Oral fipidielia! Cell Behaviour 162 
Chapter 6- In vivo Expression of x'(711 and Lympholaclin 
negative control (a) and for lymphotactin (c). Staining for XCR1 was seen on neutrophils but 
not on monocytes (b). Staining was performed three times on every sample. 
6.5.2 NORMAL ORAL MUCOSA 
Normal oral mucosa consistently stained for XCR1. Expression was predominantly 
observed in the basal keratinocytes (Figure 6.2). In addition, fibroblasts. cndothclial 
cells and some lymphocytes in the connective tissue also showed XCRI expression. 
No ly mphotactin expression was seen in the epithelium, EEL or infiltrating 
Iy mphocytes. 
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Figure 6.2. Normal oral mucosa- Immunohistochemical expression of XCR1 and lymphotactin 
(Representative sample). No staining was observed in the negative control (a) or for 
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lymphotactin (e). Staining for XCR1 was seen in the basal keratinocytes in the epithelium (b, 
c), some of the infiltrating lymphocytes (c), firboroblasts (d) and endothelial cells (d). Staining 
was performed three times on every sample. 
6.5.3 ORAL SQUAMOUS CELL CARCINOMA (OSCC) 
XCRI expression was also seen in OSCC. Staining intensity in the epithelium 
appeared much stronger than normal epithelium suggesting that XCRI might be 
upregulated in OSCC. Staining appeared to be on the cell surface as well as within the 
cytoplasm. Some negative cells were also seen in the epithelium (Figure 6.3) Strong 
XCRI staining was also seen in some of the infiltrating lymphocytes and endothelial 
cells. All the invading tumour cells and cells in tumour islands showed strong staining 
for XCRI. 
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Figure 6.3. OSCC- Immunohistochemical expression of XCR1 (Representative sample). No 
staining was observed in the negative control (a) or for lymphotactin (e). Staining for XCR1 
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was seen in the keratinocytes in the epithelium (b, c), some of the infiltrating lymphocytes (c), 
firboroblasts (c) and endothelial cells (c) and invading tumour cells (d). Abundant XCR1 
staining was seen on lymphoid cells (e) as well as the metastatic deposits (e) in regional 
lymph nodes. Staining was performed three times on every sample. 
The results for lymphotactin were very interesting. In contrast to the normal oral 
mucosa, lymphotactin expression was not only seen in the epithelium. but also in 
some of the infiltrating lymphocytes, endothelial cells and the invading tumour cells. 
Intraepithclial lymphocytes also stained for lymphotactin in OSCC. 
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Figure 6.4. OSCC- Immunohistochemical expression of lymphotactin (Representative 
sample). Staining for lymphotactin was seen in the keratinocytes in the epithelium (a, b), 
some of the infiltrating lymphocytes (b), firboroblasts (b, c) and endothelial cells (b) and 
invading tumour cells (c). Abundant XCR1 staining was seen on lymphoid cells (d) as well as 
the metastatic deposits (d) in regional lymph nodes. Staining was performed three times on 
every sample. 
Abundant XCRI and lymphotactin expression was observed in lymphoid cells within 
the regional lymph nodes. Staining for XCRI and lymphotactin was also seen in 
metastases in the regional lymph nodes (Figure 6.3 and 6.4). 
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Similar results were obtained for other OSCC samples. Strong cell surface and 
cytoplasmic XCRI expression was observed in the epithelium, invading tumour, 
endothelial cells. fibroblasts and some of the infiltrating lymphocytes. Staining for 
lymphotactin was also observed in all OSSC samples and was predominantly 
cytoplasmic. Epithelium, invading tumour. endothelial cells and some of the 
infiltrating lymphocytes consistently stained for lymphotactin. Both XCR I and 
lymphotactin showed a similar pattern of epithelial expression and staining was 
localized to the lower two third of the epithelium. 
6.5.4 DYSPLASIA 
To study whether up-regulation of XCR 1 and lymphotactin expression is specific to 
OSCC, a number of other conditions were studied including dysplasia. Similar results 
to OSCC were obtained and expression of XCRI and lymphotactin was consistently 
noticed in dysplasia in the lower two thirds of the mucosa. Infiltrating lymphocytes 
also expressed XCR1 and lymphotactin. No obvious difference in staining intensity of 
XCR1 and lvmphotactin was observed between mild, moderate and severe dysplasia. 
The pattern of staining was also similar between the different degrees of dysplasia. 
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Figure 6.5. Severe dysplasia- Immunohistochemical expression of XCR1 and lymphotactin 
(Representative sample). No staining was seen in the negative control (a). Staining for XCR1 
was seen on epithelial cells (b, c), infiltrating lymphocytes (b, c) and fibroblasts (b, c). 
Lymphotactin staining was also observed on epithelial cells (d, e), lymphocytes (d, e) and 
fibroblasts (d, e). Staining was performed three times on every sample. 
To study whether the presence of an inflammatory infiltrate was correlated to this up- 
regulation, staining was performed on lichen planus and non-specific ulceration. 
6.5.5 LICHEN PLANUS 
Staining for XCRI and lymphotactin was also observed in lichen planus. Strong 
XCRI expression was predominantly seen in the basal kcratinocytcs. endothelial 
cells, fibroblasts and in some of the infiltrating lymphocytes. Staining for 
lymphotactin however was observed throughout the thickness of the epithelium. 
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Figure 6.6. Lichen planus- Immunohistochemical expression of XCR1 and lymphotactin 
(Representative sample). No staining was seen in the negative control (a). Staining for XCR1 
was seen on epithelial cells (b, c), infiltrating lymphocytes (b, c) and fibroblasts (b, c). 
Lymphotactin staining was also observed on epithelial cells (d, e), lymphocytes (d, e) and 
fibroblasts (d, e). Staining was performed three times on every sample. 
6.5.6 NON-SPECIFIC ULCERATION 
Ulceration showed similar results to lichen planus and staining for XCRI and 
lvmphotactin was seen in the adjacent epithelium as well as endothelial cells, 
fibroblasts and some of the infiltrating lymphocytes. XCRI expression appeared 
much stronger in lichen planus and ulceration than normal oral mucosa. 
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Figure 6.7. Adjacent epithelium in non-specific ulceration- Immunohistochemical expression 
of XCR1 and lymphotactin (Original magnification x 40) (Representative sample). No staining 
The Chemokine Receptors XCRI, CXCRI and (X('R? Regulate Oral Epithelial ('eli Hehavi<nv 174 
Chapter 6- In vivo Expression oJXCRI and Lymphotactin 
was seen in the negative control (a). Staining for XCR1 was seen on epithelial cells (b), 
infiltrating lymphocytes (b) and fibroblasts (b). Lymphotactin staining was also observed on 
epithelial cells (c), lymphocytes (c) and fibroblasts (c). Staining was performed three times on 
every sample. 
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6.6 DISCUSSION 
The immunohistochemistry results showed that XCR1 is expressed in vivo in normal 
oral epithelium and appears to be up-regulated in cancer. This corroborates our 
previous in vitro results which also showed an up-regulation of XCRI. expression in 
cancerous oral epithelial cells compared with normal keratinocytes. However, this up- 
regulation does not appear to be specific to OSCC and was also seen in other diseases 
such as dysplasia, lichen planus and ulceration. A similar pattern of XCR1 staining 
was observed in all samples and staining was predominantly localized to the lower 
two third of the mucosa. In addition to the epithelium, XCRI expression was also 
observed on other cell types including lymphocytes, fibroblasts and endothelial cells. 
No obvious difference in XCRI staining intensity was noticed between OSCC, 
dysplasia, lichen planus or ulceration. However this was not studied in depth. 
XCR1 staining in the lower two third of the mucosa in some conditions (such as 
dysplasia) suggests that XCR1 expression might be correlated to proliferation as the 
basal cell layer is continuously renewing itself and maturing cells are moving upwards 
in the mucosa. In support of this is our finding that lymphotactin stimulates epithelial 
cell proliferation through XCR1 in vitro. However, this potential correlation between 
XCR1 expression and oral epithelial cell proliferation/maturation needs to be studied 
in more detail to be established. 
Stronger staining for XCR1 was also seen in infiltrating lymphocytes in OSCC 
compared with normal tissue. In addition many more lymphocytes in OSCC appeared 
to express XCRI than in normal epithelium but this was only a subjective assessment. 
This apparent up-regulation of XCR1 in lymphoid and epithelial cells may have a 
number of implications. Increased XCRI expression by epithelial cells may allow 
them to respond to lymphotactin by migrating, invading and proliferating. The 
increased recruitment of XCR1 expressing lymphocytes suggests they may have been 
attracted by lymphotactin and these lymphocytes may exert anti-tumour effects or 
produce pro-inflammatory cytokines which may or may not regulate the expression of 
XCRI and lymphotactin and ultimately play a role in the biology of the disease. 
Therefore it is important to establish the source of lymphotactin if any in the oral 
epithelium. 
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Very different results were obtained for lymphotactin. No lymphotactin expression 
was seen in the normal oral mucosa. Intraepithelial lymphocytes (IEL), infiltrating 
lymphocytes and epithelial cells did not stain for lymphotactin. In contrast to that, 
lymphotactin expression was observed in diseased oral mucosa which was 
unexpected. Lymphotactin staining was not only seen in the IEL and infiltrating 
lymphocytes but surprisingly also in the epithelium. Boismenu et al. have shown 
lymphotactin expression in activated IEL in mouse epidermis (Boismenu et al., 1996). 
However, our results suggest that there may be multiple potential sources for 
lymphotactin in the oral epithelium. It appears that IEL in oral mucosa only express 
lymphotactin in conditions like inflammation, dysplasia and cancer and not in normal 
mucosa suggesting that some sort of trigger is required for lymphotactin expression. 
However the nature of this trigger is not known. In addition, staining for lymphotactin 
on infiltrating lymphocytes in diseased oral mucosa suggests that they are producing 
lymphotactin by a similar mechanism. And last but not the least; lymphotactin 
expression by oral epithelial cells suggests that lymphotactin might have the potential 
to act back on the epithelial cells through an autocrine mechanism. 
All these in vivo findings confirm previous in vitro results and demonstrate expression 
of lymphotactin outside the lymphoid system for the first time. The different patterns 
of in vivo expression of XCR1 and lymphotactin between normal and diseased oral 
mucosa suggests an important role for them in oral epithelial cell regulation. It is 
possible that this increased receptor/ligand expression and interaction may act back on 
the oral epithelial cells in an autocrine manner and facilitate pathological cell 
migration, invasion and proliferation. Therefore, it was decided to study lymphotactin 
expression in oral epithelial cells (constitutive and in response to stimulation) in vitro 
to back up the immunohistochemistry results and to find out what triggers 
lymphotactin release from these cells. 
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7.1 INTRODUCTION 
Immunohistochemistry results showed in vivo expression of XCRI in normal, 
inflammatory and cancerous oral epithelium whereas lymphotactin expression was 
only seen in inflammation and cancer and not in normal mucosa. XCR1 expression 
was in agreement with previous in vitro results. However, lymphotactin expression 
was surprising since its in vivo expression has not been shown outside the immune 
system. Therefore, it was important to establish the expression of lymphotactin in 
vitro on normal and cancerous oral epithelial cells to back up the in vivo results. 
7.2 AIM 
The aims of this chapter were to study whether lymphotactin is present in NOK and 
OCCL in vitro and if so, what might regulate its production. 
7.3 EXPERIMENTAL PROTOCOL 
1. RT-PCR 
  RT-PCR was used to study mRNA expression of lymphotactin in NOK, HGF, 
OCCL (H357, TR146, SCC4, SCC25, CAL27 and FADU) and A375P cells. 
" Neutrophil RNA was used as positive control. 
  RNA was isolated from the cultured cells to be used for RT-PCR. Isolated RNA 
was quantified and its quality checked using gel electrophoresis and 
spectrophotometry. 
  Sense and anti-sense primers for lymphotactin were designed. 
  RNA samples were DNase-treated to remove genomic DNA contamination. 
  RT-PCR was performed three times on different occasions for all cell types. 
2. Immunofluorescence 
  Immunofluorescence was performed on cultured monolayers of cells to study 
intracellular lymphotactin expression. Staining was carried out on three different 
occasions for each cell type. 
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3. Flow Cytometry 
  Flow cytometry was performed on cultured cells (three times) to detect 
intracellular expression of lymphotactin. 
4. ELISA 
  An ELISA was performed to study the production of lymphotactin by oral 
epithelial cells in culture. 
  Cells were stimulated with PMA, TNF-a and LPS as they have previously been 
shown to stimulate the release of chemokines from epithelial cells (von Asmuth et 
al., 1994). Unstimulated cell supernatants were used as negative controls. 
  Triplicate wells for each treatment and cell type were used in every experiment. 
Assay was performed three times. 
7.4 MATERIALS AND METHODS 
7.4.1 CELL CULTURE 
Cells were grown and maintained as described previously. 
7.4.2 RNA ISOLATION 
Total RNA was isolated from the cultured cells, DNase-treated and quantified as 
described previously in Section 2.4.2. 
7.4.3 RT-PCR 
7.4.3.1 Primer Design 
The following primer sequences were used: 
F/Sense: CCTCCTTGGCATCTGCTCTC 
R/Anti-sense: ATTGGTCGATTGCTGGGTTC 
7.4.3.2 RT-PCR Reaction 
The RT reaction was performed as previously described in section 2.4.4. The PCR 
mix was prepared and 241il of this mix was moved to PCR tubes. Ipl of cDNA was 
The Chemokine Receptors XCRJ, CXCRI and CXCR2 Regulate Oral Epithelial Cell Behaviour 180 
Chapter 7- In vitro Expression of Lymphotactin in Oral Epithelial Cells 
added to each tube and samples were placed in the PCR machine. The following cycle 
was used: 
  94 °C for 1 min (Denaturation) 
" 60 °C for 2 min (Annealing) 
" 72 °C for 3 min (Extention) 
After 35 cycles of the above mentioned program, the following steps were carried out: 
  72 °C for 10 min (Final extention step) 
 4 °C forever (cooling cycle) 
7.4.3.3 Gel for PCR Products 
A 1% agarose gel was used to separate and visualize the PCR products. 
7.4.4 IMMUNOFLUORESCENCE 
Protein expression was subjectively assessed by performing immunofluorescence on 
cultured cell monolayers. Cells were grown on chamber slides as mentioned earlier 
and fixed/permeabilised with 2% paraformaldehyde containing 0.1% Triton-X100 
(Sigma) for 10min. Fixative was removed and slides washed in PBS. After PBS 
removal, rabbit anti-human lymphotactin antibody (20pg/ml) (Peprotech) was added 
for one hour. Negative controls received pre-absorbed antibody with recombinant 
lymphotactin. Excess antibody was washed off and FITC-conjugated secondary 
antibody was applied for 30min. Slides were washed again and mounted in 
vectashield mounting medium containing DAPI (Vector Labs). 
7.4.5 FLOW CYTOMETRY 
IntraPrep TM (fixation and permeabilisation) kit (Beckman Coulter, Fullerton, CA, 
USA) was used for intracytoplasmic staining. The kit contained 2 reagents, reagent 1 
(which is formaldehyde/fixation agent) and reagent 2 (which is saponine/permeability 
agent). 
Single cell suspensions were prepared as previously described and washed in staining 
buffer (PBS+2%FBS+I%BSA) by centrifugation (400xg, 5min, 4°C). The 
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supernatants were discarded and cells re-suspended (lx106cells/ml) in serum-free 
DMEM and stimulated with PMA (50ng/ml) (Peprotech) for two hours in a CO2 
incubator. PMA was used as it is a potent protein kinase C activator and has been 
shown to facilitate lymphotactin release from lymphocytes (Blaschke et al., 2003). 
Cells were washed and resuspended in staining buffer. 50µ1 of sample was added to a 
new tube with 100µl of reagent I (formaldehyde), vortexed vigorously to avoid 
clumping and incubated at RT for 15min. Samples were washed using staining buffer 
as mentioned previously and supernatant was aspirated. 100µl of reagent 2 (saponine) 
was added to each tube and allowed to diffuse naturally into the cell pellet by 
incubating at RT for 5min. Primary antibody for lymphotactin was added (20gg/ml), 
mixed by vortexing and incubated for 30min at 4°C. Rabbit serum served as the 
negative control. 
Samples were washed in Iml staining buffer (400xg, 5 min, 4°C), and re-suspended. 
Swine anti-rabbit FITC-conjugated antibody (Dako) was added (10µl/million cells), 
samples were vortexed and incubated for 30min at 4°C in the dark. Samples were 
washed again and re-suspended in staining buffer. A FACSCalibur (Becton 
Dickinson) was used to acquire the data whereas analysis was performed using 
FlowJo software (Tree Star). Staining was considered positive when the percentage of 
positive cells of lymphotactin antibody was higher than the negative controls. 
7.4.6 ELISA 
Lymphotactin levels in culture supernatants were determined by an ELISA using 
lymphotactin duo set (R&D Systems) in accordance with the manufacturer's 
instructions. All assays were performed in triplicate and a standard curve for each 
assay determined the number of cells. 
Lymphotactin capture antibody (360µg/ml of mouse anti-human lymphotactin 
antibody) was diluted to the working concentration in PBS and a 96-well microplate 
was coated with 100µl per well of the diluted capture antibody. The plate was sealed 
and incubated overnight at 4°C. The next day, the capture antibody was removed and 
each well washed three times with wash buffer (0.05% Tween20 in PBS). Remaining 
wash buffer was removed by aspirating and inverting the plate and blotting it against 
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clean paper towels. The plate was blocked by adding 300µI of reagent diluent (I %o 
BSA in PBS-filtered with 2% normal goat serum) to each well and incubated at RT 
for two hours. The aspiration/wash was repeated as described earlier. 
100µl of sample or standards were added per well. The plate was covered with an 
adhesive strip and incubated for two hours at R'l'. Samples were removed and the 
aspiration/wash step was repeated. This was followed by the addition of 100l, 11 of 
detection antibody (36µg/ml of biotinylated goat anti-human lymphotactin antibody 
diluted in reagent diluent) to each well. The plate was covered with a new adhesive 
strip and incubated for two hours at RT. After two hours, detection antibody was 
removed and plate was washed three times with wash buffer. IOOµl of working 
dilution of streptavidin-l-IRP was then added to each well. The plate was covered and 
incubated for 20min at RT in the dark. After three more washes with wash buffer, 
100µl of substrate solution (TMB) (BD) was added to each well for 20min at RT in 
the dark till the strongest colouring wells were medium to dark blue. 50[11 of stop 
solution (2N H2SO4) was added to each well to stop colour development. The optical 
density of each well was measured immediately, using a microplate reader set to 
450nm. 
7.5 RESULTS 
7.5.1 RT-PCR 
Lymphotactin mRNA was seen in NOK, I IGF and OCCI. (11357, SCC'4, 'I R 146, 
CAL27 and FADU), the positive control and the melanoma cell line A375P. Only 
SCC25 cells did not contain lymphotactin mRNA (Figure 7.1). 
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Figure 7.1. mRNA expression of lymphotactin (Representative picture). Strong bands were 
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observed for NOK, H357, SCC4, TR146, CAL27, FaDu, Neutrophils and A375P. HFG 
showed weak band intensity whereas SCC25 were negative for lymphotactin mRNA 
Multiple bands were observed in sonne cell types. All hands were gel extracted, 
transformed into E. Coli and mini-prepped. I)NA sequencing was carried out which 
confirmed the lower bands as lymphotactin (Appendix 10.5). 
7.5.2 IMMUNOFLUORESCENCE 
NOK, H357 and SCC4 cells were studied for intracellular expression of lymphutactin. 
Expression was seen in all tested cells whereas no expression was seen in the negative 
controls. Lymphotactin expression was predominantly cytoplasmic but some nuclear 
staining was also observed particularly in NOK and 11357 cells. Staining intensity 
seemed slightly stronger in H357 and SCC4 cells compared with NOK (Figure 7.2). 
Some negative cells were also observed in NOK and OCCI.. 
c) H357 negative control 
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Figure 7.2. Representative picture showing intracellular expression of lymphotactin in NOK, 
H357 and SCC4 cells as shown by immunofluorescence (Original magnification x 60 - 
antibody concentration 20pg/ml). No staining was observed in the negative controls (a, c, e). 
Intracellular staining for lymphotactin was seen in NOK (b), H357 (d) and SCC4 (e) cells. 
7.5.3 FLOW CYTOMETRY 
i) Jurkat 
Constitutive intracellular expression of lymphotactin was observed intracellularly in 
the Jurkat cells as shown by a distinct shift towards the right in the histogram. 
Stimulation of the cells with PMA failed to cause a significant increase in intracellular 
lymphotactin (Figure 7.3). 
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Figure 7.3. Representative histogram showing fluorescence intensity for lymphotactin 
expression in Jurkat cells. Red- Negative Control, - Unstimulated cells, 
Blue- Cells 
stimulated with PMA. Experiment was performed three times. 
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91.4% of unstimulated Jurkat cells expressed lymphotactin. Stimulation with I'MA 
increased expression to 93.6% but this increase was not significant compared to 
unstimulated cells (Figure 7.4). 
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Figure 7.4. Percentage of Jurkat cells expressing lymphotactin (n=average of 3 different 
experiments, error bars=SD). Constitutive intracellular staining was seen in unstimulated 
cells. 2 hour stimulation with PMA caused a slight increase compared with unstimulated cells 
but was not significant. 
ii) NOK 
Lymphotactin was also detected in unstimulated NOK. This expression was slightly 
increased after exposure to PMA but was not significant (Figure 7.5). 
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Figure 7.5. Representative histogram showing fluorescence intensity for lymphotactin 
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expression in NOK. Red- Negative Control, - Unstimulated cells, Blue- Cells stimulated 
with PMA. Experiment was performed three times. 
Analysis of the histogram revealed that 53% of unstimulated NOK constitutively 
expressed lymphotactin. Incubation with 1'MA did not significantly change the 
percentage of positive cells (Figure 7.6). 
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Figure 7.6. Percentage of NOK expressing lymphotactin (n=average of 3 different 
experiments, error bars=SD). Constitutive intracellular staining was seen in unstimulated 
cells. 2 hour stimulation with PMA caused a slight increase compared with unstimulated cells 
but was not significant. 
iii) H357 
Unstimulated H357 cells also showed consistent expression of lymphotactin (as 
shown by the histogram shift). No further shift in the histogram was observed after 
stimulation of H357 cells with PMA (Figure 7.7). 
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Figure 7.7. Representative histogram showing fluorescence intensity for lymphotactin 
expression in H357 cells. Red- Negative Control, - Unstimulated cells, Blue- Cells 
stimulated with PMA. Experiment was performed three times 
Results for H357 cells were very similar to those obtained for NOK. Lymphotactin 
was detected in 49% of 14357 cells without stimulation and stimulation with PMA has 
not significant effect (Figure 7.8). 
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Figure 7.8. Percentage of H357 cells expressing lymphotactin (n=average of 3 different 
experiments, error bars=SD). Constitutive intracellular staining was seen in unstimulated 
cells. 2 hour stimulation with PMA caused a slight increase compared with unstimulated cells 
but was not significant. 
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iv) SCC4 
SCC4 cells also expressed lymphotactin. A distinct shift towards the right was 
observed in the histogram showing that unstimulated S('('-# cells r\prrss 
lymphotactin and stimulation with PMA had no effect (Figure 7.9). 
'I'i 
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Figure 7.9. Representative histogram showing fluorescence intensity for lymphotactin 
expression in SCC4 cells. Red- Negative Control, - Unstimulated cells, Blue- Cells 
stimulated with PMA. Experiment was performed three times. 
Analysis of the acquired data showed that 75% of SCC4 cells express intracellular 
lymphotactin in the absence of any stimulation. Addition of I 'MA failed to increase 
the percentage of lymphotactin expressing cells (Figure 7.10). 
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Figure 7.10. Percentage of SCC4 cells expressing lymphotactin (n=average of 3 different 
experiments, error bars=SD). Constitutive intracellular staining was seen in unstimulated 
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cells. 2 hour stimulation with PMA caused a slight increase compared with unstimulated cells 
but was not significant. 
7.5.4 ELISA 
Cells were stimulated with PMA, TNF-a and ITS as they have previously been 
shown to stimulate chemokine production (von Asmuth c'l u/., 1994). Stimulation of 
Jurkat cells with PMA, TNF-a and LPS slightly increased lymphotactin production in 
culture however the increase was not significant compared with unstimulated cells 
(Figure 7.11 ). 
Jurkat 
u, NOK 
H357 
SCC4 
Background 
Figure 7.11. Lymphotactin production in culture (n=average of 3 different experiments done in 
triplicate, error bars=SD). No significant difference in lymphotactin production was observed 
between the background, unstimulated cells and stimulated cells in any of the cell lines 
(Jurkat, NOK, H357, SCC4). 
Similar results were obtained for NOK and the oral cancer cell lines 11357 and SC'C4. 
No lymphotactin production was observed in unstimulated NOK, 11357 and SCC4 
cells in vitro. Stimulation of these cells with P MA, TNF-u and ITS failed to cause a 
significant increase in lymphotactin release compared with unstimulated cells (Figure 
7.11). 
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7.6 DISCUSSION 
After discovering in vivo expression of lymphotactin in inllammatory and cancerous 
oral mucosa, expression of lymphotactin was studied in vitro on normal and 
cancerous oral epithelial cells. 
A band for lymphotactin rnRNA was seen in neutrophil RNA as well as NOK and 
HGF. RT-PCR showed multiple bands but gel extraction, transformation and DNA 
sequencing confirmed the presence of lymphotactin mRNA. A similar band was 
observed in the OCCL (H357, SCC4, TR146, CAL27 and FADU) whereas S('C25 
cells were negative for lymphotactin. This confirmed that the message for 
lymphotactin is present in normal and cancerous oral cells. 
The next step was to study whether lymphotactin is expressed at protein level in oral 
epithelial cells. Immunofluorescence showed presence of constitutive intracellular 
lymphotactin in oral epithelial cells. Staining was seen in NOK, 11357 and SCC4 cells 
and no difference in staining intensity was observed between the tested cells. These 
results were confirmed by flow cytornetry. Expression of lymphotactin was detected 
in unstimulated Jurkat, NOK, H357 and SCC4 cells. The percentage of Jurkal and 
SCC4 cells expressing lymphotactin constitutively was higher than NOK and 11357 
cells. Cells were stimulated with PMA for two hours to observe if it facilitated an 
increase in the percentage of' cells expressing intracellular lymphotactin. A slight 
increase in lymphotactin-expressing cells was observed alter PMA stimulation but 
was not significant compared with controls. 
An ELISA was used to study whether oral epithelial produce lymphotactin in culture. 
No lymphotactin secretion in cell supernatants was detected in unstimulated Jurkat, 
NOK, 11357 or SCC4 cells. Cells were exposed to a range of stimulants including 
PMA, TNF-a and LPS to study whether they trigger lymphotactin secretion from cells 
in culture. However, no lymphotactin production was detected in any of the cells even 
aller stimulation. This suggests that some other stimulant ºnight be required to trigger 
lymphotactin production in culture. To date. Iymphotactin secretion in culture has 
only been shown in primary isolated lymphotcytes. Stievano et ul., reported that 
CD8+ a(3+ T cells lacking expression of CDC on cell surface are the major source of 
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lymphotactin in peripheral blood. Stimulation with PMA significantly increases 
lymphotactin production in culture (Stievano et al., 2003). Lymphotactin production 
has been shown by CD4+ and CD8+ T cells only after T cell-receptor (TCR)- 
dependent stimulation using staphylococcus superantigens (TSST-1 and SEB) and not 
after treatment by inflammatory cytokines TNF-a, IL-Igor LPS (Tikhonov et al., 
2001). This is in accordance with our results as TNF-a and LPS failed to facilitate an 
increase in lymphotactin release from NOK and OCCL. Since TCR activation is 
mandatory for staphylococcus superantigen mediated T lymphocytes activation, this 
suggests that lymphotactin production can be induced by T cell-receptor signals. A 
role for Porphyromonas gingivalis in lymphotactin production in vitro has also been 
reported. Stimulation of mouse peritoneal macrophages with live P. gingivalis 
resulted in lymphotactin secretion however P. gingivalis LPS or its fimbrial protein 
FimA failed to do so (Zhou et al., 2005). This suggests that immune cells can detect 
live bacteria and their components in a different manner and this may influence the 
inflammatory response. 
To conclude, lymphotactin mRNA is present in NOK and OCCL and the protein is 
constitutively expressed intracellularly. However, no lymphotactin was detected in 
cell supernatants even after stimulation of normal and cancerous oral cells with PMA, 
TNF-a and LPS. In previous chapter abundant in vivo expression of lymphotactin in 
diseased oral epithelial cells was observed. Even though the mRNA for lymphotactin 
was observed in normal as well as cancerous oral epithelial cells, no production in 
culture was observed even after stimulation. This may be explained by the complex 
tissue microenvironment in vivo where a wide range of stimulants are operational. It is 
possible that the stimulants we used do not influence lymphotactin production from 
oral epithelial cells and some other stimulant may be more important in this regard. 
The Chemokine ReceptorsXCRI, CXCRI and CXCR2 Regulate Oral Epithelial Cell Behaviour 192 
CHAPTER 8 
Role of XCRI and Lymphotactin 
Interaction in 
Oral Epithelial Cell Adhesion 
and MMP Production 
Chapter 8- Role ofXCRI and Lymphotactin Interaction in Adhesion and MMP Production 
8.1 INTRODUCTION 
Previous chapters confirmed constitutive intracellular in vitro expression of 
lymphotactin in normal and malignant oral epithelial cells. However, in vivo 
expression of lymphotactin is observed only in diseased oral epithelium. XCRI on the 
other hand is expressed in vitro and in vivo in normal and diseased mucosa however 
its expression appears to be up-regulated in inflammation and cancer. We have also 
shown that XCR1 is functional on the surface of oral epithelial cells and can mediate 
migration, invasion and proliferation. 
Epithelial cell adhesion is a fundamental aspect of cell migration and invasion. 
Epithelial cells need to adhere to ECM components in order to move and increased 
ability to do so may be evident in wound healing (Santoro and Gaudino 2005) as well 
as in cancer (Kramer, Shen, and Zhou 2005). The interaction of chemokine receptors 
and chemokines also influences adhesion and cell migration in wound healing and 
cancer (Raja et al., 2007). Interaction of CX3CRI with fractalkine has been shown to 
facilitate adhesion of prostate cancer cells (Shulby et al., 2004). However the role of 
XCR1/lymphotactin interaction in epithelial cells adhesion has not been studied to 
date. 
MMP production also facilitates the migratory/invasive response. They are a family of 
enzymes that help the cells to break down the ECM and therefore facilitate 
physiological and pathological cell migration and invasion (Bjorklund and Koivunen 
2005; Folgueras et al., 2004; Stamenkovic 2003). The role of chemokines in MMP 
regulation is well documented in a range of cancers. Chemokine receptors such as 
CXCR4, CCR7, CCR1 facilitate an increase in MMP production and hence play an 
important role in the biology of the cancer (Redondo-Munoz et al., 2007; Wu et al., 
2007; Yuecheng and Xiaoyan 2007b). A role of lymphotactin in MMP regulation has 
been shown as stimulation of synoviocytes in the rheumatoid synovium with 
lymphotactin results in down-regulation of MMP-2 production (Blaschke et a1., 
2003). However, nothing is known about role of XCRI and lymphotactin interaction 
in MMP production and regulation in epithelial cells. 
The Chemokine Receptors XCRI, CXCR! and CXCR2 Regulate Oral Epithelial Cell Behaviour 194 
Chapter 8- Role ofXCRI and Lymphotactin Interaction in Adhesion and MMMP Production 
8.2 AIM 
The aim of this chapter was to establish the role of XCR1 and its ligand lymphotactin 
in adhesion of oral epithelial cells to ECM components and in MMP production by 
these cells in vitro. 
8.3 EXPERIMENTAL PROTOCOL 
  NOK, H357 and SCC4 cells were used in these assays. 
  Adhesion assays were performed to study the role of XCRI and lymphotactin in 
adhesion to fibronectin and collagen using cell titre cell proliferation reagent 
(Promega). 
  Production of total MMP-2, -7 and -9 was studied in culture supernatants since 
they have been shown to be important in the biology of OSCC which is discussed 
in detail later (de Vicente et al., 2005; de Vicente et al., 2007; Kato et al., 2005; 
Patel et al., 2007; Vairaktaris et al., 2007). In addition, oral epithelial have been 
shown to produce MMP-2, MMP-7 and MMP-9 in culture. For this purpose, 
Quantikine ELISA kits were used. 
  Blocking antibody for XCR1 was used to study its role in cell adhesion and MMP 
production. 
CCL25/TECK was used as an irrelevant chemokine and CXCR1 as an irrelevant 
antibody. 
  Triplicate wells for each treatment and cell type were used in every adhesion and 
MMP assays. Both experiments were performed three times on different 
occasions. 
8.4 MATERIALS AND METHODS 
8.4.1 CELL CULTURE 
Cells were grown and maintained as described previously. 
8.4.2 ADHESION ASSAY 
Adhesion assays were performed using fibronectin and collagen (Sigma) in 96-well 
tissue culture plates (Corning). The plates were coated with fibronectin or collagen 
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(Sigma) (IOµg/ml) via an overnight incubation at 4°C. Negative control wells were 
not coated. Non-specific adhesion was blocked by incubating the plate for one hour 
with PBS containing 1% BSA (filter sterilized) at 37°C in a CO2 incubator. 
Cells were non-enzymatically removed from tissue culture flasks using cell 
dissociation solution (Sigma) and re-suspended in serum free medium (Appendix 
10.1.5). Some cells were incubated with XCR1 antibody (Lifespan) (20pg/ml) or an 
irrelevant antibody for at least 30min at 37°C. Cells were then stimulated with 
lymphotactin (R&D Systems) (lOng/ml, IOOng/ml and 500ng/ml) for two hours at 
37°C with gentle agitation. Sterile PBS was used to wash the 96 well plate and 
aspirated completely. 4x104 cells were seeded in each well and allowed to adhere for 
an hour at 37°C. Cells in the control wells were stimulated with an irrelevant 
chemokine CCL25/TECK (Peprotech) (100ng/ml). 
After an hour medium was aspirated and unbound cells were washed off by washing 
twice in PBS. Fresh medium was added to all wells. 20µ1 of cell titre proliferation 
reagent (Promega) was added to each well. It contains the tetrazolium salt MTS 
which is cleaved by metabolically active cells and provides a way to quantify the 
number and percentage of adhered cells. Absorbance was recorded at 492nm using a 
microplate reader. A standard curve for each assay determined the number of cells 
and all assays were performed in triplicate. Data was expressed as percentage increase 
in cell adhesion. 
8.4.3 MMP PRODUCTION IN VITRO 
8.4.3.1 Treatments and sample collection 
MMP production in culture was studied using Quantikine ELISA kits for MMP-2, -7 
and -9 (R&D Systems). NOK, H357 and SCC4 cells (1x105 cells per well) were 
seeded in 6 well tissue culture plates and allowed to adhere overnight. Medium was 
aspirated and cells washed thoroughly with PBS to remove any traces of FBS. In 
some wells, cells were incubated with XCR1 blocking antibody or the irrelevant 
CXCR1 antibody for 60 min at 37°C in a CO2 incubator. Afterwards, cells were 
exposed to serum free DMEM containing lymphotactin (R&D Systems)(100ng/ml), 
PMA (Sigma)(50ng/ml), TNF-a (Peprotech)(100ng/ml) and LPS 
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(Peprotech)(100ng/ml) or the irrelevant chemokine TECK (Peprotech)(100ng/ml) for 
48 hours. Supernatants were collected, briefly centrifuged to remove any cellular 
debris, aliquoted and stored at -80°C. 
8.4.3.2 Assay procedure 
The assays were performed in accordance with the manufacturer's instructions. All 
reagents and samples were brought to RT before use and prepared as directed. 
Samples were diluted in assay diluent and added to the 96 well plate (pre-coated with 
capture antibody), the plate was sealed and incubated for 2 hours at RT on a 
horizontal orbital microplate shaker set at 500 rpm. 
All samples were aspirated and the plate was washed with wash buffer (provided with 
the kit) three times using a squirt bottle. Remaining wash buffer was removed by 
aspirating and the plate was dried by inverting and blotting it against clean paper 
towels. 200µl of conjugated secondary antibody was added to each well. The plate 
was sealed with a new adhesive strip and incubated for 2 hours at RT on the shaker. 
After 2 hours the secondary antibody was removed and the plate was washed three 
times and dried as described previously. 200µl of substrate solution was added to each 
well and incubated for 30min at RT in the dark. This was followed by the addition of 
50µl of stop solution to each well which changed the colour from blue to yellow. The 
optical density of each well was determined using a microplate reader set to 450nm. 
All treatments were performed in triplicate. 
8.4.4 STATISTICAL ANALYSIS 
Data are presented as means +/- SD. Paired student's T test was used to determine the 
significance of the results obtained from the adhesion and MMP assays. A p-value of 
< 0.05 was considered significant. 
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8.5 RESULTS 
8.5.1 ADHESION ASSAYS 
8.5.1.1 Adhesion to fibronectin 
i) NOK 
Stimulation of NOK with lymphotactin resulted in a significant increase in adhesion 
to tibronectin (p<0.001) in a dose dependent manner whereas no such effect was 
observed with the irrelevant chemokine TECK (Figure 8.1). Addition of XCRI 
blocking antibody significantly reduced adhesion at all doses (p<0.05) and brought it 
back to control level. The irrelevant control antibody CXCRI on the other hand failed 
to reduce adhesion. 
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Figure 8.1. Percentage increase in the adhesion of NOK to fibronectin after stimulation with 
lymphotactin (n=average of 3 different experiments done in triplicate, error bars=SD) where 
FN= fibronectin, Lymphotactin concentration=ng/ml. Lymphotactin increased adhesion to 
fibronectin in a dose dependent manner whereas no affect was seen with the irrelevant 
chemokine TECK. Preincubation with XCR1 antibody (and not CXCR1) blocked the increase 
in adhesion at all lymphotactin concentrations. 
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ii) H357 and SCC4 
Adhesion of H357 and SCC4 cells to fibronectin also increased significantly after 
stimulation with lymphotactin in a dose dependent manner (p<0.001 and p<0.0001 
respectively) (Figure 8.2 and 8.3). Pre-incubation of H357 and SCC4 cells with XCR I 
antibody caused a significant reduction in adhesion at all lymphotactin doses (p<0.001 
and p<0.0001 respectively) and reduced it to control levels. The irrelevant control 
chemokine and antibody TECK and CCL25 did not have any effect on adhesion. 
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Figure 8.2. Percentage increase in the adhesion of H357 cells to fibronectin after stimulation 
with lymphotactin (n=average of 3 different experiments done in triplicate, error bars=SD) 
where FN= fibronectin, Lymphotactin concentration= ng/m1. Lymphotactin increased adhesion 
to fibronectin in a dose dependent manner whereas no affect was seen with the irrelevant 
chemokine TECK. Preincubation with XCR1 antibody (and not CXCR1) blocked the increase 
in adhesion at all lymphotactin concentrations. 
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Figure 8.3. Percentage increase in the adhesion of SCC4 cells to fibronectin after stimulation 
with lymphotactin (n=average of 3 different experiments done in triplicate, error bars=SD) 
where FN= fibronectin, Lymphotactin concentration=ng/ml. Lymphotactin increased adhesion 
to fibronectin in a dose dependent manner whereas no affect was seen with the irrelevant 
chemokine TECK. Preincubation with XCR1 antibody (and not CXCR1) blocked the increase 
in adhesion at all lymphotactin concentrations. 
The NOK were the least adhesive to fibronectin of the tested cells. At three different 
doses of lymphotactin (l Ong/mI, l00ng/mI and 500ng/ml) an increase in adhesion of 
4.3%0,6.5% and 9.1 % was observed respectively. Exposure to lymphotactin caused a 
significantly higher increase in adhesion of H357 cells than NOK to fibronectin (10%, 
18.6% and 27.1%) (p<0.01). Similarly, significantly higher adhesion of SCC4 cells to 
fibronectin was seen compared with NOK after lymphotactin stimulation at all doses 
(11%, 20.9% and 33.6%) (p<0.001). No significant difference was observed between 
adhesion of H357 and SCC4 cells (Figure 8.4). 
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Figure 8.4. Comparison of percentage increase in adhesion of NOK, H357 and SCC4 cells to 
fibronectin after lymphotactin stimulation (n=average of 3 different experiments done in 
triplicate, error bars=SD). Lymphotactin increased adhesion to lymphotactin in a dose 
dependent manner. The H357 and SCC4 cells significantly higher adhesion than NOK. 
8.5.1.2 Adhesion to Collagen 
i) NOK 
No increase in adhesion of NOK to collagen was observed after incubation with 
lymphotactin at any dose. No difference was observed between different treatments 
including addition of XCRI antibody, TECK or CXCRI antibody (Figure 8.5). 
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Figure 8.5. Percentage increase in the adhesion of NOK to collagen after stimulation with 
lymphotactin (n=average of 3 different experiments done in triplicate, error bars=SD) where 
FN= fibronectin, Lymphotactin concentration=ng/ml. Lymphotactin failed to increase adhesion 
of NOK to collagen at any of the tested concentrations. Similarly no affect was seen with the 
irrelevant chemokine TECK, the XCR1 or the CXCR1 antibody. 
ii) 11357 and SCC4 
Different results were obtained for the cancer cells. Adhesion of both H357 and SCC4 
cells to collagen significantly increased after lymphotactin stimulation (p<0.001 and 
p<0.001 respectively) in a dose dependent manner (Figure 8.6 and 8.7). A significant 
decrease in this adhesion was observed after pre-incubation of 11357 and SCC4 cells 
with XCRI antibody (p<0.001 and p<0.001 respectively) and adhesion was reduced 
to control levels. The irrelevant chemokine TECK or the irrelevant antibody CXCRI 
failed to elicit any response. 
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Figure 8.6. Percentage increase in the adhesion of H357 cells to collagen after stimulation 
with lymphotactin (n=average of 3 different experiments done in triplicate, error bars=SD) 
where FN= fibronectin, Lymphotactin concentration=ng/ml. Lymphotactin increased adhesion 
of H357 cells to collagen in a dose dependent manner whereas no affect was seen with the 
irrelevant chemokine TECK. Preincubation with XCR1 antibody (and not CXCR1) blocked the 
increase in adhesion at all lymphotactin concentrations. 
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Figure 8.7. Percentage increase in the adhesion of SCC4 cells to collagen after stimulation 
with lymphotactin (n=average of 3 different experiments done in triplicate, error bars=SD) 
where FN= fibronectin, Lymphotactin concentration=ng/ml. Lymphotactin increased adhesion 
of H357 cells to collagen in a dose dependent manner whereas no affect was seen with the 
irrelevant chemokine TECK. Preincubation with XCR1 antibody (and not CXCR1) blocked the 
increase in adhesion at all lymphotactin concentrations. 
Comparison of the three cells showed a highly significant increase in H357 and SCC4 
adhesion to collagen compared with NOK (p<0.001 and p<0.0001 respectively). At 
three different doses of lymphotactin (lOng/ml, IOOng/mI and 500ng/ml), adhesion of 
H357 cells to collagen increased by 10.4%, 19.3% and 25.5% respectively. Similarly, 
SCC4 cells showed an increase of 11.6%, 22.7% and 32.2% in adhesion to collagen 
after incubation with lymphotactin (Figure 8.8). No significant difference was 
observed between adhesion of H357 and SCC4 cells. 
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Figure 8.8. Comparison of percentage increase in adhesion of NOK, H357 and SCC4 cells to 
collagen after lymphotactin stimulation (n=average of 3 different experiments done in 
triplicate, error bars=SD). No increase in adhesion of NOK to collagen was seen after 
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lymphotactin stimulation. However, adhesion of H357 and SCC4 cells was significantly 
increased (compared with collagen alone) in a dose dependent manner. 
8.5.2 1111P PRODUCTION 
8.5.2.1 M1MM P-2 
i) NOK 
Constitutive MMP-2 expression was seen in NOK as unstimulated cells produced low 
levels. Incubation of NOK with PMA, TNF-a and LPS significantly increased MMP- 
2 production (p<0.00001) (Figure 8.9). A small yet significant increase in MMP-2 
release was also seen after lymphotactin stimulation (p<0.05) and addition of XCRI 
antibody significantly reduced MMP-2 expression (p<0.01). Addition of the irrelevant 
control chemokine TECK or the control antibody CXCR I did not have any effect. 
2.5 - 
_2 
E 
1.5 
Unstim PMA TNF-a LPS Lptn TECK XCR1 + CXCR1 + 
Lptn Lptn 
Figure 8.9. MMP-2 production by NOK (n=average of 3 different experiments done in 
triplicate, error bars=SD). MMP-2 was detected in unstimulated cells and stimulation with 
PMA, TNF-a and LPS caused a highly significant up-regulation in MMP-2 release. 
Lymphotactin also caused a small but significant increase in MMP-2 release and this increase 
could be blocked by addition of an XCR1 blocking antibody. The irrelevant chemokine TECK 
and irrelevant antibody CXCR1 did not have any influence. 
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ii) 11357 and SCC4 cells 
Constitutive MMP-2 expression was also seen in supernatants of 11357 and SCC4 
cells. Stimulation with PMA, TNF-u and LPS caused a highly significant increase in 
MMP-2 release from H357 and SCC4 cells (p<0.0001 and p<0.00001 respectively) 
(Figure 8.10 and 8.1 1). 
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Figure 8.10. MMP-2 production by H357 cells (n=average of 3 different experiments done in 
triplicate, error bars=SD). MMP-2 was detected in unstimulated cells and stimulation with 
PMA, TNF-a and LPS caused a highly significant up-regulation in MMP-2 release. 
Lymphotactin also caused a small but significant increase in MMP-2 release and this increase 
could be blocked by addition of an XCR1 blocking antibody. The irrelevant chemokine TECK 
and irrelevant antibody CXCR1 did not have any influence. 
Addition of lymphotactin also caused a significant increase in MMP-2 production 
from H357 and SCC4 cells (p<0.05 and p<0.001 respectively) and administration of 
XCRI blocking antibody reduced MMP-2 secretion to control levels. No response 
was observed when TECK or CXCR 1 were used (Figure 8.10 and 8.1 1). 
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Figure 8.11. MMP-2 production by SCC4 cells (n=average of 3 different experiments done in 
triplicate. error bars=SD). MMP-2 was detected in unstimulated cells and stimulation with 
PMA. TNF-a and LPS caused a highly significant up-regulation in MMP-2 release. 
Lymphotactin also caused a small but significant increase in MMP-2 release and this increase 
could be blocked by addition of an XCR1 blocking antibody. The irrelevant chemokine TECK 
and irrelevant antibody CXCR1 did not have any influence. 
Comparison of MMP-2 expression between NOK and OCCL revealed that the 
constitutive MMP-2 expression by 11357 and SCC4 cells was significantly higher than 
NOK (p<0.01 and p<0.01 respectively) (Figure 8.12). Similarly addition of I'MA, 
TNF-u, LPS and lvmphotactin caused a higher increase in MMP-2 secretion from 
1-1357 (p-0.00001. p--0.00001, p<0.001 and p<0.05 respectively) and SCC4 cells 
(p. 0.00001. p<0.0000 1, p<0.0000I and p<0.000I respectively) than NOK. 11357 and 
SCC4 cells also showed a significantly higher increase in MMP-2 release in response 
to Ik mphotactin stimulation than NOK (p<0.05 and p<0.05 respectively). 
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Figure 8.12. Comparison of MMP-2 production between NOK, H357 and SCC4 cells 
(n=average of 3 different experiments done in triplicate, error bars=SD). An increase in MMP- 
2 production was seen in response to PMA, TNF-a, LPS and lymphotactin. Addition of XCR1 
antibody blocked the increase in response to lymphotactin. The H357 and SCC4 cells 
produced significantly higher amount of MMP-2 in culture compared with NOK 
8.5.2.2 MMP-7 
i) NOK 
No constitutive expression of MMP-7 was seen in the NOK supernatants. Addition of 
PMA. TNF-a or LPS tailed to stimulate MMP-7 production. Similarly addition of 
l) mphotactin, XCR 1. TECK or CXCR I did not have any effect (Figure 8.13). 
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Figure 8.13. MMP-2 production by NOK (n=average of 3 different experiments done in 
triplicate, error bars=SD). No MMP-7 was detected in unstimulated NOK and stimulation with 
PMA, TNF-a, LPS or lymphotactin failed to stimulate MMP-7 release. The irrelevant 
chemokine TECK and irrelevant antibody CXCR1 also did not have any influence. 
ii) 11357 and SCC4 cells 
Results were very different for OCCL. Stimulation with PMA, TNF-a and LPS 
sizniticantly up-regulated MMP-7 secretion from H357 (p<O. 00I, p<0.001 and 
p<0.0001 respectively) and SCC4 cells (p<0.0001, p<0.001 and p-1.0.0001 
respectively) compared with unstimulated cells (Figure 8.14 and 8.15). 
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Figure 8.14. MMP-7 production by H357 cells (n=average of 3 different experiments done in 
triplicate, error bars=SD). No MMP-7 was detected in unstimulated cells and stimulation with 
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PMA, TNF-a and LPS caused a highly significant up-regulation in MMP-7 release. 
Lymphotactin also caused a significant increase in MMP-7 release and this increase could be 
blocked by addition of an XCR1 blocking antibody The irrelevant chemokine TECK and 
irrelevant antibody CXCR1 did not have any influence. 
Incubation with lymphotactin also caused a significant increase in MMP-7 production 
from 11357 (p<O. 00I) and SCC4 cells (p<0.001). Addition of anti-XCRI antibody 
significantly reduced MMP-7 production to control levels whereas no response was 
seen when TECK or CXCRI were used (Figure 8.14 and 8.15). 
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Figure 8.15. MMP-7 production by SCC4 cells (n=average of 3 different experiments done in 
triplicate, error bars=SD). No MMP-7 was detected in unstimulated cells and stimulation with 
PMA, TNF-a and LPS caused a highly significant up-regulation in MMP-7 release. 
Lymphotactin also caused a highly significant increase in MMP-7 release and this increase 
could be blocked by addition of an XCR1 blocking antibody. The irrelevant chemokine TECK 
and irrelevant antibody CXCR1 did not have any influence. 
A big difference in MMP-7 expression was seen between NOK and OCCL. No MMP- 
7 production was observed from unstimulated and stimulated NOK. In contrast, 
addition of PMA. TNF-a and LPS caused a highly significant increase in MMP-7 
production from H357 (p<O. 001, p<0.001 and p<0.00001 respectively) and SCC4 
cells (p<0.01, p<0.01, p<0.01 respectively) (Figure 8.16). Lymphotactin had no effect 
on MMP-7 release from NOK whereas H357 cells showed significantly higher MMP- 
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7 production than NOK (p<0.001). The SCC4 cells were the most responsive to 
I\mphotactin and showed a highly significant increase in MMP-7 production 
compared to both NOK and H357 cells (p<0.001 and p<0.001 respectively) (Figure 
8.16). 
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Figure 8.16. Comparison of MMP-7 production between NOK, H357 and SCC4 cells 
(n=average of 3 different experiments done in triplicate, error bars=SD). H357 and SCC4 cells 
showed an increase in MMP-7 production in response to PMA, TNF-a, LPS and lymphotactin. 
Addition of XCR1 antibody blocked the increase in response to lymphotactin. No MMP-7 
production was detected in NOK supernatants. 
8.5.2.3 ! 111 P-9 
i) NOK 
like MMP-2. constitutive expression of MMP-9 was detected in NOK culture 
supernatants. Incubation of NOK with PMA, TNF-a or LPS significantly increased 
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MMP-9 secretion compared with unstimulated cells (p<0.01, p<0.05 and p<0.000I 
respectively) (Figure 8.17). Lymphotactin also caused a small but significant increase 
in MMP-9 release (p<0.05) and this effect was abolished by the addition of XCRI 
blocking antibody (p<0.05). The irrelevant control chemokine and antibody (TECK 
and CXCR I) failed to have any effect. 
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Figure 8.17. MMP-9 production by NOK (n=average of 3 different experiments done in 
triplicate, error bars=SD). MMP-2 was detected in unstimulated cells and stimulation with 
PMA, TNF-a and LPS caused a highly significant up-regulation in MMP-9 release. 
Lymphotactin also caused a small but significant increase in MMP-9 release and this increase 
could be blocked by addition of an XCR1 blocking antibody. The irrelevant chemokine TECK 
and irrelevant antibody CXCR1 did not have any influence. 
ii) 11357 and SCC4 cells 
Constitutive MMP-9 release was also detected in culture supernatants of H357 and 
SCC4 cells. Stimulation with PMA, TNF-a or LPS significantly increased MMP-9 
secretion from H357 (p<0.001, p<0.001 and p<0.01 respectively) and SCC4 cells 
(p<0.00001. p<0.0001 and p<0.01 respectively) compared with unstimulated cells 
(Figure 8.18 and 8.19). 
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Figure 8.18. MMP-9 production by H357 cells (n=average of 3 different experiments done in 
triplicate, error bars=SD). MMP-2 was detected in unstimulated cells and stimulation with 
PMA, TNF-a and LPS caused a highly significant up-regulation in MMP-9 release. 
Lymphotactin also caused a small but significant increase in MMP-9 release and this increase 
could be blocked by addition of an XCR1 blocking antibody. The irrelevant chemokine TECK 
and irrelevant antibody CXCR1 did not have any influence. 
A significant increase in MMP-9 production was also seen after stimulation of H357 
and SCC4 cells with lymphotactin (p<0.001 and p<0.001 respectively) but not with 
TECK. Preincubation of cells with an antibody against XCR I caused a significant 
reduction in MMP-9 release (p<0.0001 and p<0.0001 respectively) and reduced it to 
control levels. The irrelevant CXCRI antibody failed to reduce MMP-9 secretion 
(Figure 8.18 and 8.19). 
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Figure 8.19. MMP-9 production by SCC4 cells (n=average of 3 different experiments done in 
triplicate, error bars=SD). MMP-9 was detected in unstimulated cells and stimulation with 
PMA, TNF-a and LPS caused a highly significant up-regulation in MMP-9 release. 
Lymphotactin also caused a small but significant increase in MMP-9 release and this increase 
could be blocked by addition of an XCR1 blocking antibody The irrelevant chemokine TECK 
and irrelevant antibody CXCR1 did not have any influence. 
Comparison of NOK and OCCL showed that the levels of constitutive MMP-9 
released in culture from H357 and SCC4 cells were significantly higher than NOK 
(p<0.01 and p<0.01 respectively). Stimulation of F1357 cells with PMA, TNF-u or 
LPS caused a significantly bigger increase in MMP-9 secretion compared with NOK 
(p<0.01, p<0.05 and p<0.05 respectively) (Figure 8.20). A similar response was 
observed in SCC4 cells as addition of PMA, TNF-u or LPS facilitated significantly 
higher levels of MMP-9 compared with NOK (p<0.00I, p<0.05 and p<0.05 
respectively). Exposure of H357 and SCC4 cells to lymphotactin also facilitated a 
bigger increase in MMP-9 production compared with NOK (p<0.01 and p<0.001 
respectively). No significant difference in MMP-9 secretion was observed between 
H357 and SCC4 cells (Figure 8.20). 
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Figure 8.20. Comparison of MMP-9 production between NOK, H357 and SCC4 cells 
(n=average of 3 different experiments done in triplicate, error bars=SD). An increase in MMP- 
9 production was seen in response to PMA, TNF-a, LPS and lymphotactin. Addition of XCR1 
antibody blocked the increase in response to lymphotactin. The H357 and SCC4 cells 
produced significantly higher amount of MMP-2 in culture compared with NOK 
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8.6 DISCUSSION 
In this chapter, the role of the interaction between XCRI and lymphotactin was 
studied in adhesion and MMP production of normal and malignant oral epithelial cells 
in l iti ). 
1. ADHESION 
Adhesion to fibronectin 
Stimulation of NOK and OCCL with lymphotactin resulted in increased adhesion to 
tihronectin in a dose dependent manner. However, both the cancer cell lines 11357 and 
SCC4 showed much greater adhesion to fibronectin after exposure to lymphotactin 
than NOK. This adhesion was completely blocked by an XCRI blocking antibody 
whereas the irrelevant control chemokine and antibody failed to do so. These results 
suggest that lymphotactin may induce a stronger response in cancer cells compared 
with normal. However, the 11357 and SCC4 cells were significantly more adhesive 
than NOK to fibronectin even in the absence of lymphotactin. Therefore it is likely 
that the greater adhesion after lymphotactin stimulation may just be due to the greater 
adhesive capability of cancer cells compared with normal. 
Adhesion to collagen 
the results \%ere very different for adhesion to collagen. Addition of lymphotactin 
failed to increase adhesion of NOK to collagen at any dose. Similarly, no effect was 
observed after addition of XCRI antibody, TECK or CXCRI antibody. Contrasting 
results were obtained for OCCL as stimulation with lymphotactin caused a significant 
increase in H357 and SCC4 cell adhesion to collagen in a dose dependent manner. 
The increase in adhesion to collagen was completely abolished when XCRI blocking 
antibody was added. These differential results between NOK and OCCL show that 
normal and cancer cells respond to lymphotactin in a different manner and that XCR I 
may mediate an adhesive response in cancer cells and not in normal cells. It is also 
likely that XCRI-lyrnphotactin interaction is influencing expression of certain 
integrins or adhesion molecules on cancer cells that might have a different expression 
pattern compared with normal cells. Oral epithelial cells are known to hind to 
tibronectin through the integrins a513I and aVß6 (only in wound healing and cancer) 
whereas they utilise the a2(31 integrin to bind to collagen (Poomsawat et ul., 2003; 
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Sugiyama et a!., 1993; Thomas et a!., 2001 d; Thomas et a!., 2001 c; Thomas et al., 
2001b; Thomas, Jones, and Speight 1997; Thomas and Speight 2001). It would be 
interesting to study the expression patterns of these integrins on NOK and OCCL and 
find out whether there is a difference in expression between normal and cancer cells. 
Another possibility is that lymphotactin may be altering the expression of these 
integrins in some manner (either affecting expression or avidity of these integrins). In 
addition, it is also possible that incubation of cells on collagen or fibronectin may 
affect XCR1 expression by upregulating or downregulating it. 
Role of chemokines and their receptors in adhesion 
A role of chemokines and their receptors in epithelial cell adhesion to ECM 
components has been shown. The chemokine receptor CXCR4 mediates tumour cell 
adhesion to ECM components. Stimulation of prostate cancer cell lines LNCaP and 
DU-145 with SDF-la (ligand for CXCR4) significantly up-regulates adhesion to 
fibronectin, collagen and laminin by up-regulation of the integrins a5 and ß3 and this 
effect is significantly reduced after addition of an anti-CXCR4 antibody (Engl et a!., 
2006). A similar response is observed in small cell lung cancer (SCLC) cells as 
stimulation with SDF-la in addition to CXCR4 activation upregulates a2, a4, a5 and 
ßl integrin expression (Hartmann et al., 2005). In addition, binding of tumour cells to 
ECM can up-regulate expression of chemokine receptors and their ligands thus 
providing an autocrine mechanism of activation. Growth of pancreatic tumour cells on 
laminin-1 results in an up-regulation in CXCR4 expression (mediated by the a6ß1 
integrin) and IL-8 expression (mediated by the a6 ßl and a3ß 1 integrins) (Grzesiak et 
a!., 2007). Role of other chemokines and receptors in epithelial cell adhesion to ECM 
is not well characterized. CCL21 has been shown to increase adhesion of non-small 
cell lung carcinoma cell lines Lu-99 and A549 to endothelium. The chemokines 
fractalkine and CCL21 have been shown to increase adhesion of prostate and non- 
small cell lung cancer cells to the endothelium (Koizumi et al., 2007; Shulby et al., 
2004). However, none of these studies compared the adhesion of normal cells to 
cancer cells. 
Chemokines and their receptors in oral epithelial cell adhesion 
The role of chemokines and their receptors in adhesion of oral epithelial cells to ECM 
components has not been shown to date. Recently a group has studied the expression 
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and role of the chemokine receptor CXCR4 in mucoepidermoid carcinoma of salivary 
glands. Gene knockdown of CXCR4 from highly metastatic mucoepidermoid 
carcinoma Mc3 cells results in significantly diminished adhesion to matrigel 
compared with their CXCR4-expressing counterparts (Wen et al., 2007). However 
they did not study the effect of SDF-la stimulation on these cells and also did not 
compare adhesion to normal keratinocytes. 
Our findings show for the first time that chemokine-chemokine receptor interaction 
can facilitate adhesion of normal and malignant oral cells to ECM. Adhesion of both 
normal and cancer cells to fibronectin is increased after stimulation with lymphotactin 
whereas for collagen, lymphotactin stimulation only facilitates increased adhesion of 
cancer cells. This increased adhesion is mediated through XCR1 and may play a role 
in the increased migration and invasion in response to lymphotactin (as seen with our 
experiments in chapter 4). Due to time constraints, the effect of XCR1 and 
lymphotactin interaction on adhesion to other ECM components (such as laminin and 
tenascin) could not be studied. Similarly, the mechanism of adhesion and the integrins 
that are involved in the process were not studied. Since adhesion is a fundamental 
aspect of epithelial cells motility these results are very interesting and may have 
potential implications in oral epithelial cell migration and invasion in wound healing 
and cancer. 
2. MMMP PRODUCTION IN VITRO 
Matrix metalloproteinases (MMPs) are a family of zinc and calcium-dependent 
proteases primarily involved in the breakdown of ECM. They play an important role 
in many physiological processes such as embryonic development, morphogenesis, 
reproduction and tissue remodeling (Bjorklund and Koivunen 2005; Stamenkovic 
2003). MMPs are also implicated in many pathological processes such as arthritis 
(Xue et al., 2007), cardiovascular disease (Sivakumar et al., 2007) and cancer (Lynch 
and Matrisian 2002; Stamenkovic 2000). 
a) MMP-2 and MMP-9 
MMP-2 (gelatinase A) is primarily expressed in mesenchymal cells during 
development and tissue regeneration (Bai et al., 2005; Xue, Le, and Jackson 2006). It 
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is highly expressed in stromal cells surrounding the invading front of metastasizing 
tumours and is associated with many connective tissue cells as well as neutrophils, 
macrophages and monocytes (Lynch and Matrisian 2002; Stamenkovic 2000). 
Together with MMP-9 (gelatinase B), it degrades type IV collagen (the major 
component of basement membranes) and gelatin. It can also degrade other types of 
collagens (V, VII and X) as well as elastin and fibronectin. 
MMP-9 is also involved in inflammation (Xue et al., 2007), tissue remodelling and 
wound healing (Puchelle et al., 2006) in addition to tumour invasion and metastasis 
(Deryugina and Quigley 2006; Stamenkovic 2000). Substrates for MMP-9 include 
collagens type IV, V, VII, X and XI, denatured collagen type I (gelatin), fibrinogen, 
vitronectin, IL-1ß and entactin, a molecule that bridges laminin and type IV collagen 
(Bjorklund and Koivunen 2005). 
Expression and role of MMP-2 and MMP-9 in tumours 
Expression of MMP-2 and MMP-9 has been shown in a wide range of tumours such 
as breast and prostate cancer (Incorvaia et al., 2007), lung cancer (Drac et al., 2007; 
Kopczynska et al., 2007), pancreatic cancer (Bloomston et al., 2002), melanoma 
(Hofmann et al., 2000), bladder cancer (Kanayama 2001), hepatocellular carcinoma 
(Qin and Tang 2002), colorectal carcinoma (Mook, Frederiks, and Van Noorden 
2004)and glioma (Nakada, Okada, and Yamashita 2003) where they facilitate ECM 
breakdown and migration, invasion and metastasis of tumour cells. 
Expression of MMP-2 and MMP-9 in normal and malignant oral epithelium 
Expression of MMP-2 and MMP-9 has also been shown in normal as well as 
malignant oral epithelial cells. MMP-2 and MMP-9 are highly expressed in vivo in 
OSCC patients (Guttman et al., 2004) and expression is correlated to alcohol 
consumption and the grade of differentiation and is associated with poor survival rates 
(de Vicente et al., 2005). In addition to in vivo tissue expression, MMP-2 and MMP-9 
levels are also elevated in plasma compared with disease free individuals. Patients 
with lymph node metastases express significantly higher active MMP-2 and MMP-9 
compared with patients without metastases (Patel et al., 2005; Patel et al., 2007). 
Constitutive in vitro expression of MMP-2 and MMP-9 is detected in culture 
supernatants of NOK as well as oral cancer cell lines KB and OC-2 (Tsai et al., 2003). 
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However, the OCCL secrete significantly higher levels of MMP-2 and MMP-9 
compared with NOK suggesting an important role for MMP-2 and MMP-9 in oral 
cancer biology. 
Author/ year (Reference) Association with cünicopathological 
parameters 
(Kusukawa et at., 1993) Lymph node metastasis and mode of 
Invasion 
(Kawamata et al., 1997) MMP2 expression related to lymph node 
metastasis and bone Invasion 
(Charous et al., 1.997) Expression in tumour front- No difference 
between primary tumour and metastasis 
(Ikebe et al., 1999; Kurahara et al., Invasion and lymph node metastasis 
1999) 
(Hong et al., 2000) Lymph node metastasis (only MMP9) 
(Imanishi et al., 2000) Associated with MU-MMP and lymph 
node metastasis 
(Tokumaru et al., 2000) Lymph node metastasis 
(Riedel et al., 2000a; Riedel et al., Elevated serum levels associated with 
2000b) cancer stage, Worse survival (only 
MMP9). 
(Yoshizaki et al., 2001) MMP-2 expression associated with poor 
prognosis. 
(Yorioka et al., 2002) Lower MMP concentration associated 
with longer disease free survival 
(Franchi et at., 2002) MMP9 expression associated with 
angiogenesis and p53 expression in 
OSCC. 
(Robinson et al., 2003) Expression of MMP2 and MMP9 in OCCL 
associated with Invasiveness in vitro and 
tumourigenesis In vivo. 
(Katayama et al., 2004) Lymph node metastasis, Worse survival 
(only MMP9) 
(Nagel et al., 2004) MMP2 expression associated with 
Invasiveness of salivary gland tumours 
Table 8.1. Summary of reported findings of MMP-2 and MMP-9 expression in OSCC. 
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Chemokines in MMP-2 and MMP-9 regulation 
A role for chemokines and their receptors in MMP-2 and MMP-9 regulation is well 
documented. Interaction of CXCR4 and SDF-la causes a significant increase in 
MMP-2 and MMP-9 production from ovarian cancer cells in vitro (Yuecheng and 
Xiaoyan 2007b). SDF-la also stimulates MMP-9 release from lung cancer cell lines 
and silencing of the MMP-9 gene inhibits tumour cell invasion towards SDF-la 
(Tang et al., 2007a). However both these groups did not study the role of CXCR4 as 
they did not use blocking antibodies against the receptor. Knockdown of the 
chemokine receptor CCRI from a hepatocellular carcinoma cell line HCCLM3 
significantly inhibits MMP-2 production from the cells as well as reducing their 
invasive ability (Wu et al., 2007) suggesting an important role for CCRI in HCC 
biology. The role of chemokines and receptors in MMP regulation from oral epithelial 
cells is not very well characterized. Stimulation of OCCL with SDF-la significantly 
up-regulates MMP-9 production in a dose dependent manner (Samara et al., 2004). 
However they did not compare expression to NOK or study the role of CXCR4. 
Chemokines have been shown to influence MMP production in other cancers. SDF-la 
up-regulates MMP-9 expression in prostate cancer (Chinni et al., 2006), colorectal 
cancer (Brand et al., 2005), myeloma (Parmo-Cabanas et al., 2006), HCC (Chu et al., 
2007), lung cancer (Tang et al., 2007b) and ovarian cancer (Yuecheng and Xiaoyan 
2007a). Treatment of pancreatic cancer cells with IL-8 significantly up-regulates 
MMP-2 expression (Kuwada et al., 2003) whereas RANTES has a similar effect on 
breast cancer cells (Azenshtein et al., 2002). As previously observed, none of these 
studies compared MMP expression between cancerous and normal cells or use a 
receptor blocking antibody. 
Our findings 
In agreement with the literature our results also showed constitutive MMP-2 and 
MMP-9 production in culture supernatants of NOK and OCCL. The level of 
constitutive MMP-2 and MMP-9 secretion in H357 and SCC4 cells was significantly 
higher than NOK. Stimulation of NOK, H357 and SCC4 cells with PMA, TNF-a or 
LPS resulted in a significant increase in MMP-2 and MMP-9 release and the secretion 
levels were higher in cancer cells than normal cells. Interestingly, exposure of normal 
and cancerous oral cells to lymphotactin also caused a small but significant increase in 
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MMP-2 and MMP-9 secretion and pre-incubation of cells with XCRI blocking 
antibody reduced secretion to control levels (unstimulated cells). Lymphotactin 
facilitated a significantly bigger release in MMP-2 and MMP-9 production from H357 
and SCC4 cancer cells than NOK. No difference between MMP-2 and MMP-9 
expression could be detected between the two cancer cell lines H357 and SCC4 cells. 
These results suggest that lymphotactin can facilitate an increase in MMP-2 and 
MMP-9 concentration from oral keratinocytes. This effect is more pronounced in 
cancer cells than normal cells and is mediated through XCR1. Lymphotactin has been 
previously shown to down-regulate MMP-2 production from synoviocytes in culture 
which is different to our findings (Blaschke et al., 2003). This may be explained by 
the difference in origin of the cells used in their study and ours. XCR1 expression 
between synoviocytes and oral epithelial cells may differ and it is possible that they 
respond differently when exposed to lymphotactin. 
Expression of MMP-2 and MMP-9 by oral epithelial cells has previously been shown. 
Bennett et al. reported that a skin keratinocyte cell line UP and H357 oral cancer cells 
constitutively express both MMP-2 and MMP-9 which is in agreement with our 
findings (Bennett et al., 2000). Stimulation of these cells with scatter factor 
significantly increases MMP-2 and MMP-9 activity and a blocking antibody against 
scatter factor inhibited this increase. However, they did not study expression in NOK. 
Robinson et al. reported that NOK and a range of OCCL (including H357 cells) 
constitutively express pro-MMP-2 and MMP-9 in culture (Robinson et al., 2003). 
They also reported that pro-MMP-2 production from OCCL is generally higher than 
NOK whereas pro-MMP-9 levels are higher in NOK than OCCL. This could be 
explained by the pattern of integrin expression by these cells as a correlation between 
integrin expression and MMP-2 expression has been shown. Expression of the avß6 
integrin has been shown to be directly proportional to MMP-9 expression (Thomas et 
al., 2001a). Transfection of the avß6 integrin in the H357 cell line results in a 
significant increase in MMP-9 release from these cells. This increase in MMP-9 
expression then facilitates migration of oral keratinocytes and their adhesion to 
fibronectin in vitro. The OCCL used in the study of Robinson et al. expressed very 
low levels of the av subunit compared with NOK which may have influenced MMP-9 
expression. The pattern of integrin expression is different between normal 
keratinocytes, in wound healing and in cancer. Therefore, it is possible that different 
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integrins may influence MMP expression in different conditions. Constitutive 
expression of MMP-2 and MMP-9 from normal and malignant oral epithelial cells has 
also been reported by Tsai et al. They found that NOK and OCCL (KB and OC2) 
constitutively produce MMP-2 and MMP-9 in culture and that the levels are 
significantly higher in OCCL compared with NOK which is in agreement with our 
findings (Tsai et al., 2003). 
b) MMP-7 
Expression of MMP-7 (matrilysin) has been reported in epithelial cells of normal as 
well as diseased tissues (Hajj et al., 2007; Kassim et al., 2007; Kuivanen et al., 2006). 
MMP-7 is capable of degrading a range of ECM proteins such as collagen IV, gelatin, 
laminin, aggrecan, entactin, elastin and versican. It can activate other proteinases such 
as urokinase plasminogen activator and pro-MMP-1, -2, -9, and can cleave additional 
substrates such as osteopontin (Ii et al., 2006). 
Expression and role of MMP-7 in tumours 
MMP-7 is expressed in a variety of tumours including breast (Jiang et al., 2005), 
colon (Adachi et al., 2001), prostate (Hashimoto et al., 1998), lung (Liu et al., 2007), 
ovary (Sillanpaa et al., 2006) and skin (Kawasaki et al., 2007). MMP-7-mediated 
cleavage of Fas ligand protects tumour cells from chemotherapeutic drug cytotoxicity 
hence facilitating tumour growth and progression (Mitsiades et al., 2001). MMP-7 
expression has also been shown in vivo in endometrial cancers and the production 
levels directly correlate with lymph node metastasis (Shiomi and Okada 2003). In 
vivo expression has also been shown in colorectal and gastric carcinomas and a 
correlation is observed between staining intensity and vascular invasion and 
metastases (Aihara et al., 2005; Kitoh et al., 2004; Lee et al., 2006; Zheng et al., 
2003). Liver metastases of colorectal carcinoma show up-regulation of MMP-7 
mRNA and protein compared with the normal liver tissue. Strong in vivo expression 
of MMP-7 is observed localized in the tumour front and cytoplasm (Ogawa et al., 
2005; Pesta et al., 2007). In addition, significantly higher levels of latent MMP-7 are 
detected in liver metastases samples compared with normal liver tissue but the active 
form of MMP-7 is only detected in the metastatic cells in the liver and not in the 
normal cells (Zeng et al., 2002). This suggests an important role for active MMP-7 in 
metastasis of colorectal carcinomas to the liver. Transfection of the MMP-7 gene into 
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a breast cancer cell line MCF-7 results in production of increased levels of pro- and 
active MMP-7 and significantly increases invasion through matrigel compared with 
the untransfected cells (Wang, Reierstad, and Fishman 2006). 
Expression of MMP-7 in oral cancer 
A role for MMP-7 in the biology of oral cancer has also been reported (Birkedal- 
Hansen et al, 2000; Impola et al., 2004). Expression of MMP-7 is observed in oral 
tumours but not in normal tissue and is significantly correlated with lymph node 
metastasis and patient survival (de Vicente et al., 2007). This suggests that MMP-7 
can be used a prognostic indicator, particularly in patients with lymph node 
metastasis. 
Chemokines in MMP-7 regulation 
The role of chemokines in MMP-7 regulation is not very well characterized. To date, 
MMP-7 production in response to chemokine stimulation has been reported from 
malignant oral keratinocytes in vitro. Stimulation of two oral cancer cell lines NA 
and HSC-4 with IL-8 significantly up-regulates MMP-7 expression at mRNA level 
and its production in culture (Watanabe et al., 2002). However, this group did not 
compare MMP-7 production from OCCL to that from NOK. 
Our findings 
Our experiment showed different results for MMP-7 compared with MMP-2 and 
MMP-9. No constitutive expression was observed in NOK or OCCL. Stimulation of 
NOK with PMA, TNF-a, LPS or lymphotactin failed to increase MMP-7 secretion in 
culture. However, in OCCL H357 and SCC4 a pronounced up-regulation in MMP-7 
expression was observed after stimulation with PMA, TNF-a or LPS. In addition, 
stimulation of H357 and SCC4 cells with lymphotactin also caused a significant 
increase in MMP-7 release compared with unstimulated controls. Lymphotactin 
stimulation facilitated release of significantly very high levels of MMP-7 in SCC4 
cells compared with H357 cells. Preincubation of cells with XCR1 antibody 
significantly reduced MMP-7 production to control levels. These results show that 
lymphotactin can stimulate production of MMP-7 from oral cancer cells but not from 
normal cells. In addition, SCC4 cells which are almost 100% positive for XCRI 
secrete very high levels of MMP-7 after exposure to lymphotactin compared with 
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H357 cells which release a much smaller amount suggesting that MMP-7 production 
may have a correlation with number of XCR1 expressing cells. 
These findings can have a number of implications. Up-regulation of MMP-2, MMP-7 
and MMP-9 from NOK and OCCL after lymphotactin stimulation suggests that 
XCRI/lymphotactin interaction may be important in MMP production from oral 
epithelial cells. A large increase in MMP-7 production from SCC4 cells suggests a 
correlation between XCRI expression and MMP-7 production and indicates that 
XCR1 and lymphotactin interaction may be more important in MMP-7 regulation 
than MMP-2 or MMP-9. However, the ELISA kits used in these experiments only 
measure total MMP and cannot distinguish between the pro and active forms of the 
enzymes. 
Release of MMP-2, MMP-7 and MMP-9 is hallmark of wound healing, tumour 
progression, invasion and metastasis as increased expression allows cells to attach to 
and break down ECM thus allowing migration and invasion. As our previous results 
have shown abundant lymphotactin expression in diseased oral mucosa it is possible 
that XCR1 may play an important role in the biology of these processes by regulating 
MMP expression and thus influencing physiological epithelial cell migration and 
adhesion in wound healing or inflammation or by affecting tumour cell invasion and 
metastasis. 
The Chemokine Receptors XCRI, CXCRI and CXCR2 Regulate Oral Epithelial Cell Behaviour 225 
CHAPTER 9 
Discussion and Conclusions 
Chapter 9- Discussion and Conclusions 
9.1 DISCUSSION 
As explained in Chapter 1, the principal function of chemokines is chemoattraction, 
trafficking and localisation of lymphocytes. However, expression of chemokine receptors 
has been shown on epithelial cells where they mediate a range of effects (including cell 
migration and invasion) and influence the behaviour of cells. Chemokine receptors have 
been implicated in a wide range of cancers where they facilitate tumour invasion and 
metastasis to lymph nodes along the gradient of their respective chemokine. 
Our preliminary microarray results suggested a difference in mRNA levels of the 
chemokine receptors XCR1 and CXCR1 between normal and cancerous oral epithelial 
cells. These results were exciting as XCRI expression has never been shown on epithelial 
cells whereas the expression of CXCRI on oral epithelial cells is not well characterised. 
XCRI binds to the chemokine lymphotactin whereas CXCR1 (along with CXCR2) binds 
with the highest affinity to IL-8. To date, expression of XCRI outside the lymphoid 
system has only been shown on fibroblast-like synoviocytes in rheumatoid synovium 
(Blaschke et al., 2003) and very recently in melanocytic lesions (Seidl et al., 2007). 
Therefore, the preliminary results were explored further and the aim of this project was to 
establish the expression of XCRI and CXCR1 (and CXCR2 since it also binds to IL-8) 
on normal and malignant oral epithelial cells and to observe if they have a role in the 
regulation of oral epithelial cell behaviour. 
9.1.1 CXCR1 and CXCR2 
Our results show that CXCR1 and CXCR2 are expressed at mRNA and protein level by 
normal as well as cancerous oral epithelial cells. More cancer cells express the receptors 
than normal keratinocytes and show a greater response to IL-8 (acting through CXCRI 
and CXCR2) in activation of the ERKI/2 signaling cascade, migration, invasion and 
proliferation in vitro. 
The findings with NOK show that normal cells have the ability to respond to the ligands 
if provided with the apt stimulus. Activation of ERKI/2, increase in proliferation and 
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migration of NOK in vitro suggests a potential role for CXCRI and CXCR2 in vivo in 
physiological epithelial cell turnover as well as in wound healing and inflammatory 
conditions. A role for IL-8 in wound healing has been shown in the skin (Engelhardt, et 
al., 1998). Our finding that CXCR1 and CXCR2 are expressed by NOK suggests that IL- 
8 and GRO-a may play a role in wound healing in the oral cavity by stimulating 
proliferation and migration of epithelial cells. However whether IL-8 or GRO-a is 
expressed by oral epithelial cells or other cell types in oral wounds is 
unknown. Normal oral epithelial cells express CXCRI and CXCR2 in vivo (Sfakianakis, 
Barr, and Kreutzer 2002) and expression is also observed in periodontitis. However, the 
results from this study are not very convincing and whether CXCRI and CXCR2 
expression is altered in oral wounds is not clear. 
In general, a higher percentage of OCCL were positive for CXCRI and CXCR2 than 
NOK and cancer cells showed a stronger response to stimulation with the ligands than 
normal cells. This difference in expression and behaviour between normal and cancer 
cells suggests a possible role for CXCRI and CXCR2 in the biology of oral cancer. 
Expression of IL-8, CXCR1 and CXCR2 has previously been shown in oral cancer in 
vitro and in vivo (Cohen et al., 1995; Richards et al., 1997; Watanabe et al., 2002). 
However, expression between normal and cancerous cells has not been compared before. 
In addition, the individual roles of CXCR1 and CXCR2 in IL-8 mediated effects in 
epithelial cell invasion and proliferation have never been reported. CXCR1 and CXCR2 
have been shown to mediate OCCL migration in response to IL-8 in only one study 
(Watanabe et al., 2002). However this group did not use both antibodies in combination 
to find out whether it caused any further decrease in migration compared to CXCRI or 
CXCR2 alone. The results of this thesis suggest that CXCR1 and CXCR2 mediate both 
invasion and migration but that interaction between both receptors may be important in 
some cancer cell lines. Furthermore CXCR1 appears to play a more important role that 
CXCR2 in proliferation although both may mediate the effects of their respective ligands. 
Strong IL-8 expression is observed in OSCC and expression in OSCC primary cultures 
and cell lines is upregulated after stimulation with TNF-a and IL-lß both of which are 
expressed in tumours (Cohen et al., 1995; Watanabe et al., 2002). The abundant 
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expression of IL-8 in OSCC coupled with the fact that more oral cancer cells are positive 
for both IL-8 receptors and respond more than NOK to IL-8 (as indicated by our findings) 
suggests that CXCRI and CXCR2 may play a role in the pathogenesis of oral cancer by 
facilitating tumour cell proliferation, migration, invasion and possibly metastasis. 
9.1.1.1 CONCLUSIONS (CXCRI and CXCR2) 
Our findings show that CXCRI and CXCR2 are expressed on normal and malignant oral 
epithelial cells and are functional as they facilitate signaling, migration, invasion and 
proliferation in response to IL-8 and GRO-a. While CXCR1 and CXCR2 appear to 
mediate both migration and invasion there is some evidence that CXCRI may be more 
important in proliferation. These findings raise the possibility that CXCR1 and CXCR2 
may regulate the behaviour of normal oral epithelial cells in vivo in physiological 
processes such as epithelial cell turnover as well as in wound healing. In addition, cancer 
cells appear more migratory, invasive and proliferative in response to the ligands than 
NOK and these findings suggest a potential role for CXCRI and CXCR2 in the biology 
of oral cancer. 
9.1.2 XCR1 AND LYMPHOTACTIN 
XCRI expression was observed at mRNA and protein level in NOK, HGF and OCCL. In 
general, a higher percentage of cancer cells were positive for XCRI than NOK but 
exposure to lymphotactin facilitated in vitro signal transduction, migration, invasion and 
proliferation in both. The cancer cells however showed a greater quantitative response 
than NOK in all experiments. Differences between the responses of normal and cancer 
cells to lymphotactin were also observed. XCR1 mediated an increase in adhesion of both 
NOK and OCCL to fibronectin after stimulation with lymphotactin but for collagen, 
exposure to lymphotactin only increased adhesion of OCCL and not of NOK. The 
mechanisms underlying this increase is not clear but it is possible that lymphotactin may 
affect the expression or avidity of integrins involved in binding to fibronectin (a5ß1, 
avß6) and type I collagen (alß1, a2ß1). The difference in the response between NOK 
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and OCCL in adhesion to collagen may reflect differences in all, a2ß1 expression 
between the cells. Further work is required to investigate this in detail. 
A difference in MMP production between normal and cancer cells was also noticed. 
XCRI/lymphotactin facilitated a small increase in MMP-2 and MMP-9 from NOK and 
OCCL. However, an increase in MMP-7 in response to lymphotactin was only seen in 
cancer cells and not in NOK. As observed with signaling, proliferation, migration and 
invasion the increase in adhesion and MMP-2 and MMP-9 was greater in OCCL than 
NOK. 
Differences between normal and cancerous oral mucosa were also seen in vivo. XCR1 
expression was seen in normal oral mucosa (NOM) but appeared much stronger in 
OSCC. Expression was not only seen on epithelial cells but also on infiltrating 
lymphocytes, fibroblasts and endothelial cells. In contrast no staining for lymphotactin 
was observed in normal mucosa (epithelium or IEL) but abundant lymphotactin 
expression was seen in OSCC on epithelial cells, infiltrating lymphocytes, IEL, 
fibroblasts and endothelial cells. In addition, strong XCR1 and lymphotactin expression 
was observed in regional lymph nodes. The invading tumour cells as well as the 
metastases in regional lymph nodes also exhibited strong expression of both XCR1 and 
lymphotactin. However, both NOK and OCCL constitutively expressed intracellular 
lymphotactin in vitro but failed to release it in culture. XCRI and lymphotactin also 
appeared to be upregulated in vivo in dysplasia, lichen planus and non-specific ulceration 
suggesting that upregulation of XCR1 and lymphotactin expression is not restricted to 
OSCC but is also increased in inflammatory conditions. 
All these findings suggest a role for XCRI and lymphotactin in regulation of normal as 
well as cancer cells. Epithelial cells in NOM in vivo express XCRI but do not stain for 
lymphotactin which raises a question about the function of XCRI and the source of 
lymphotactin in healthy mucosa. Previously, IEL in murine epidermis have been shown 
to produce lymphotactin in vivo (Boismenu et al., 1996) but we did not observe 
lymphotactin expression on IEL in NOM. However, only three cases of NOM were 
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studied and it is possible that the protocol or conditions of our immunocytochemical 
staining were not perfectly optimised. This may also be the explanation as to why 
lymphotactin was not found in the epithelial cells when it was present intracellularly in 
NOK in vitro. 
Abundant lymphotactin and XCR1 expression was seen on epithelial cells in lichen 
planus and non-specific ulceration as well as on infiltrating lymphocytes which indicates 
that some sort of trigger is required to stimulate the production of lymphotactin. It is 
possible that the inflammatory infiltrate acts as a trigger by producing inflammatory 
mediators but it is also possible that the increase in lymphotactin production attracts the 
inflammatory infiltrate. Alternatively a combination of these may be operative. More 
work is required in vivo to study the relationship between the infiltrate and increased 
expression of lymphotactin and XCR1. 
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Figure 9.1. Suggested XCR1/lymphotactin expression in normal oral mucosa in vivo. XCR1 is 
expressed by normal oral epithelial cells as well as some of the infiltrating lymphocytes. 
Expression of XCR1 by epithelial cells may enable them to interact with the lymphotactin which 
may be produced by IEL thus influencing the behaviour of epithelial cells. 
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Since expression of XCR1 and lymphotactin has not been shown by epithelial cells 
before, nothing is known about the regulation of their expression. In addition to a 
possible role for inflammatory mediators, it possible is that lymphotactin itself may 
regulate expression of XCR1. However at this stage we do not know which mediator 
influences XCR1 or lymphotactin expression. Our in vitro studies were unable to show a 
role for PMA, TNF-a LPS in the release of lymphotactin from keratinocytes in culture. 
Recent reports have shown lymphotactin production from lymphocytes after stimulation 
with bacterial pathogens such as Staphylococcus äureus (Tikhonov et al., 2001) and 
Porphyromonas gingivalis (Zhou et al., 2005). Our preliminary results indicate that 
exposure of oral keratinocytes to S. aureus or P. gingivalis stimulates lymphotactin 
production from these cells (results not shown). However, more work needs to be done to 
establish the regulation of lymphotactin expression by epithelial cells. 
The significance of the increased XCR1 and lymphotactin expression by epithelial cells 
and lymphocytes in lichen planus and non-specific ulceration is not clear. However 
expression in non-specific ulceration raises the possibility XCR1 and lymphotactin may 
play a role in wound healing by increasing proliferation and migration across the ulcer 
surface. These processes may be helped in part by the increases in MMP production and 
adhesion to fibronectin observed in this study. Another possible function of lymphotactin 
may be attraction of neutrophils and other inflammatory cells once the ulceration has 
occurred. In oral lichen planus destruction of the basal cells is associated a dense 
lymphocyte dominated infiltrate in the lamina propria. Lymphotactin may play a role in 
attracting this infiltrate but also may promote healing by stimulating proliferation. 
Expression of XCRI and lymphotactin is also detected in dysplasia and OSCC and 
appears to be upregulated compared with NOM. This difference in XCR1 and 
lymphotactin expression between NOM and OSCC suggests a potential role for XCRI 
and lymphotactin interaction in the biology of OSCC. These findings provided an insight 
into the source of lymphotactin within the oral mucosa as expression was seen in IEL, 
infiltrating lymphocytes and in epithelial cells suggesting that there are a number of 
potential sources for lymphotactin within the oral mucosa in OSCC. The in vivo 
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expression of lymphotactin in abundance by lymphocytes and epithelial cells suggests 
that Ikmphotactin may facilitate tumour cell migration and invasion through increased 
adhesion and MMP production in addition to acting as strong proliferative influence. 
Thus lymphotactin may increase the aggressive behaviour of the tumour. However it is 
also possible that lymphotactin production by the epithelial cells and the tumour 
facilitates chemotaxis of cytotoxic T lymphocytes (with upregulated XCR 1) which may 
act on the tumour and cause a reduction in its size and effects. "These opposing potential 
effects combined with the possibility that the stimulated lymphocytic infiltrate releases 
other cy tokines or growth factors which may play a role in lymphotactin or epithelial cell 
regulation . 
indicates the complexity of the scenario. Further work needs to be done to 
understand the precise role and regulation of XCRI and lymphotactin in OSCC. 
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Figure 9.2. XCR1/lymphotactin expression in inflammation and OSCC in vivo showing possible 
sources of lymphotactin. In conditions like inflammation or cancer, Strong XCR1 expression is 
seen on the epithelial cells as well as the infiltrating lymphocytes. In addition, strong lymphotactin 
expression is also observed in these conditions and it appears to be produced by IEL, infiltrating 
lymphocytes and the epithelial cells thus providing multiple sources of lymphotactin within the oral 
epithelium. 
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As mentioned earlier the invading tumour cells as well as the metastatic deposits in the 
regional nodes exhibit strong XCRI and lymphotactin expression and lymphotactin is 
produced in abundance in cervical lymph nodes. This may provide a gradient to tumour 
cells (with upregulated XCRI expression) in the lymphatics allowing them to metastasise 
via increased adhesion, MMP production and invasion. The chemokinc receptor CXCR4 
and its ligand have been implicated in the metastasis of OSCC as increased CXCR4 
expression is associated with increased tumour cell migration, invasion and metastasis 
(Almofti et al., 2004; Ishikawa et al., 2006; Muller et a/., 2006). Recent reports have 
shown autocrine chemokine/receptor signaling plays a more important role in distant 
OSCC metastases than paracrine signaling. Tumour cells capable of autocrine signaling 
(i. e. expressing CXCR4 as well as its ligand SDF-la) show increased frequency and foci 
of metastasis in the regional lymph nodes compared with cells expressing only the 
receptor CXCR4 (thus having only paracrine activation). In addition, the cells co- 
expressing CXCR4/SDF-la exhibit distant metastases to the lung whereas no distant 
metastases are seen with cells expressing CXCR4 on its own (Uchida et a!., 2007). Our 
results showed co-expression of XCRI and lymphotactin in cancer cells in vitro and in 
vivo and strong expression of both the receptor and the ligand was also seen on the 
invading tumour cells and metastases in regional lymph nodes. Therefore, it is possible 
that XCRI/lymphotactin interaction may act in a similar manner to CXCR4/SDF-la in 
OSCC metastasis. 
9.1.2.1 CONCLUSIONS (XCR1) 
Our results show widespread expression of XCR I in normal and cancerous oral epithelial 
cells in Wow and in vivo and expression appears to be upregulated on cancer cells. 
Lymphotactin (the ligand for XCR 1) is also expressed constitutively in vitro by NOK and 
OCCL however in vivo expression is only evident in inflammatory conditions and cancer. 
Findings from normal epithelial cells suggest that XCRI may play a role in modulating 
the behaviour of these cells and therefore may have a role in physiological cell turnover 
as suggested by proliferation of NOK in response to lymphotactin. XCRI may also 
mediate migration and invasion of normal epithelial cells in wound healing. Production of 
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lymphotactin from oral epithelial cells may facilitate chemotaxis of lymphocytes and 
neutrophils which may exert anti-inflammatory or pro-inflammatory effects. Up- 
regulation of XCR1 and lymphotactin on epithelial cells and lymphocytes in OSCC 
suggests a potential role in the pathogenesis of OSCC. Invading tumour cells and 
metastatic tumour deposits show strong expression of both XCR1 and lymphotactin and 
regional lymph nodes express lymphotactin and XCRI in abundance which may provide 
a gradient for tumour cell invasion and metastasis. Together these findings suggest a 
potential role for XCR1/lymphotactin interaction in the pathogenesis of OSCC. 
XCR1 and lymphotactin are widely expressed in the oral tissues in vivo and increases in 
both are seen in non-specific ulceration, oral lichen planus and oral malignancy. Both are 
also expressed by normal and malignant epithelial cells in vitro and lymphotactin 
mediates proliferation, migration, and invasion as well as increasing MMP production 
and cell adhesion. These findings raise the possibility that XCR1 and lymphotactin may 
play an important role in normal mucosa, inflammatory disease and oral cancer. 
9.2 FUTURE WORK 
Our findings have raised a number of questions that need to be addressed in detail to find 
out the precise role, regulation and mechanism of action of XCR1 and lymphotactin in 
the pathogenesis of OSCC. 
1. Since XCRI appears to be upregulated in OSCC compared with NOM, it would be 
interesting to study the reason for this increase in XCRI expression and the regulation of 
its expression. It is possible that XCRI expression is correlated to the cell cycle and could 
be studied using propidium idodide staining and flow cytometry. We could also study the 
effect of hypoxia on XCRI expression as tumours have diminished oxygen supply and 
therefore the cells may be hypoxic. CXCR4 has been shown to be highly upregulated in 
response to hypoxia. We could also study whether lymphotactin has any role in the 
regulation of XCRI expression. 
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2. Similarly it would be important to establish the regulation of lymphotactin expression 
and what triggers its production. A wide range of inflammatory mediators could be 
studied in that regard. As already mentioned, our preliminary results showed 
lymphotactin production from oral keratinocytes after exposure to S. aureus or P. 
gingivalis and this association between lymphotactin production and bacterial pathogens 
should be studied further. 
3. The mechanism of XCRI activation and signalling should also be studied. Since we 
have already studied the ERKI/2 pathway, we could analyse calcium mobilisation and 
actin polymerisation in oral epithelial cells in response to lymphotactin. Other signalling 
pathways such as FAK may also be studied in addition to the correlation between 
expression of XCR1 and other adhesion molecules (such as integrins). 
4. Our understanding of the role of XCRI and lymphotactin in oral epithelial cell 
migration and invasion could be improved by performing these assays using organotypic 
cultures or reconstructed oral mucosa models. 
5. Similarly, knocking the XCRI gene down in cancer cells using Si-RNA and repeating 
the functional assays (signaling, migration, invasion, proliferation, adhesion and MMP 
production) would lead to a better understanding of the role of XCRI in cancer cell 
regulation. It would also be interesting to find out if knocking down the lymphotactin 
gene would have any effects on the functionality and expression of XCRI. 
6. Since only the role of XCRI/lymphotactin interaction in adhesion of oral epithelial 
cells to fibronectin and type I collagen was studied it would be interesting to investigate 
adhesion to other ECM components such as laminin, tenascin and other types of collagen. 
7. The association between XCRI/lymphotactin expression and OSCC pathogenesis 
should also be studied. This can be achieved by an in depth study of in vivo expression of 
XCRI and lymphotactin and using more tissue samples, different grades and stages of 
OSCC and correlating it with clinicopathologic parameters such as lymph node 
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metastasis and patient survival. This could be backed up by in vivo studies on mice by 
studying whether increased XCR1 expression is related to increased tumourigenesis and 
whether knocking out XCR1 or lymphotactin genes makes any difference. 
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10.1 MEDIA FOR CELLS 
10.1.1 Keratinocyte Growth Medium (KGM) 
The following reagents were used to make up 400 ml of KGM. 
  Dulbecco's modified eagle medium (DMEM) with sodium pyruvate and 1000 mg/ml 
glucose (Invitrogen): 270 ml. 
  HAM F12 Nutrient mixture (Invitrogen): 90 ml. 
  10 % Foetal bovine serum (FBS), not heat activated (Invitrogen) : 40 ml. 
  Epidermal growth factor (Sigma): 400µl (10 ng/ml) 
  Hydrocortisone (Sigma): 4m1(400ng/ml) 
" Transferrin (Sigma): 5gg/m1. 
  Insulin (Sigma): 200µl (5µg/ml). 
  Cholera Toxin (Sigma): 60Oµ1(1 x 10"1°M) 
  Penicillin/Streptomycin (Invitrogen): 4 ml (2.5 gg/ml) 
  Fungizone (Invitrogen): 4 ml (2.5 gg/m1) 
" Adenine (Sigma): 5ml (1.8 x 104M). 
10.1.2 Medium for HGF, TR146 and A375P cells 
All utilize the same medium containing: 
" DMEM (Invitrogen): 500m1 
  Penicillin/Streptomycin (Invitrogen): 5m1 (50µg/ml) 
  Fungizone (Invitrogen): 5m1 (2.5 µg/ml) 
  10 % FBS (Invitrogen): 50m1 
10.1.3 Medium for SCC4 and SCC25 
500m1 of medium contained: 
  DMEM: F12 (1: 1 mix) with 15mM Hepes and L-Glutamine, (Invitrogen): 500m1 
" Penicillin/Streptomycin (Invitrogen): 5m1(50µg/ml) 
  Fungizone (Invitrogen): 5ml (2.5 gg/ml) 
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  Hydrocortisone: 4ml (400ng/ml). 
  10% FBS (Invitrogen): 50m1 
10.1.4 Medium for CAL27 and FaDu cell lines 
500m1 of medium contained: 
  RPMI-1640 with 25mM Hepes and L-Glutamine (Invitrogen): 500m1 
  Penicillin/Streptomycin (Invitrogen): 5ml (50pg/ml) 
  Fungizone (Invitrogen): 5m1 (2.5µg/ml) 
  10 % FBS (Invitrogen): 50m1 
10.1.5 Serum-free Media 
Serum-free media for all cells (where required) were prepared using their respective 
medium (i. e. DMEM, RPMI or DMEM: F12) with penicillin and streptomycin but 
without FBS. 
10.2 RNA ISOLATION, EXTRACTION AND ANALYSIS 
10.2.1 Materials used for RNA isolation 
  Chloroform (Sigma) 
  RNase-free 0.1% DEPC water (Diethylpyrocarbonate) (Sigma) 
  Isopropanol (Fluka Biochemika) 
  Ethanol (Sigma) 
  Heraeus Megafuge capable of > 10,000 xg 
  RNase-free centrifuge tubes (2 ml) with secure closures 
10.2.2 Materials used for RNA analysis 
  Spectrophotometer (BioRad) 
  Reagents and apparatus for preparation and electrophoresis of agarose gels. 
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10.2.3 Analysis of isolated RNA 
10.2.3.1 Spectrophotometric analysis 
I he ti)Ilovv ing \ alucs ere obtained for some of'the isolated RNA samples. 
Serial No. Sample Type [RNA] ig/NI 
1. NOK 1.425 Ng/NI 
2. HGF 0.864 ug/NI 
3. NSK 1.327 Ng/NI 
4. TR146 0.628 Ng/NI 
5. H357 1.236 Ng/NI 
6. SCC4 1.924 Ng/NI 
7. SCC25 2.469 Ng/NI 
8. CAL27 1.576 pg/NI 
9. FaDu 1.628 pg/NI 
10. A375P 2.106 ug/NI 
Table 7.1. Spectophotometric analysis of RNA samples (Representative values). 
10.2.3.2 Gel electrophoresis 
An example of the results of the gel electrophoresis of the isolated RNA samples is 
Figure 10.1. Sample result of RNA gel electrophoresis before DNase treatment. The 18S and 
The Chemokine Receptors XCR1, CXCRI and CVCR2 Regulate Oral Epithelial Cell Behaviour 
241 
Chapter 10- Appendix 
28S bands can be clearly observed in most of the samples. DNA contamination can be observed 
in some samples. 
10.3 FLOW CYTOMETRY 
10.3.1 Neutrophil Isolation 
Human venous blood from healthy volunteers was obtained after informed consent 
(Division of Genomic Medicine, Royal Hallamshire Hospital, University of Sheffield) 
and was anti-coagulated with 0.1 ml of 3.8%w/v sodium citrate solution per ml of blood. 
Blood was centrifuged at 400 xg for 20min and the upper serum layer removed. The 
remaining blood cells were diluted 50: 50 with HBSS without Ca" or Mgt (Cambrex, 
East Rutherford, NJ, USA) overlaid onto lymphocyte separation medium (PAA, 
Pasching, Austria), and centrifuged at 400 xg for 40min. The mononuclear layer 
containing monocytes and lymphocytes was removed and washed once in HBSS. The 
polymorphonuclear leukocyte (PMNL)/erythrocyte layer containing the neutrophils was 
collected and PMNL isolated by hypertonic lysis. Erythrocytes were lysed by adding 
sterile water to the PMNL/erythrocyte phase for 30sec followed by an equal volume of 
1.8% NaCl to bring the suspension to an isotonic state. Cells were centrifuged at 400 xg 
for 10min and the process repeated 3-4 times until all erythocytes had been lysed. Finally, 
PMNLs were washed in HBSS with 0.1% BSA and re-suspended to the required cell 
density. 
10.4 IMMUNOHISTOCHEMISTRY 
10.4.1 Polymorphonuclear cell clotting in fibrin 
PMNL were isolated as described previously and supernatant was removed. 2OORI FBS 
(Invitrogen) was added and the pellet resuspended. This was followed by the addition of 
200µI of fibrinogen (Sigma), mixed thoroughly and left at RT for 2-3min to allow clot 
formation. Once the clot was formed, it was transferred into a processing cassette and 
fixed with 70% ethanol (Sigma) until processed. 
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10.5 GEL EXTRACTION AND DNA SEQUENCING 
10.5.1 Gel Extraction 
Gel extractions were carried out using a gel extraction kit (Qiagen, Crawley, UK). The 
DNA fragment was excised from the agarose gel using a sharp scalpel and weighed in a 
colourless tube. 3 volumes of buffer QG (provided with kit) were added to I volume of 
gel and incubated at 50°C for 10min (or until the gel had dissolved). To ensure gel 
dissolution, the tube was vortexed every 2-3min. The colour of the mixture turns yellow 
once the gel gets dissolved. 1 volume of isopropanol (Sigma) was added to the sample 
and mixed. The sample was then transferred to a QlAquick column in a 2ml collection 
tube (provided with kit) and centrifuged for 1min. The flow-through was discarded and 
the QlAcolumn was placed back in the same collection tube. 0.5m1 of buffer QG was 
added to the QlAquick column and centrifuged for Imin to remove any remaining 
agarose. The column was then washed with 0.75ml of buffer PE (provided with kit) by 
centrifuging it for 1min. The flow-through was removed and the QlAquick column was 
centrifuged for an additional Imin at 17,900 xg (13000 rpm). The column was 
transferred to a clean 1.5m1 microcentrifuge tube. 50µl of sterile water (Qiagen) was 
added to the center of the QlAquick membrane and centrifuged for Imin to elute the 
DNA. 
10.5.2 Growth of bacterial culture 
Top 10 E. coli cells (Promega, UK) were used for transformation. This strain carries the 
ampicillin gene; therefore bacterial growth was carried out in the presence of ampicillin 
(50mg/ml). 
10.5.3 Transformation 
For transformation, l00µ1 of cells per transformation were thawed on ice. 5µl of eluted 
DNA was added to each 1001il aliquot, mixed and incubated on ice for 30min. Cells were 
heat shocked by placing tubes in a water bath at 42°C for 30sec followed by chilling on 
ice for 2min. 900µl SOC medium (Invitrogen) was added to the cells and incubated at 
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37°C on a shaker for lhr. Cells were plated out on LB agar plates containing ampicillin 
(50mg/ml) and incubated at 37°C overnight. 
The next day, single colonies were picked from the agar plates with a pipette tip and 
transferred to a tube containing 2m1 LB broth and ampicillin and incubated on a shaker at 
37°C overnight. After 24hrs pipette tips were removed from the tubes. Medium was 
centrifuged at 2500-3000rpm for 10min after which a mini-prep kit (Qiagen) was used to 
isolate DNA using 1.5m1 of sample. 
10.5.4 Mini Prep 
Bacterial pellet was resuspended in 250µ1 in buffer P1 (provided with kit) and transferred 
to a micro-centrifuge tube. This was followed by the addition of 200µl of buffer P2 
(provided with kit) and thoroughly mixing was carried out by inverting the tube. 350µl of 
buffer N3 (provided with kit) added, mixed immediately by inverting the tube and 
centrifuged for 10min at 13000 rpm. Supernatant was added to a QlAprep spin column 
(Qiagen) and centrifuged for 30-60sec. The flow-through was drained and the spin 
column was washed by a 30-60sec centrifugation with 0.75ml buffer PE (provided with 
kit). The flow-through was removed and the spin column was centrifuged again to 
remove residual wash buffer. The QlAprep column was then moved to a clean 1.5m1 
micro-centrifuge tube. DNA elution was achieved by adding 50µl of water to the centre 
of the spin column, allowed to stand for Imin and then centrifuged for 1min. The eluted 
DNA was collected, its concentration using a spectrophotometer and stored in the freezer. 
10.5.5 Restriction digests 
8 RI of DNA was digested with O. 5µ1 HindIIl (Promega) and 0.5µl NotI (Promega) 
enzymes (mixed with 1µl buffer) and incubated at 3 7°C for 4hr. The samples were run on 
a 1% agarose gel (Figure 10.2). 
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10.5.6 Gel 
The samples were loaded on the gel and run at 100 volts for 20-30min. The gel showed 
hands at 7000bp (representing plasmid/vector) and around 300bp (representing 
Ivmphotactin). The gel photograph was taken by Gene Snap software (Syngene). 
lllý- 
AaI 
____ ** 
Figure 7.2. Gel electrophoresis showing plasmid/vector and lymphotactin insert. 
The samples were sent for sequencing to the Genetic Core Facility, Division of Genomic 
Medicine, University of Sheffield, UK. Sequences were visualized using the finch'I'V 
software (Geospiza Incorporated, Seattle, WA, USA) and confirmed using BLAST 
(http: //www. ncbi. ntnl. nih. gov/blast) {Altschul, 1990 69 /id; (Figure 10.3). 
Pie C'hemokine Receptors XCR1, C'. \'C'R1 and CXCR2 Regulate Oral Epithelial Cell Behaviour 245 
Charter / 0- .I ppppcndrx 
_-o 
- U[J 
- (7 
nr 
ýw (7 
ar Q 
sQ 
ýr Q 
Q 
U 
V 
ý^ S 
rQ 
ý C7 0 
C9 
-N 
-Üm 
ý. Q 
.o0 
-0 
-o 
_.. , Ü 
ýd 
-r U 
oU 
ýY 
^a. 
U' 
- ýU 
ý+U 
U 
rU 
aq 
ýw y 
YU': 
7d 
- C9 
.U 
vU 
""'U rv 
U 
.. U 
U 
rU 
U 
Uo 
Z 
Z 
Z 
2 
2 
li 
q ýz 
0 -'0 C 
U 
' d 
NoL 
[ 
-o r 
~ý 
U 
U 
q 
CwC 
_ 
c 
U 
o w _ o 
-'q S 
r- 
_ 
7 
.U ...., 0 < 
.... 
Ü < 0 
o 
Wý 
u0 °- U 
ý t0 
. (7 
4N 
a. + C7 m 
_. Ur 
0Q 
.(J 
^- C7 
-U 
"Cý 
i' 
>... C 
C) 
YVJ 
U 
U 
U 
q. ý 
C7 
O 
°^ U 
-. -.. 
O 
-Un 
U 
-ý U 
v- U 
.. » r 
U uý 
:y am w. V 
m. 4 ý1 
.,.. n. f 
U 
.. a Q 
o 
- C7 
.. Q 
Uo 
"U 
C) 
"Z 
w .( 
c7 
-U 
"d 
«« U, r 
U, 
W .L 
.. q 
U 
°v 
- "C r. 
U 
.. q 
_. U 
.ýq 
"ý C) N 
.. C7 A 
.. .YO 
-V ýF- 
U' ö 
Vr 
.e 
^'" 
wV 
W ,. ý _ý 
_ý 
-U 
0 
Vo 
^v c7 r 
WV 
«- r 
U 
d 
r 
fU_ 
Figure 10.3. Representative lymphotactin sequence (from gel extraction) as observed with 
FinchTV software. 
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